<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Diethylstilbestrol</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Diethylstilbestrol">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Diethylstilbestrol</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Diethylstilbestrol</b> (<b>DES</b>), also known as <b>stilbestrol</b> or <b>stilboestrol</b>, is a nonsteroidal estrogen medication, which is rarely used.<span class="mw-ref" id="cite_ref-pmid4276416_4-0"><a href="#cite_note-pmid4276416-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-Elks2014_5-0"><a href="#cite_note-Elks2014-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span><span class="mw-ref" id="cite_ref-Kuhl2005_6-0"><a href="#cite_note-Kuhl2005-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> In the past, it was widely used for a variety of indications, including pregnancy support for women with a history of recurrent miscarriage, hormone therapy for menopausal symptoms and estrogen deficiency in women, treatment of prostate cancer in men and breast cancer in women, and other uses.<span class="mw-ref" id="cite_ref-pmid4276416_4-1"><a href="#cite_note-pmid4276416-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Today, it is only used in the treatment of prostate cancer and less commonly breast cancer.<span class="mw-ref" id="cite_ref-Watkins2007_7-0"><a href="#cite_note-Watkins2007-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> While most commonly taken by mouth, DES was available for use by other routes as well, for instance, vaginal, topical, and by injection.</p>



<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Diethylstilbestrol</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Diethylstilbestrol.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Diethylstilbestrol.svg.png" data-file-width="512" data-file-height="225" data-file-type="drawing" height="110" width="250"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Diethylstilbestrol_molecule_ball.png" tppabs="https://ptable.com/wiki/compounds/I/m/Diethylstilbestrol_molecule_ball.png" data-file-width="2560" data-file-height="1556" data-file-type="bitmap" height="152" width="250"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Other names</th><td>DES; Stilboestrol; Stilbestrol; (<i>E</i>)-11,12-Diethyl-4,13-stilbenediol</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/cons/diethylstilbestrol.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/cons/diethylstilbestrol.html'" tppabs="https://www.drugs.com/cons/diethylstilbestrol.html" class="external text external">Micromedex Detailed Consumer Information</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">

<ul><li>X</li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>By mouth, vaginal, topical, intravenous, intramuscular injection (as an ester)</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Drug class</th><td>Nonsteroidal estrogen</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>G03CB02<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=G03CB02  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=G03CB02'" tppabs="https://www.whocc.no/atc_ddd_index/?code=G03CB02" class="external text external">WHO</a></span>)<span> </span>G03CC05<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=G03CC05  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=G03CC05'" tppabs="https://www.whocc.no/atc_ddd_index/?code=G03CC05" class="external text external">WHO</a></span>), L02AA01<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=L02AA01  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=L02AA01'" tppabs="https://www.whocc.no/atc_ddd_index/?code=L02AA01" class="external text external">WHO</a></span>)</li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>Well-absorbed<span class="mw-ref" id="cite_ref-ChabnerLongo1996_1-0"><a href="#cite_note-ChabnerLongo1996-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>&gt;95%<span class="mw-ref" id="cite_ref-OelschlägerRothley1988_2-0"><a href="#cite_note-OelschlägerRothley1988-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Hydroxylation, oxidation, glucuronidation<span class="mw-ref" id="cite_ref-ChabnerLongo1996_1-1"><a href="#cite_note-ChabnerLongo1996-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-OelschlägerRothley1988_2-1"><a href="#cite_note-OelschlägerRothley1988-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-pmid8428334_3-0"><a href="#cite_note-pmid8428334-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolites</th><td>• <a href="Dienestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Dienestrol" title="Dienestrol">(<i>Z</i>,<i>Z</i>)-Dienestrol</a><span class="mw-ref" id="cite_ref-ChabnerLongo1996_1-2"><a href="#cite_note-ChabnerLongo1996-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><br>• Paroxypropione<span class="mw-ref" id="cite_ref-ChabnerLongo1996_1-3"><a href="#cite_note-ChabnerLongo1996-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><br>• Glucuronides<span class="mw-ref" id="cite_ref-OelschlägerRothley1988_2-2"><a href="#cite_note-OelschlägerRothley1988-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-pmid8428334_3-1"><a href="#cite_note-pmid8428334-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>24 hours<span class="mw-ref" id="cite_ref-ChabnerLongo1996_1-4"><a href="#cite_note-ChabnerLongo1996-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Urine, feces<span class="mw-ref" id="cite_ref-OelschlägerRothley1988_2-3"><a href="#cite_note-OelschlägerRothley1988-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-pmid8428334_3-2"><a href="#cite_note-pmid8428334-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">4-[(<i>E</i>)-4-(4-hydroxyphenyl)hex-3-en-3-yl]phenol</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=56-53-1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=56-53-1'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=56-53-1" class="external text external">56-53-1</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/448537  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/448537'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/448537" class="external text external">448537</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2801  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2801'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2801" class="external text external">2801</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB00255  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB00255'" tppabs="https://www.drugbank.ca/drugs/DB00255" class="external text external">DB00255</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.395306.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.395306.html'" tppabs="http://www.chemspider.com/Chemical-Structure.395306.html" class="external text external">395306</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=731DCA35BT  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=731DCA35BT'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=731DCA35BT" class="external text external">731DCA35BT</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D00577  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D00577'" tppabs="https://www.kegg.jp/entry/D00577" class="external text external">D00577</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:41922  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:41922'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:41922" class="external text external">CHEBI:41922</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL411  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL411'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL411" class="external text external">ChEMBL411</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID3020465  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID3020465'" tppabs="https://comptox.epa.gov/dashboard/DTXSID3020465" class="external text external">DTXSID3020465</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.000.253  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.000.253'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.000.253" class="external text external">100.000.253</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>18</sub><span>H</span><sub>20</sub><span>O</span><sub>2</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">268.356</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=Oc2ccc%28%2FC%28%3DC%28%2Fc1ccc%28O%29cc1%29CC%29CC%29cc2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=Oc2ccc%28%2FC%28%3DC%28%2Fc1ccc%28O%29cc1%29CC%29CC%29cc2'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=Oc2ccc%28%2FC%28%3DC%28%2Fc1ccc%28O%29cc1%29CC%29CC%29cc2" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Oc2ccc(/C(=C(/c1ccc(O)cc1)CC)CC)cc2</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C18H20O2/c1-3-17(13-5-9-15(19)10-6-13)18(4-2)14-7-11-16(20)12-8-14/h5-12,19-20H,3-4H2,1-2H3/b18-17+<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:RGLYKWWBQGJZGM-ISLYRVAYSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=464188812&page2=Diethylstilbestrol  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=464188812&page2=Diethylstilbestrol'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=464188812&page2=Diethylstilbestrol" class="external text external">(verify)</a></span></span></td></tr></tbody></table>

<p>DES is an estrogen, or an agonist of the estrogen receptors, the biological target of estrogens like <a href="Estradiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Estradiol" title="Estradiol">estradiol</a>.<span class="mw-ref" id="cite_ref-Kuhl2005_6-1"><a href="#cite_note-Kuhl2005-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> It is a synthetic and nonsteroidal estrogen of the stilbestrol group, and differs from the natural estrogen estradiol in various ways.<span class="mw-ref" id="cite_ref-Kuhl2005_6-2"><a href="#cite_note-Kuhl2005-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> Compared to estradiol, DES has greatly improved bioavailability when taken by mouth, is more resistant to metabolism, and shows relatively increased effects in certain parts of the body like the liver and uterus.<span class="mw-ref" id="cite_ref-Kuhl2005_6-3"><a href="#cite_note-Kuhl2005-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> These differences result in DES having an increased risk of blood clots, cardiovascular issues, and certain other adverse effects.<span class="mw-ref" id="cite_ref-Kuhl2005_6-4"><a href="#cite_note-Kuhl2005-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>


<p>DES was discovered in 1938 and introduced for medical use in 1939.<span class="mw-ref" id="cite_ref-pmid16096877_8-0"><a href="#cite_note-pmid16096877-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-FeldbergLadd-Taylor2003_9-0"><a href="#cite_note-FeldbergLadd-Taylor2003-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> From about 1940 to 1971, the medication was given to pregnant women in the incorrect belief that it would reduce the risk of pregnancy complications and losses.<span class="mw-ref" id="cite_ref-pmid16096877_8-1"><a href="#cite_note-pmid16096877-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> In 1971, DES was shown to cause clear-cell carcinoma, a rare vaginal tumor, in girls and women who had been exposed to this medication <i>in utero</i>.<span class="mw-ref" id="cite_ref-pmid16096877_8-2"><a href="#cite_note-pmid16096877-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-pmid4276416_4-2"><a href="#cite_note-pmid4276416-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> The United States Food and Drug Administration subsequently withdrew approval of DES as a treatment for pregnant women.<span class="mw-ref" id="cite_ref-pmid16096877_8-3"><a href="#cite_note-pmid16096877-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-pmid4276416_4-3"><a href="#cite_note-pmid4276416-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Follow-up studies have indicated that DES also has the potential to cause a variety of significant adverse medical complications during the lifetimes of those exposed.<span class="mw-ref" id="cite_ref-pmid16096877_8-4"><a href="#cite_note-pmid16096877-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-urlDES_Update:_For_Consumers._Centers_for_Disease_Control_and_Prevention_10-0"><a href="#cite_note-urlDES_Update:_For_Consumers._Centers_for_Disease_Control_and_Prevention-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></p>

<p>The United States National Cancer Institute recommends<span class="mw-ref" id="cite_ref-11"><a href="#cite_note-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> women born to mothers who took DES to undergo special medical exams on a regular basis to screen for complications as a result of the medication. Individuals who were exposed to DES during their mothers' pregnancies are commonly referred to as "DES daughters" and "DES sons".<span class="mw-ref" id="cite_ref-pmid16096877_8-5"><a href="#cite_note-pmid16096877-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-Broadly-DES-Daughters-2017_12-0"><a href="#cite_note-Broadly-DES-Daughters-2017-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> Since the discovery of the toxic effects of DES, it has largely been discontinued and is now mostly no longer marketed.<span class="mw-ref" id="cite_ref-pmid16096877_8-6"><a href="#cite_note-pmid16096877-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-pmid15063479_13-0"><a href="#cite_note-pmid15063479-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></p>

<style data-mw-deduplicate="TemplateStyles:r886046785">.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}</style><div class="toclimit-3"><meta property="mw:PageProp/toc"></div>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    


<p>DES has been used in the past for the following indications:<span class="mw-ref" id="cite_ref-pmid4276416_4-4"><a href="#cite_note-pmid4276416-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>

<ul><li>Recurrent miscarriage in pregnancy</li>
<li>Menopausal hormone therapy for the treatment of menopausal symptoms such as hot flashes and vaginal atrophy</li>
<li>Hormone therapy for hypoestrogenism (e.g., gonadal dysgenesis, premature ovarian failure, and after oophorectomy)</li>
<li>Postpartum lactation suppression to prevent or reverse breast engorgement<span class="mw-ref" id="cite_ref-Vorherr2012_14-0"><a href="#cite_note-Vorherr2012-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span></li>
<li>Gonorrheal vaginitis (discontinued following the introduction of the antibiotic penicillin)</li>
<li>Prostate cancer and breast cancer</li>
<li>Prevention of tall stature in tall adolescent girls</li>
<li>Treatment of acne in girls and women</li>
<li>As an emergency postcoital contraceptive</li>
<li>As a means of chemical castration for hypersexuality and paraphilias in men and sex offenders</li>
<li>Prevention of the <a href="Testosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Testosterone" title="Testosterone">testosterone</a> flare at the start of gonadotropin-releasing hormone agonist (GnRH agonist) therapy<span class="mw-ref" id="cite_ref-pmid16986003_15-0"><a href="#cite_note-pmid16986003-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span><span class="mw-ref" id="cite_ref-pmid8481213_16-0"><a href="#cite_note-pmid8481213-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span><span class="mw-ref" id="cite_ref-pmid2973364_17-0"><a href="#cite_note-pmid2973364-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span><span class="mw-ref" id="cite_ref-pmid3920802_18-0"><a href="#cite_note-pmid3920802-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span><span class="mw-ref" id="cite_ref-pmid2969641_19-0"><a href="#cite_note-pmid2969641-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span><span class="mw-ref" id="cite_ref-pmid7688656_20-0"><a href="#cite_note-pmid7688656-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span><span class="mw-ref" id="cite_ref-pmid10678560_21-0"><a href="#cite_note-pmid10678560-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span></li>
<li>Feminizing hormone therapy for transgender women<span class="mw-ref" id="cite_ref-Hamburger1969_22-0"><a href="#cite_note-Hamburger1969-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span><span class="mw-ref" id="cite_ref-pmid794803_23-0"><a href="#cite_note-pmid794803-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span></li></ul>

<p>DES was used at a dosage of 0.2 to 0.5<span>&nbsp;</span>mg/day in menopausal hormone therapy.<span class="mw-ref" id="cite_ref-Buchsbaum2012_24-0"><a href="#cite_note-Buchsbaum2012-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span><span class="mw-ref" id="cite_ref-pmid4276416_4-5"><a href="#cite_note-pmid4276416-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>

<p>Interest in the use of DES to treat prostate cancer in men continues today.<span class="mw-ref" id="cite_ref-pmid29600433_25-0"><a href="#cite_note-pmid29600433-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span><span class="mw-ref" id="cite_ref-pmid24256023_26-0"><a href="#cite_note-pmid24256023-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span><span class="mw-ref" id="cite_ref-pmid22578092_27-0"><a href="#cite_note-pmid22578092-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span><span class="mw-ref" id="cite_ref-pmid14532759_28-0"><a href="#cite_note-pmid14532759-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span><span class="mw-ref" id="cite_ref-pmid15046698_29-0"><a href="#cite_note-pmid15046698-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span><span class="mw-ref" id="cite_ref-pmid11502463_30-0"><a href="#cite_note-pmid11502463-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span><span class="mw-ref" id="cite_ref-pmid7500443_31-0"><a href="#cite_note-pmid7500443-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span> However, use of bioidentical parenteral estrogens like polyestradiol phosphate has been advocated in favor of oral synthetic estrogens like DES due to their much lower risk of cardiovascular toxicity.<span class="mw-ref" id="cite_ref-pmid17239273_32-0"><a href="#cite_note-pmid17239273-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span><span class="mw-ref" id="cite_ref-pmid15046698_29-1"><a href="#cite_note-pmid15046698-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span><span class="mw-ref" id="cite_ref-pmid7500443_31-1"><a href="#cite_note-pmid7500443-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span> In addition to prostate cancer, some interest in the use of DES to treat breast cancer in women continues today as well.<span class="mw-ref" id="cite_ref-pmid27889048_33-0"><a href="#cite_note-pmid27889048-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span><span class="mw-ref" id="cite_ref-pmid1627392_34-0"><a href="#cite_note-pmid1627392-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span> However, similarly to the case of prostate cancer, arguments have been made for the use bioidentical estrogens like estradiol instead of DES for breast cancer.<span class="mw-ref" id="cite_ref-pmid27889048_33-1"><a href="#cite_note-pmid27889048-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span><span class="mw-ref" id="cite_ref-EllisDehdahti2014_35-0"><a href="#cite_note-EllisDehdahti2014-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span></p>

<p>Oral DES at 0.25 to 0.5<span>&nbsp;</span>mg/day is effective in the treatment of hot flashes in men undergoing androgen deprivation therapy for prostate cancer.<span class="mw-ref" id="cite_ref-pmid31367069_36-0"><a href="#cite_note-pmid31367069-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span></p>

<span>
</span><table class="wikitable mw-collapsible mw-collapsed" style="text-align:left; margin-left:auto; margin-right:auto; border:none;">
<caption class="nowrap"> Estrogen dosages for breast cancer</caption>
<tbody><tr>
<th>Route/form</th><th>Estrogen</th><th>Dosage</th></tr>
<tr>
<td rowspan="8">Oral</td><td>Estradiol</td><td>10 mg 3x/day<br><i><abbr>AI</abbr>-resistant:</i> 2 mg 1–3x/day</td></tr>
<tr>
<td>Estradiol valerate</td><td><i><abbr>AI</abbr>-resistant:</i> 2 mg 1–3x/day</td></tr>
<tr>
<td>Conjugated estrogens</td><td>10 mg 3x/day</td></tr>
<tr>
<td>Ethinylestradiol</td><td>0.5–1 mg 3x/day</td></tr>
<tr>
<td>Diethylstilbestrol</td><td>5 mg 3x/day</td></tr>
<tr>
<td><a href="Dienestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Dienestrol" title="Dienestrol">Dienestrol</a></td><td>5 mg 3x/day</td></tr>
<tr>
<td>Dimestrol</td><td>30 mg/day</td></tr>
<tr>
<td><a href="Chlorotrianisene.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorotrianisene" title="Chlorotrianisene">Chlorotrianisene</a></td><td>24 mg/day</td></tr>
<tr>
<td rowspan="5"><abbr>IM</abbr> or <abbr>SC</abbr> injection</td><td>Estradiol benzoate</td><td>5 mg 2–3x/week</td></tr>
<tr>
<td>Estradiol dipropionate</td><td>5 mg 2–3x/week</td></tr>
<tr>
<td>Estradiol valerate</td><td>30 mg 1x/2 weeks</td></tr>
<tr>
<td>Polyestradiol phosphate</td><td>40–80 mg 1x/4 weeks</td></tr>
<tr>
<td>Estrone</td><td>5 mg ≥3x/week</td></tr>
<tr class="sortbottom">
<td colspan="4" style="width: 1px; background-color:#eaecf0; text-align: center;"><b>Notes:</b> (1) Only in women who are at least 5<span>&nbsp;</span>years postmenopausal. (2) Dosages are not necessarily equivalent. <b>Sources:</b> See template.</td></tr>
</tbody></table>

<span>
</span><table class="wikitable mw-collapsible mw-collapsed" style="text-align:left; margin-left:auto; margin-right:auto; border:none;">
<caption class="nowrap"> Estrogen dosages for prostate cancer</caption>
<tbody><tr>
<th>Route/form</th><th>Estrogen</th><th>Dosage</th></tr>
<tr>
<td rowspan="11">Oral</td><td>Estradiol</td><td>1–2 mg 3x/day</td></tr>
<tr>
<td>Conjugated estrogens</td><td>1.25–2.5 mg 3x/day</td></tr>
<tr>
<td>Ethinylestradiol</td><td>0.15–3 mg/day</td></tr>
<tr>
<td>Ethinylestradiol sulfonate</td><td>1–2 mg 1x/week</td></tr>
<tr>
<td>Diethylstilbestrol</td><td>1–3 mg/day</td></tr>
<tr>
<td><a href="Dienestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Dienestrol" title="Dienestrol">Dienestrol</a></td><td>5 mg/day</td></tr>
<tr>
<td>Hexestrol</td><td>5 mg/day</td></tr>
<tr>
<td><a href="Fosfestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Fosfestrol" title="Fosfestrol">Fosfestrol</a></td><td>100–480 mg 1–3x/day</td></tr>
<tr>
<td><a href="Chlorotrianisene.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorotrianisene" title="Chlorotrianisene">Chlorotrianisene</a></td><td>12–48 mg/day</td></tr>
<tr>
<td>Quadrosilan</td><td>900 mg/day</td></tr>
<tr>
<td>Estramustine phosphate</td><td>140–1400 mg/day</td></tr>
<tr>
<td>Transdermal patch</td><td>Estradiol</td><td>2–6x 100 μg/day<br><i>Scrotal:</i> 1x 100 μg/day</td></tr>
<tr>
<td rowspan="6"><abbr>IM</abbr> or <abbr>SC</abbr> injection</td><td>Estradiol benzoate</td><td>1.66 mg 3x/week</td></tr>
<tr>
<td>Estradiol dipropionate</td><td>5 mg 1x/week</td></tr>
<tr>
<td>Estradiol valerate</td><td>10–40 mg 1x/1–2 weeks</td></tr>
<tr>
<td>Estradiol undecylate</td><td>100 mg 1x/4 weeks</td></tr>
<tr>
<td>Polyestradiol phosphate</td><td><i>Alone:</i> 160–320 mg 1x/4 weeks<br><i>With oral <abbr>EE</abbr>:</i> 40–80 mg 1x/4 weeks</td></tr>
<tr>
<td>Estrone</td><td>2–4 mg 2–3x/week</td></tr>
<tr>
<td rowspan="2"><abbr>IV</abbr> injection</td><td><a href="Fosfestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Fosfestrol" title="Fosfestrol">Fosfestrol</a></td><td>300–1200 mg 1–7x/week</td></tr>
<tr>
<td>Estramustine phosphate</td><td>240–450 mg/day</td></tr>
<tr class="sortbottom">
<td colspan="4" style="width: 1px; background-color:#eaecf0; text-align: center;"><b>Note:</b> Dosages are not necessarily equivalent. <b>Sources:</b> See template.</td></tr>
</tbody></table>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Side_effects">Side effects</h2></summary>
    
<p>At more than 1<span>&nbsp;</span>mg/day, DES is associated with high rates of side effects including nausea, vomiting, abdominal discomfort, headache, and bloating (incidence of 15–50%).<span class="mw-ref" id="cite_ref-pmid13638626_37-0"><a href="#cite_note-pmid13638626-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Breast_changes_and_feminization">Breast changes and feminization</h3></summary>
    
<p>The pigmentation of the breast areolae are often very dark and almost black with DES therapy.<span class="mw-ref" id="cite_ref-pmid4276416_4-6"><a href="#cite_note-pmid4276416-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-Del_CastilloArgonz1954_38-0"><a href="#cite_note-Del_CastilloArgonz1954-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span><span class="mw-ref" id="cite_ref-Labhart2012_39-0"><a href="#cite_note-Labhart2012-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span><span class="mw-ref" id="cite_ref-DavisBoynton1941_40-0"><a href="#cite_note-DavisBoynton1941-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span><span class="mw-ref" id="cite_ref-DavisBoynton1945_41-0"><a href="#cite_note-DavisBoynton1945-41" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span><span class="mw-ref" id="cite_ref-pmid21433876_42-0"><a href="#cite_note-pmid21433876-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span><span class="mw-ref" id="cite_ref-LisserCurtis1947_43-0"><a href="#cite_note-LisserCurtis1947-43" style="counter-reset: mw-Ref 43;"><span class="mw-reflink-text">[43]</span></a></span><span class="mw-ref" id="cite_ref-Hamblen1943_44-0"><a href="#cite_note-Hamblen1943-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span> The pigmentation that occurs with synthetic estrogens such as DES is much greater than with natural estrogens such as estradiol.<span class="mw-ref" id="cite_ref-pmid4276416_4-7"><a href="#cite_note-pmid4276416-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-Del_CastilloArgonz1954_38-1"><a href="#cite_note-Del_CastilloArgonz1954-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span> The mechanism of the difference is unknown.<span class="mw-ref" id="cite_ref-pmid4276416_4-8"><a href="#cite_note-pmid4276416-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Progestogens like hydroxyprogesterone caproate have been reported to reduce the nipple hyperpigmentation induced by high-dose estrogen therapy.<span class="mw-ref" id="cite_ref-pmid14278040_45-0"><a href="#cite_note-pmid14278040-45" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span></p>

<p>In men treated with it for prostate cancer, DES has been found to produce high rates of gynecomastia (breast development) of 41 to 77%.<span class="mw-ref" id="cite_ref-pmid16321765_46-0"><a href="#cite_note-pmid16321765-46" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Blood_clots_and_cardiovascular_issues">Blood clots and cardiovascular issues</h3></summary>
    
<p>In studies of DES as a form of high-dose estrogen therapy for men with prostate cancer, it has been associated with considerable cardiovascular morbidity and mortality.<span class="mw-ref" id="cite_ref-pmid24256023_26-1"><a href="#cite_note-pmid24256023-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span><span class="mw-ref" id="cite_ref-pmid4276416_4-9"><a href="#cite_note-pmid4276416-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> The risk is dose-dependent.<span class="mw-ref" id="cite_ref-pmid24256023_26-2"><a href="#cite_note-pmid24256023-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span> A dosage of 5<span>&nbsp;</span>mg/day DES has been associated with a 36% increase in non-cancer-related (mostly cardiovascular) deaths.<span class="mw-ref" id="cite_ref-pmid24256023_26-3"><a href="#cite_note-pmid24256023-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span> In addition, there is an up to 15% incidence of venous thromboembolism.<span class="mw-ref" id="cite_ref-pmid24932461_47-0"><a href="#cite_note-pmid24932461-47" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span> A 3<span>&nbsp;</span>mg/day dosage of DES has been associated with an incidence of thromboembolism of 9.6 to 17%, with an incidence of cardiovascular complications of 33.3%.<span class="mw-ref" id="cite_ref-pmid24256023_26-4"><a href="#cite_note-pmid24256023-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span> A lower dosage of 1<span>&nbsp;</span>mg/day DES has been associated with a rate of death due to cardiovascular events of 14.8% (relative to 8.3% for orchiectomy alone).<span class="mw-ref" id="cite_ref-pmid24256023_26-5"><a href="#cite_note-pmid24256023-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Other_long-term_effects">Other long-term effects</h3></summary>
    


<p>DES has been linked to a variety of long-term adverse effects, such as increased risk of vaginal clear-cell adenocarcinoma, vaginal adenosis, T-shaped uterus, uterine fibroids, cervical weakness, breast cancer, infertility, hypogonadism, intersex defects, depression, and others, in women who were treated with it during pregnancy and/or in their offspring.<span class="mw-ref" id="cite_ref-pmid12918007_48-0"><a href="#cite_note-pmid12918007-48" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span></p>

<p>A comprehensive animal study in 1993 found a plethora of adverse effects from DES such as [but not limited to] genotoxicity (due to quinone metabolite), teratogenicity, penile and testicular hypoplasia, cryptorchidism (rats and rhesus monkeys), liver and renal cancer (hamsters), ovarian papillary carcinoma (canines), and malignant uterine mesothelioma (squirrel monkeys).<span class="mw-ref" id="cite_ref-49"><a href="#cite_note-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span> Evidence was also found linking ADHD to F2 generations, demonstrating that there is at least some neurological and transgenerational effects in addition to the carcinogenic.<span class="mw-ref" id="cite_ref-50"><a href="#cite_note-50" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span> Rodent studies reveal female reproductive tract cancers and abnormalities reaching to the F2 generation, and there is evidence of adverse effects such as irregular menstrual cycles in grandchildren of DES mothers.<span class="mw-ref" id="cite_ref-51"><a href="#cite_note-51" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span> Additionally, evidence also points to transgenerational effects in F2 sons like hypospadias.<span class="mw-ref" id="cite_ref-52"><a href="#cite_note-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span> At this time however, the extent of DES transgenerational effects in regards to humans is not fully understood.</p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Overdose">Overdose</h2></summary>
    
<p>DES has been assessed in the past in clinical studies at extremely high doses of as much as 1,500 to 5,000<span>&nbsp;</span>mg/day.<span class="mw-ref" id="cite_ref-pmid27889048_33-2"><a href="#cite_note-pmid27889048-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span><span class="mw-ref" id="cite_ref-pmid576887_53-0"><a href="#cite_note-pmid576887-53" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span><span class="mw-ref" id="cite_ref-pmid13005120_54-0"><a href="#cite_note-pmid13005120-54" style="counter-reset: mw-Ref 54;"><span class="mw-reflink-text">[54]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacology">Pharmacology</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacodynamics">Pharmacodynamics</h3></summary>
    


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Estrogenic_activity">Estrogenic activity</h4></summary>
    
<p>DES is an estrogen; specifically, it is a highly potent full agonist of both of the estrogen receptors (ERs).<span class="mw-ref" id="cite_ref-Jordan2013_55-0"><a href="#cite_note-Jordan2013-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span><span class="mw-ref" id="cite_ref-SeilerAutrup2012_56-0"><a href="#cite_note-SeilerAutrup2012-56" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span> It has approximately 468% and 295% of the affinity of estradiol at the ERα and ERβ, respectively.<span class="mw-ref" id="cite_ref-pmid9048584_57-0"><a href="#cite_note-pmid9048584-57" style="counter-reset: mw-Ref 57;"><span class="mw-reflink-text">[57]</span></a></span> However, EC<sub>50</sub> values of 0.18<span>&nbsp;</span>nM and 0.06<span>&nbsp;</span>nM of DES for the ERα and ERβ, respectively, have been reported, suggesting, in spite of its binding affinity for the two receptors, several-fold preference for activation of the ERβ over the ERα.<span class="mw-ref" id="cite_ref-pmid22294742_58-0"><a href="#cite_note-pmid22294742-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span> In addition to the nuclear ERs, DES is an agonist of the G protein-coupled estrogen receptor (GPER), albeit with relatively low affinity (~1,000<span>&nbsp;</span>nM).<span class="mw-ref" id="cite_ref-pmid26023144_59-0"><a href="#cite_note-pmid26023144-59" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span></p>

<p>A dosage of 1<span>&nbsp;</span>mg/day DES is approximately equivalent to a dosage of 50<span>&nbsp;</span>µg/day ethinylestradiol in terms of systemic estrogenic potency.<span class="mw-ref" id="cite_ref-ChabnerLongo1996_1-5"><a href="#cite_note-ChabnerLongo1996-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> Similarly to ethinylestradiol, DES shows a marked and disproportionately strong effect on liver protein synthesis.<span class="mw-ref" id="cite_ref-Kuhl2005_6-5"><a href="#cite_note-Kuhl2005-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> Whereas its systemic estrogenic potency was about 3.8-fold of that of estropipate (piperazine estrone sulfate), which has similar potency to micronized estradiol, the hepatic estrogenic potency of DES was 28.4-fold that of estropipate (or about 7.5-fold stronger potency for a dosage with equivalent systemic estrogenic effect).<span class="mw-ref" id="cite_ref-ChabnerLongo1996_1-6"><a href="#cite_note-ChabnerLongo1996-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>

<p>DES has at least three mechanisms of action in the treatment of prostate cancer in men.<span class="mw-ref" id="cite_ref-DenisGriffiths1999_60-0"><a href="#cite_note-DenisGriffiths1999-60" style="counter-reset: mw-Ref 60;"><span class="mw-reflink-text">[60]</span></a></span> It suppresses gonadal androgen production and hence circulating androgen levels due to its antigonadotropic effects; it stimulates hepatic sex hormone-binding globulin (SHBG) production, thereby increasing circulating levels of SHBG and decreasing the free fraction of testosterone and <a href="Dihydrotestosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydrotestosterone" title="Dihydrotestosterone">dihydrotestosterone</a> (DHT) in the circulation; and it may have direct cytotoxic effects in the testes and prostate gland.<span class="mw-ref" id="cite_ref-DenisGriffiths1999_60-1"><a href="#cite_note-DenisGriffiths1999-60" style="counter-reset: mw-Ref 60;"><span class="mw-reflink-text">[60]</span></a></span> DES has also been found to decrease DNA synthesis at high doses.<span class="mw-ref" id="cite_ref-DenisGriffiths1999_60-2"><a href="#cite_note-DenisGriffiths1999-60" style="counter-reset: mw-Ref 60;"><span class="mw-reflink-text">[60]</span></a></span></p>

<p>DES is a long-acting estrogen, with a nuclear retention of around 24<span>&nbsp;</span>hours.<span class="mw-ref" id="cite_ref-RunnebaumRabe2013_61-0"><a href="#cite_note-RunnebaumRabe2013-61" style="counter-reset: mw-Ref 61;"><span class="mw-reflink-text">[61]</span></a></span><span class="mw-ref" id="cite_ref-WallachHammond1982_62-0"><a href="#cite_note-WallachHammond1982-62" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span></p>

<span>
</span><table style="margin-left: auto; margin-right: auto; border: none;" class="wikitable sortable mw-collapsible mw-collapsed">
<caption class="nowrap"> Relative oral potencies of estrogens</caption>
<tbody><tr>
<th>Estrogen</th><th>Type</th><th data-sort-type="number"><abbr>HF</abbr></th><th data-sort-type="number"><abbr>VE</abbr></th><th data-sort-type="number"><abbr>UCa</abbr></th><th data-sort-type="number"><abbr>FSH</abbr></th><th data-sort-type="number"><a href="Luteinizing_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Luteinizing_hormone" title="Luteinizing hormone"><abbr>LH</abbr></a></th><th data-sort-type="number"><abbr>HDL</abbr>-<a href="Cholesterol.htm" tppabs="https://ptable.com/wiki/compounds/A/Cholesterol" title="Cholesterol"><abbr>C</abbr></a></th><th data-sort-type="number"><abbr>SHBG</abbr></th><th data-sort-type="number"><abbr>CBG</abbr></th><th data-sort-type="number"><abbr>AGT</abbr></th><th data-sort-type="number"><abbr>Liver</abbr></th></tr>
<tr>
<td>Estradiol</td><td>Bioidentical</td><td>1.0</td><td>1.0</td><td>1.0</td><td>1.0</td><td>1.0</td><td>1.0</td><td>1.0</td><td>1.0</td><td>1.0</td><td>1.0</td></tr>
<tr>
<td>Estrone</td><td>Bioidentical</td><td>?</td><td>?</td><td>?</td><td>0.3</td><td>0.3</td><td>?</td><td>?</td><td>?</td><td>?</td><td>?</td></tr>
<tr>
<td>Estriol</td><td>Bioidentical</td><td>0.3</td><td>0.3</td><td>0.1</td><td>0.3</td><td>0.3</td><td>0.2</td><td>?</td><td>?</td><td>?</td><td>0.67</td></tr>
<tr>
<td>Estrone sulfate</td><td>Bioidentical</td><td>?</td><td>0.9</td><td>0.9</td><td>0.8–0.9</td><td>0.9</td><td>0.5</td><td>0.9</td><td>0.5–0.7</td><td>1.4–1.5</td><td>0.56–1.7</td></tr>
<tr>
<td>Conjugated estrogens</td><td>Natural</td><td>1.2</td><td>1.5</td><td>2.0</td><td>1.1–1.3</td><td>1.0</td><td>1.5</td><td>3.0–3.2</td><td>1.3–1.5</td><td>5.0</td><td>1.3–4.5</td></tr>
<tr>
<td>Equilin sulfate</td><td>Natural</td><td>?</td><td>?</td><td>1.0</td><td>?</td><td>?</td><td>6.0</td><td>7.5</td><td>6.0</td><td>7.5</td><td>?</td></tr>
<tr>
<td>Ethinylestradiol</td><td>Synthetic</td><td>120</td><td>150</td><td>400</td><td>60–150</td><td>100</td><td>400</td><td>500–600</td><td>500–600</td><td>350</td><td>2.9–5.0</td></tr>
<tr>
<td>Diethylstilbestrol</td><td>Synthetic</td><td>?</td><td>?</td><td>?</td><td>2.9–3.4</td><td>?</td><td>?</td><td>26–28</td><td>25–37</td><td>20</td><td>5.7–7.5</td></tr>
<tr class="sortbottom">
<td colspan="12" style="width: 1px; background-color:#eaecf0; text-align: center;"><b>Notes:</b> Values are ratios, with estradiol as standard (i.e., 1.0). <b>Abbreviations:</b> <abbr>HF</abbr> = Clinical relief of hot flashes. <abbr>VE</abbr> = Increased proliferation of vaginal epithelium. <abbr>UCa</abbr> = Decrease in <abbr>UCa</abbr>. <abbr>FSH</abbr> = Suppression of <abbr>FSH</abbr> levels. <abbr>LH</abbr> = Suppression of <a href="Luteinizing_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Luteinizing_hormone" title="Luteinizing hormone"><abbr>LH</abbr></a> levels. <abbr>HDL</abbr>-<abbr>C</abbr>, <abbr>SHBG</abbr>, <abbr>CBG</abbr>, and <abbr>AGT</abbr> = Increase in the serum levels of these liver proteins. Liver = Ratio of liver estrogenic effects to general/systemic estrogenic effects (specifically hot flashes relief and gonadotropin suppression). <b>Type:</b> Bioidentical = Identical to those found in humans. Natural = Naturally occurring but not identical to those found in humans (e.g., estrogens of other species). Synthetic = Man-made, does not occur naturally in animals or in the environment. <b>Sources:</b> See template.</td></tr>
</tbody></table>

<span>
</span><table class="wikitable sortable mw-collapsible mw-collapsed" style="margin: 1em auto;">
<caption class="nowrap"> Oral potencies of estrogens</caption>
<tbody><tr>
<th>Estrogen</th><th>Type</th><th>Class</th><th class="unsortable"><abbr>ETD</abbr><br><small>(2–3<span>&nbsp;</span>weeks)</small></th><th class="unsortable"><abbr>EPD</abbr><br><small>(2–3<span>&nbsp;</span>weeks)</small></th><th class="unsortable"><abbr>MSD</abbr><br><small>(2–3<span>&nbsp;</span>weeks)</small></th><th class="unsortable"><abbr>MSD</abbr><br><small>(daily)</small></th><th class="unsortable"><abbr>OID</abbr><br><small>(daily)</small></th><th class="unsortable"><abbr>TSD</abbr><br><small>(daily)</small></th></tr>
<tr>
<td>Estradiol (non-micronized)</td><td>Bioidentical</td><td>Steroidal</td><td>30 mg</td><td>≥120–300 mg</td><td>120 mg</td><td>6 mg</td><td>?</td><td>?</td></tr>
<tr>
<td>Estradiol (micronized)</td><td>Bioidentical</td><td>Steroidal</td><td>6–12 mg</td><td>60–80 mg</td><td>14–42 mg</td><td>1–2 mg</td><td>&gt;5 mg</td><td>&gt;8 mg</td></tr>
<tr>
<td>Estradiol valerate</td><td>Bioidentical</td><td>Steroidal</td><td>6–12 mg</td><td>60–80 mg</td><td>14–42 mg</td><td>1–2 mg</td><td>?</td><td>&gt;8 mg</td></tr>
<tr>
<td>Estradiol benzoate</td><td>Bioidentical</td><td>Steroidal</td><td>?</td><td>60–140 mg</td><td>?</td><td>?</td><td>?</td><td>?</td></tr>
<tr>
<td>Estriol</td><td>Bioidentical</td><td>Steroidal</td><td>20 mg<sup>a</sup></td><td>120–150 mg<sup>b</sup></td><td>28–126 mg</td><td>1–6 mg</td><td>&gt;5 mg</td><td>?</td></tr>
<tr>
<td>Estriol succinate</td><td>Bioidentical</td><td>Steroidal</td><td>?</td><td>140–150 mg<sup>b</sup></td><td>28–126 mg</td><td>2–6 mg</td><td>?</td><td>?</td></tr>
<tr>
<td>Estrone sulfate</td><td>Bioidentical</td><td>Steroidal</td><td>12 mg</td><td>60 mg</td><td>42 mg</td><td>2 mg</td><td>?</td><td>?</td></tr>
<tr>
<td>Conjugated estrogens</td><td>Natural</td><td>Steroidal</td><td>5–12 mg</td><td>60–80 mg</td><td>8.4–25 mg</td><td>0.625–1.25 mg</td><td>&gt;3.75 mg</td><td>7.5 mg</td></tr>
<tr>
<td>Ethinylestradiol</td><td>Synthetic</td><td>Steroidal</td><td>200 μg</td><td>1–2 mg</td><td>280 μg</td><td>20–40 μg</td><td>100 μg</td><td>100 μg</td></tr>
<tr>
<td><a href="Mestranol.htm" tppabs="https://ptable.com/wiki/compounds/A/Mestranol" title="Mestranol">Mestranol</a></td><td>Synthetic</td><td>Steroidal</td><td>300 μg</td><td>1.5–3.0 mg</td><td>300–600 μg</td><td>25–30 μg</td><td>&gt;80 μg</td><td>?</td></tr>
<tr>
<td><a href="Quinestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinestrol" title="Quinestrol">Quinestrol</a></td><td>Synthetic</td><td>Steroidal</td><td>300 μg</td><td>2–4 mg</td><td>500 μg</td><td>25–50 μg</td><td>?</td><td>?</td></tr>
<tr>
<td>Methylestradiol</td><td>Synthetic</td><td>Steroidal</td><td>?</td><td>2 mg</td><td>?</td><td>?</td><td>?</td><td>?</td></tr>
<tr>
<td>Diethylstilbestrol</td><td>Synthetic</td><td>Nonsteroidal</td><td>2.5 mg</td><td>20–30 mg</td><td>11 mg</td><td>0.5–2.0 mg</td><td>&gt;5 mg</td><td>3 mg</td></tr>
<tr>
<td>Diethylstilbestrol dipropionate</td><td>Synthetic</td><td>Nonsteroidal</td><td>?</td><td>15–30 mg</td><td>?</td><td>?</td><td>?</td><td>?</td></tr>
<tr>
<td><a href="Dienestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Dienestrol" title="Dienestrol">Dienestrol</a></td><td>Synthetic</td><td>Nonsteroidal</td><td>5 mg</td><td>30–40 mg</td><td>42 mg</td><td>0.5–4.0 mg</td><td>?</td><td>?</td></tr>
<tr>
<td>Dienestrol diacetate</td><td>Synthetic</td><td>Nonsteroidal</td><td>3–5 mg</td><td>30–60 mg</td><td>?</td><td>?</td><td>?</td><td>?</td></tr>
<tr>
<td>Hexestrol</td><td>Synthetic</td><td>Nonsteroidal</td><td>?</td><td>70–110 mg</td><td>?</td><td>?</td><td>?</td><td>?</td></tr>
<tr>
<td><a href="Chlorotrianisene.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorotrianisene" title="Chlorotrianisene">Chlorotrianisene</a></td><td>Synthetic</td><td>Nonsteroidal</td><td>?</td><td>&gt;100 mg</td><td>?</td><td>?</td><td>&gt;48 mg</td><td>?</td></tr>
<tr>
<td><a href="Methallenestril.htm" tppabs="https://ptable.com/wiki/compounds/A/Methallenestril" title="Methallenestril">Methallenestril</a></td><td>Synthetic</td><td>Nonsteroidal</td><td>?</td><td>400 mg</td><td>?</td><td>?</td><td>?</td><td>?</td></tr>
<tr class="sortbottom">
<td colspan="9" style="width: 1px; background-color:#eaecf0; text-align: center;"><b>Footnotes:</b> <sup>a</sup> = Very variable, often higher. <sup>b</sup> = In divided doses, 3x/day; irregular and atypical proliferation. <b>Sources:</b> See template.</td></tr>
</tbody></table>

<span>
</span><table class="wikitable sortable mw-collapsible mw-collapsed" style="margin: 1em auto;">
<caption class="nowrap"> Parenteral potencies and durations of nonsteroidal estrogens</caption>
<tbody><tr>
<th>Estrogen</th><th>Form</th><th>Major brand name(s)</th><th data-sort-type="number"><abbr>EPD</abbr> (14 days)</th><th colspan="2" data-sort-type="number">Duration</th></tr>
<tr>
<td>Diethylstilbestrol (DES)</td><td>Oil solution</td><td>Metestrol</td><td>20 mg</td><td>1 mg ≈ 2–3 days; 3 mg ≈ 3 days</td></tr>
<tr>
<td rowspan="2">Diethylstilbestrol dipropionate</td><td>Oil solution</td><td>Cyren B</td><td>12.5–15 mg</td><td>2.5 mg ≈ 5 days</td></tr>
<tr>
<td>Aqueous suspension</td><td>?</td><td>5 mg</td><td>? mg = 21–28 days</td></tr>
<tr>
<td>Dimestrol (<abbr>DES</abbr> dimethyl ether)</td><td>Oil solution</td><td>Depot-Cyren, Depot-Oestromon, Retalon Retard</td><td>20–40 mg</td><td>?</td></tr>
<tr>
<td><a href="Fosfestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Fosfestrol" title="Fosfestrol">Fosfestrol (<abbr>DES</abbr> diphosphate)</a><sup>a</sup></td><td>Aqueous solution</td><td>Honvan</td><td>?</td><td>&lt;1 day</td></tr>
<tr>
<td>Dienestrol diacetate</td><td>Aqueous suspension</td><td>Farmacyrol-Kristallsuspension</td><td>50 mg</td><td>?</td></tr>
<tr>
<td>Hexestrol dipropionate</td><td>Oil solution</td><td>Hormoestrol, Retalon Oleosum</td><td>25 mg</td><td>?</td></tr>
<tr>
<td>Hexestrol diphosphate<sup>a</sup></td><td>Aqueous solution</td><td>Cytostesin, Pharmestrin, Retalon Aquosum</td><td>?</td><td>Very short</td></tr>
<tr class="sortbottom">
<td colspan="5" style="width: 1px; background-color:#eaecf0; text-align: center;"><b>Note:</b> All by intramuscular injection unless otherwise noted. <b>Footnotes:</b> <sup>a</sup> = By intravenous injection. <b>Sources:</b> See template.</td></tr>
</tbody></table>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Antigonadotropic_effects">Antigonadotropic effects</h4></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:302px"><img src="../I/m/Testosterone_levels_with_different_estrogen_therapies_in_men_with_prostate_cancer.png" tppabs="https://ptable.com/wiki/compounds/I/m/Testosterone_levels_with_different_estrogen_therapies_in_men_with_prostate_cancer.png" data-file-width="2046" data-file-height="1348" data-file-type="bitmap" height="198" width="300"><div class="thumbcaption" style="text-align: left">Testosterone levels with no treatment and with various estrogens in men with prostate cancer.<span class="mw-ref" id="cite_ref-pmid4359746_63-0"><a href="#cite_note-pmid4359746-63" style="counter-reset: mw-Ref 63;"><span class="mw-reflink-text">[63]</span></a></span> Determinations were made with an early radioimmunoassay (RIA).<span class="mw-ref" id="cite_ref-pmid4359746_63-1"><a href="#cite_note-pmid4359746-63" style="counter-reset: mw-Ref 63;"><span class="mw-reflink-text">[63]</span></a></span> Source was Shearer et al. (1973).<span class="mw-ref" id="cite_ref-pmid4359746_63-2"><a href="#cite_note-pmid4359746-63" style="counter-reset: mw-Ref 63;"><span class="mw-reflink-text">[63]</span></a></span></div></div></div>
<div class="thumb tright"><div class="thumbinner" style="width:302px"><img src="../I/m/Testosterone_levels_with_0.2_to_5_mg_per_day_diethylstilbestrol_in_men_with_prostate_cancer.png" tppabs="https://ptable.com/wiki/compounds/I/m/Testosterone_levels_with_0.2_to_5_mg_per_day_diethylstilbestrol_in_men_with_prostate_cancer.png" data-file-width="1742" data-file-height="1242" data-file-type="bitmap" height="214" width="300"><div class="thumbcaption" style="text-align: left">Testosterone levels with placebo and 0.2 to 5<span>&nbsp;</span>mg/day diethylstilbestrol (DES) for 6<span>&nbsp;</span>months in men with prostate cancer.<span class="mw-ref" id="cite_ref-pmid4699685_64-0"><a href="#cite_note-pmid4699685-64" style="counter-reset: mw-Ref 64;"><span class="mw-reflink-text">[64]</span></a></span> Determinations were made with a radioimmunoassay (RIA).<span class="mw-ref" id="cite_ref-pmid4699685_64-1"><a href="#cite_note-pmid4699685-64" style="counter-reset: mw-Ref 64;"><span class="mw-reflink-text">[64]</span></a></span> Source was Kent et al. (1973).<span class="mw-ref" id="cite_ref-pmid4699685_64-2"><a href="#cite_note-pmid4699685-64" style="counter-reset: mw-Ref 64;"><span class="mw-reflink-text">[64]</span></a></span></div></div></div>

<p>Due to its estrogenic activity, DES has antigonadotropic effects.<span class="mw-ref" id="cite_ref-pmid29603164_65-0"><a href="#cite_note-pmid29603164-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span><span class="mw-ref" id="cite_ref-DenisGriffiths1999_60-3"><a href="#cite_note-DenisGriffiths1999-60" style="counter-reset: mw-Ref 60;"><span class="mw-reflink-text">[60]</span></a></span><span class="mw-ref" id="cite_ref-Salam2003_66-0"><a href="#cite_note-Salam2003-66" style="counter-reset: mw-Ref 66;"><span class="mw-reflink-text">[66]</span></a></span><span class="mw-ref" id="cite_ref-pmid16406864_67-0"><a href="#cite_note-pmid16406864-67" style="counter-reset: mw-Ref 67;"><span class="mw-reflink-text">[67]</span></a></span> That is, it exerts negative feedback on the hypothalamic–pituitary–gonadal axis (HPG axis), suppresses the secretion of the gonadotropins, <a href="Luteinizing_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Luteinizing_hormone" title="Luteinizing hormone">luteinizing hormone</a> (LH) and follicle-stimulating hormone (FSH), and suppresses sex hormone production as well as gamete production or maturation in the gonads.<span class="mw-ref" id="cite_ref-pmid29603164_65-1"><a href="#cite_note-pmid29603164-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span><span class="mw-ref" id="cite_ref-DenisGriffiths1999_60-4"><a href="#cite_note-DenisGriffiths1999-60" style="counter-reset: mw-Ref 60;"><span class="mw-reflink-text">[60]</span></a></span><span class="mw-ref" id="cite_ref-Salam2003_66-1"><a href="#cite_note-Salam2003-66" style="counter-reset: mw-Ref 66;"><span class="mw-reflink-text">[66]</span></a></span><span class="mw-ref" id="cite_ref-pmid16406864_67-1"><a href="#cite_note-pmid16406864-67" style="counter-reset: mw-Ref 67;"><span class="mw-reflink-text">[67]</span></a></span> A study of ovulation inhibition in women found that 5<span>&nbsp;</span>mg/day oral DES was 92% effective, with ovulation occurring in only a single cycle.<span class="mw-ref" id="cite_ref-Greenblatt1966_68-0"><a href="#cite_note-Greenblatt1966-68" style="counter-reset: mw-Ref 68;"><span class="mw-reflink-text">[68]</span></a></span><span class="mw-ref" id="cite_ref-HerrRevesz1970_69-0"><a href="#cite_note-HerrRevesz1970-69" style="counter-reset: mw-Ref 69;"><span class="mw-reflink-text">[69]</span></a></span> DES consistently suppresses testosterone levels in men into the castrate range (&lt;50<span>&nbsp;</span>ng/dL) within 1 to 2<span>&nbsp;</span>weeks at doses of 3<span>&nbsp;</span>mg/day and above.<span class="mw-ref" id="cite_ref-pmid29603164_65-2"><a href="#cite_note-pmid29603164-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span><span class="mw-ref" id="cite_ref-pmid16406864_67-2"><a href="#cite_note-pmid16406864-67" style="counter-reset: mw-Ref 67;"><span class="mw-reflink-text">[67]</span></a></span> Conversely, a dosage of 1<span>&nbsp;</span>mg/day DES is unable to fully suppress testosterone levels into the castrate range in men, which instead often stabilize at just above castrate levels (&gt;50<span>&nbsp;</span>ng/dL).<span class="mw-ref" id="cite_ref-pmid24256023_26-6"><a href="#cite_note-pmid24256023-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span><span class="mw-ref" id="cite_ref-DenisGriffiths1999_60-5"><a href="#cite_note-DenisGriffiths1999-60" style="counter-reset: mw-Ref 60;"><span class="mw-reflink-text">[60]</span></a></span><span class="mw-ref" id="cite_ref-Salam2003_66-2"><a href="#cite_note-Salam2003-66" style="counter-reset: mw-Ref 66;"><span class="mw-reflink-text">[66]</span></a></span> However, it has also been reported that 1<span>&nbsp;</span>mg/day DES results in approximately 50% suppression of testosterone levels, albeit with wide interindividual variability.<span class="mw-ref" id="cite_ref-pmid29603164_65-3"><a href="#cite_note-pmid29603164-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span><span class="mw-ref" id="cite_ref-pmid2669792_70-0"><a href="#cite_note-pmid2669792-70" style="counter-reset: mw-Ref 70;"><span class="mw-reflink-text">[70]</span></a></span> It has been said that doses of DES of less than 1<span>&nbsp;</span>mg/day have no effect on testosterone levels.<span class="mw-ref" id="cite_ref-pmid29603164_65-4"><a href="#cite_note-pmid29603164-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span> However, the addition of an "extremely low" dosage of 0.1<span>&nbsp;</span>mg/day DES to cyproterone acetate has been found to result in a synergistic antigonadotropic effect and to suppress testosterone levels into the castrate range in men.<span class="mw-ref" id="cite_ref-SchröderRadlmaier2009_71-0"><a href="#cite_note-SchröderRadlmaier2009-71" style="counter-reset: mw-Ref 71;"><span class="mw-reflink-text">[71]</span></a></span><span class="mw-ref" id="cite_ref-pmid2973529_72-0"><a href="#cite_note-pmid2973529-72" style="counter-reset: mw-Ref 72;"><span class="mw-reflink-text">[72]</span></a></span><span class="mw-ref" id="cite_ref-pmid8677581_73-0"><a href="#cite_note-pmid8677581-73" style="counter-reset: mw-Ref 73;"><span class="mw-reflink-text">[73]</span></a></span> DES at 3<span>&nbsp;</span>mg/day has similar testosterone suppression to a dose of 300<span>&nbsp;</span>mg/day, suggesting that suppression of testosterone levels is maximal by 3<span>&nbsp;</span>mg/day.<span class="mw-ref" id="cite_ref-pmid5124437_74-0"><a href="#cite_note-pmid5124437-74" style="counter-reset: mw-Ref 74;"><span class="mw-reflink-text">[74]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Other_activities">Other activities</h4></summary>
    
<p>In addition to the ERs, an <i>in vitro</i> study found that DES also possesses activity, albeit relatively weak, at a variety of other steroid hormone receptors.<span class="mw-ref" id="cite_ref-pmid22294742_58-1"><a href="#cite_note-pmid22294742-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span> Whereas the study found EC<sub>50</sub> values of 0.18<span>&nbsp;</span>nM and 0.06<span>&nbsp;</span>nM of DES for the ERα and ERβ, respectively, the medication showed significant glucocorticoid activity at a concentration of 1<span>&nbsp;</span>μM that surpassed that of 0.1<span>&nbsp;</span>nM <a href="Dexamethasone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dexamethasone" title="Dexamethasone">dexamethasone</a>, as well as significant antagonism of the androgen, progesterone, and mineralocorticoid receptors (75%, 85%, and 50% inhibition of positive control stimulation, respectively, all at a concentration of 1<span>&nbsp;</span>μM).<span class="mw-ref" id="cite_ref-pmid22294742_58-2"><a href="#cite_note-pmid22294742-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span> It also showed approximately 25% inhibition of the activation of PPARγ and LXRα at a concentration of 10<span>&nbsp;</span>μM.<span class="mw-ref" id="cite_ref-pmid22294742_58-3"><a href="#cite_note-pmid22294742-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span> The researchers stated that, to the best of their knowledge, they were the first to report such actions of DES, and hypothesized that these actions could be involved in the clinical effects of DES, for instance, in prostate cancer (notably in which particularly high dosages of DES are employed).<span class="mw-ref" id="cite_ref-pmid22294742_58-4"><a href="#cite_note-pmid22294742-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span> However, they also noted that the importance of the activities requires further study in animal models at pharmacologically relevant doses.<span class="mw-ref" id="cite_ref-pmid22294742_58-5"><a href="#cite_note-pmid22294742-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span></p>

<p>DES has been identified as an antagonist of all three isotypes of the estrogen-related receptors (ERRs), the ERRα, ERRβ, and ERRγ.<span class="mw-ref" id="cite_ref-pmid15161930_75-0"><a href="#cite_note-pmid15161930-75" style="counter-reset: mw-Ref 75;"><span class="mw-reflink-text">[75]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacokinetics">Pharmacokinetics</h3></summary>
    
<p>DES is well-absorbed with oral administration.<span class="mw-ref" id="cite_ref-ChabnerLongo1996_1-7"><a href="#cite_note-ChabnerLongo1996-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> With an oral dosage of 1<span>&nbsp;</span>mg/day DES, plasma levels of DES at 20<span>&nbsp;</span>hours following the last dose ranged between 0.9 and 1.9<span>&nbsp;</span>ng/mL (3.4 to 7.1<span>&nbsp;</span>nmol/L).<span class="mw-ref" id="cite_ref-ChabnerLongo1996_1-8"><a href="#cite_note-ChabnerLongo1996-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> Sublingual administration of DES appears to have about the same estrogenic potency of oral DES in women.<span class="mw-ref" id="cite_ref-RabinowitzMyerson1967_76-0"><a href="#cite_note-RabinowitzMyerson1967-76" style="counter-reset: mw-Ref 76;"><span class="mw-reflink-text">[76]</span></a></span> Intrauterine DES has been studied for the treatment of uterine hypoplasia.<span class="mw-ref" id="cite_ref-pmid14926876_77-0"><a href="#cite_note-pmid14926876-77" style="counter-reset: mw-Ref 77;"><span class="mw-reflink-text">[77]</span></a></span></p>

<p>The distribution half-life of DES is 80<span>&nbsp;</span>minutes.<span class="mw-ref" id="cite_ref-ChabnerLongo1996_1-9"><a href="#cite_note-ChabnerLongo1996-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> It has no affinity for SHBG or corticosteroid-binding globulin, and hence is not bound to these proteins in the circulation.<span class="mw-ref" id="cite_ref-pmid7195405_78-0"><a href="#cite_note-pmid7195405-78" style="counter-reset: mw-Ref 78;"><span class="mw-reflink-text">[78]</span></a></span> The plasma protein binding of DES is greater than 95%.<span class="mw-ref" id="cite_ref-OelschlägerRothley1988_2-4"><a href="#cite_note-OelschlägerRothley1988-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>

<p>Hydroxylation of the aromatic rings of DES and subsequent conjugation of the <a href="Ethyl_group.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethyl_group" title="Ethyl group">ethyl</a> side chains accounts for 80 to 90% of DES metabolism, while oxidation accounts for the remaining 10 to 20% and is dominated by conjugation reactions.<span class="mw-ref" id="cite_ref-OelschlägerRothley1988_2-5"><a href="#cite_note-OelschlägerRothley1988-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-pmid8428334_3-3"><a href="#cite_note-pmid8428334-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> Conjugation of DES consists of glucuronidation, while oxidation includes dehydrogenation into <a href="Dienestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Dienestrol" title="Dienestrol">(<i>Z</i>,<i>Z</i>)-dienestrol</a>.<span class="mw-ref" id="cite_ref-ChabnerLongo1996_1-10"><a href="#cite_note-ChabnerLongo1996-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-OelschlägerRothley1988_2-6"><a href="#cite_note-OelschlägerRothley1988-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-pmid8428334_3-4"><a href="#cite_note-pmid8428334-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> The medication is also known to produce paroxypropione as a metabolite.<span class="mw-ref" id="cite_ref-.v_79-0"><a href="#cite_note-.v-79" style="counter-reset: mw-Ref 79;"><span class="mw-reflink-text">[79]</span></a></span> DES produces transient <a href="Quinone.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinone" title="Quinone">quinone</a>-like reactive intermediates that cause cellular and genetic damage, which may help to explain the known carcinogenic effects of DES in humans.<span class="mw-ref" id="cite_ref-ChabnerLongo1996_1-11"><a href="#cite_note-ChabnerLongo1996-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> However, other research indicates that the toxic effects of DES may simply be due to overactivation of the ERs.<span class="mw-ref" id="cite_ref-pmid15458790_80-0"><a href="#cite_note-pmid15458790-80" style="counter-reset: mw-Ref 80;"><span class="mw-reflink-text">[80]</span></a></span> In contrast to estradiol, the hydroxyl groups of DES do not undergo oxidation into an estrone-like equivalent.<span class="mw-ref" id="cite_ref-pmid19737574_81-0"><a href="#cite_note-pmid19737574-81" style="counter-reset: mw-Ref 81;"><span class="mw-reflink-text">[81]</span></a></span></p>

<p>The elimination half-life of DES is 24<span>&nbsp;</span>hours.<span class="mw-ref" id="cite_ref-ChabnerLongo1996_1-12"><a href="#cite_note-ChabnerLongo1996-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> The metabolites of DES are excreted in urine and feces.<span class="mw-ref" id="cite_ref-OelschlägerRothley1988_2-7"><a href="#cite_note-OelschlägerRothley1988-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-pmid8428334_3-5"><a href="#cite_note-pmid8428334-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Chemistry">Chemistry</h2></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:267px"><img src="../I/m/Estradiol_and_diethylstilbestrol.png" tppabs="https://ptable.com/wiki/compounds/I/m/Estradiol_and_diethylstilbestrol.png" data-file-width="1716" data-file-height="2100" data-file-type="bitmap" height="324" width="265"><div class="thumbcaption" style="text-align: left">Chemical structures of estradiol and DES.<span class="mw-ref" id="cite_ref-WermuthAldous2015_82-0"><a href="#cite_note-WermuthAldous2015-82" style="counter-reset: mw-Ref 82;"><span class="mw-reflink-text">[82]</span></a></span> Note the preservation of the two hydroxyl groups in DES and the similar distance between them relative to estradiol, which is notable when it is considered that DES was discovered serendipitously.<span class="mw-ref" id="cite_ref-WermuthAldous2015_82-1"><a href="#cite_note-WermuthAldous2015-82" style="counter-reset: mw-Ref 82;"><span class="mw-reflink-text">[82]</span></a></span><span class="mw-ref" id="cite_ref-Sneader2005_83-0"><a href="#cite_note-Sneader2005-83" style="counter-reset: mw-Ref 83;"><span class="mw-reflink-text">[83]</span></a></span><span class="mw-ref" id="cite_ref-Ravina2011_84-0"><a href="#cite_note-Ravina2011-84" style="counter-reset: mw-Ref 84;"><span class="mw-reflink-text">[84]</span></a></span></div></div></div>

<p>DES belongs to the stilbestrol (4,4'-dihydroxystilbene) group of compounds.<span class="mw-ref" id="cite_ref-AcademicPress1945_85-0"><a href="#cite_note-AcademicPress1945-85" style="counter-reset: mw-Ref 85;"><span class="mw-reflink-text">[85]</span></a></span> It is a nonsteroidal open-ring analogue of the steroidal estrogen estradiol.<span class="mw-ref" id="cite_ref-WermuthAldous2015_82-2"><a href="#cite_note-WermuthAldous2015-82" style="counter-reset: mw-Ref 82;"><span class="mw-reflink-text">[82]</span></a></span> DES can be prepared from <a href="Anethole.htm" tppabs="https://ptable.com/wiki/compounds/A/Anethole" title="Anethole">anethole</a>, which also happens to be weakly estrogenic.<span class="mw-ref" id="cite_ref-AcademicPress1945_85-1"><a href="#cite_note-AcademicPress1945-85" style="counter-reset: mw-Ref 85;"><span class="mw-reflink-text">[85]</span></a></span><span class="mw-ref" id="cite_ref-MaximovMcDaniel2013_86-0"><a href="#cite_note-MaximovMcDaniel2013-86" style="counter-reset: mw-Ref 86;"><span class="mw-reflink-text">[86]</span></a></span><span class="mw-ref" id="cite_ref-Ravina2011_84-1"><a href="#cite_note-Ravina2011-84" style="counter-reset: mw-Ref 84;"><span class="mw-reflink-text">[84]</span></a></span><span class="mw-ref" id="cite_ref-Sneader2005_83-1"><a href="#cite_note-Sneader2005-83" style="counter-reset: mw-Ref 83;"><span class="mw-reflink-text">[83]</span></a></span> Anethole was demethylated to form anol and anol then spontaneously dimerized into dianol and hexestrol, with DES subsequently being synthesized via structural modification of hexestrol.<span class="mw-ref" id="cite_ref-AcademicPress1945_85-2"><a href="#cite_note-AcademicPress1945-85" style="counter-reset: mw-Ref 85;"><span class="mw-reflink-text">[85]</span></a></span><span class="mw-ref" id="cite_ref-MaximovMcDaniel2013_86-1"><a href="#cite_note-MaximovMcDaniel2013-86" style="counter-reset: mw-Ref 86;"><span class="mw-reflink-text">[86]</span></a></span><span class="mw-ref" id="cite_ref-Ravina2011_84-2"><a href="#cite_note-Ravina2011-84" style="counter-reset: mw-Ref 84;"><span class="mw-reflink-text">[84]</span></a></span><span class="mw-ref" id="cite_ref-Sneader2005_83-2"><a href="#cite_note-Sneader2005-83" style="counter-reset: mw-Ref 83;"><span class="mw-reflink-text">[83]</span></a></span> As shown by X-ray crystallography, the molecular dimensions of DES are almost identical to those of estradiol, particularly in regards to the distance between the terminal hydroxyl groups.<span class="mw-ref" id="cite_ref-Sneader2005_83-3"><a href="#cite_note-Sneader2005-83" style="counter-reset: mw-Ref 83;"><span class="mw-reflink-text">[83]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Synthesis">Synthesis</h3></summary>
    
<p>DES was first synthesized in early 1938 by Leon Golberg, then a graduate student of Sir Robert Robinson at the Dyson Perrins Laboratory at the University of Oxford. Golberg's research was based on work by Wilfrid Lawson at the Courtauld Institute of Biochemistry, (led by Sir Edward Charles Dodds at Middlesex Hospital Medical School now part of University College London). A report of its synthesis was published in <i>Nature</i> on 5 February 1938.<span class="mw-ref" id="cite_ref-Dodds_1938_87-0"><a href="#cite_note-Dodds_1938-87" style="counter-reset: mw-Ref 87;"><span class="mw-reflink-text">[87]</span></a></span><span class="mw-ref" id="cite_ref-dodds2_88-0"><a href="#cite_note-dodds2-88" style="counter-reset: mw-Ref 88;"><span class="mw-reflink-text">[88]</span></a></span><span class="mw-ref" id="cite_ref-meyers_89-0"><a href="#cite_note-meyers-89" style="counter-reset: mw-Ref 89;"><span class="mw-reflink-text">[89]</span></a></span></p>

<p>DES research was funded by the UK Medical Research Council (MRC), which had a policy against patenting drugs discovered using public funds. Because it was not patented, DES was produced by more than 200 pharmaceutical and chemical companies worldwide.</p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Clinical_use">Clinical use</h3></summary>
    
<p>DES was first marketed for medical use in 1939.<span class="mw-ref" id="cite_ref-FeldbergLadd-Taylor2003_9-1"><a href="#cite_note-FeldbergLadd-Taylor2003-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> It was approved by the United States Food and Drug Administration (FDA) on September 19, 1941 in tablets up to 5<span>&nbsp;</span>mg for four indications: gonorrheal vaginitis, atrophic vaginitis, menopausal symptoms, and postpartum lactation suppression to prevent breast engorgement.<span class="mw-ref" id="cite_ref-meyers_89-1"><a href="#cite_note-meyers-89" style="counter-reset: mw-Ref 89;"><span class="mw-reflink-text">[89]</span></a></span> The gonorrheal vaginitis indication was dropped when the antibiotic penicillin became available. From its very inception, the drug was highly controversial.<span class="mw-ref" id="cite_ref-langston_90-0"><a href="#cite_note-langston-90" style="counter-reset: mw-Ref 90;"><span class="mw-reflink-text">[90]</span></a></span><span class="mw-ref" id="cite_ref-seaman_91-0"><a href="#cite_note-seaman-91" style="counter-reset: mw-Ref 91;"><span class="mw-reflink-text">[91]</span></a></span></p>

<p>In 1941, Charles Huggins and Clarence Hodges at the University of Chicago found estradiol benzoate and DES to be the first effective drugs for the treatment of metastatic prostate cancer.<span class="mw-ref" id="cite_ref-pmid4625049_92-0"><a href="#cite_note-pmid4625049-92" style="counter-reset: mw-Ref 92;"><span class="mw-reflink-text">[92]</span></a></span><span class="mw-ref" id="cite_ref-93"><a href="#cite_note-93" style="counter-reset: mw-Ref 93;"><span class="mw-reflink-text">[93]</span></a></span> DES was the first cancer drug.<span class="mw-ref" id="cite_ref-Lupulescu1990_94-0"><a href="#cite_note-Lupulescu1990-94" style="counter-reset: mw-Ref 94;"><span class="mw-reflink-text">[94]</span></a></span></p>

<p>Orchiectomy or DES or both were the standard initial treatment for symptomatic advanced prostate cancer for over 40 years, until the GnRH agonist <a href="Leuprorelin.htm" tppabs="https://ptable.com/wiki/compounds/A/Leuprorelin" title="Leuprorelin">leuprorelin</a> was found to have efficacy similar to DES without estrogenic effects and was approved in 1985.<span class="mw-ref" id="cite_ref-pmid6436700_95-0"><a href="#cite_note-pmid6436700-95" style="counter-reset: mw-Ref 95;"><span class="mw-reflink-text">[95]</span></a></span></p>

<p>From the 1940s until the late 1980s, DES was FDA-approved as estrogen replacement therapy for estrogen deficiency states such as ovarian dysgenesis, premature ovarian failure, and after oophorectomy.</p>

<p>In the 1940s, DES was used off-label to prevent adverse pregnancy outcomes in women with a history of miscarriage. On July 1, 1947, the FDA approved the use of DES for this indication. The first such approval was granted to Bristol-Myers Squibb, allowing use of 25<span>&nbsp;</span>mg (and later 100<span>&nbsp;</span>mg) tablets of DES during pregnancy. Approvals were granted to other pharmaceutical companies later in the same year.<span class="mw-ref" id="cite_ref-dutton_96-0"><a href="#cite_note-dutton-96" style="counter-reset: mw-Ref 96;"><span class="mw-reflink-text">[96]</span></a></span> The recommended regimen started at 5<span>&nbsp;</span>mg per day in the seventh and eighth weeks of pregnancy (from first day of last menstrual period), increased every other week by 5<span>&nbsp;</span>mg per day through the 14th week, and then increased every week by 5<span>&nbsp;</span>mg per day from 25<span>&nbsp;</span>mg per day in the 15th week to 125<span>&nbsp;</span>mg per day in the 35th week of pregnancy.<span class="mw-ref" id="cite_ref-pdr1961_97-0"><a href="#cite_note-pdr1961-97" style="counter-reset: mw-Ref 97;"><span class="mw-reflink-text">[97]</span></a></span>
DES was originally considered effective and safe for both the pregnant woman and the developing baby. It was aggressively marketed and routinely prescribed. Sales peaked in 1953.</p>

<p>In the early 1950s, a double-blind clinical trial at the University of Chicago assessed pregnancy outcomes in women who were assigned to either receive or not receive DES.<span class="mw-ref" id="cite_ref-dieckmann_98-0"><a href="#cite_note-dieckmann-98" style="counter-reset: mw-Ref 98;"><span class="mw-reflink-text">[98]</span></a></span> The study showed no benefit of taking DES during pregnancy; adverse pregnancy outcomes were not reduced in the women who were given DES. By the late 1960s, six of seven leading textbooks of obstetrics said DES was ineffective at preventing miscarriage.<span class="mw-ref" id="cite_ref-dutton_96-1"><a href="#cite_note-dutton-96" style="counter-reset: mw-Ref 96;"><span class="mw-reflink-text">[96]</span></a></span><span class="mw-ref" id="cite_ref-apfel_99-0"><a href="#cite_note-apfel-99" style="counter-reset: mw-Ref 99;"><span class="mw-reflink-text">[99]</span></a></span></p>

<p>Despite an absence of evidence supporting the use of DES to prevent adverse pregnancy outcomes, DES continued to be given to pregnant women through the 1960s. In 1971, a report published in the <i>New England Journal of Medicine</i> showed a probable link between DES and vaginal clear cell adenocarcinoma in girls and young women who had been exposed to this drug <i>in utero</i>. Later in the same year, the FDA sent an FDA Drug Bulletin to all U.S. physicians advising against the use of DES in pregnant women. The FDA also removed prevention of miscarriage as an indication for DES use and added pregnancy as a contraindication for DES use.<span class="mw-ref" id="cite_ref-fr1971_100-0"><a href="#cite_note-fr1971-100" style="counter-reset: mw-Ref 100;"><span class="mw-reflink-text">[100]</span></a></span> On February 5, 1975, the FDA ordered 25<span>&nbsp;</span>mg and 100<span>&nbsp;</span>mg tablets of DES withdrawn, effective February 18, 1975.<span class="mw-ref" id="cite_ref-des25mg_101-0"><a href="#cite_note-des25mg-101" style="counter-reset: mw-Ref 101;"><span class="mw-reflink-text">[101]</span></a></span> The number of persons exposed to DES during pregnancy or <i>in utero</i> during the period of 1940 to 1971 is unknown, but may be as high as 2 million in the United States. DES was also used in other countries, most notably France, the Netherlands, and Great Britain.</p>

<p>From the 1950s through the beginning of the 1970s, DES was prescribed to prepubescent girls to begin puberty and thus stop growth by closing growth plates in the bones. Despite its clear link to cancer, doctors continued to recommend the hormone for "excess height".<span class="mw-ref" id="cite_ref-102"><a href="#cite_note-102" style="counter-reset: mw-Ref 102;"><span class="mw-reflink-text">[102]</span></a></span></p>

<p>In 1960, DES was found to be more effective than androgens in the treatment of advanced breast cancer in postmenopausal women.<span class="mw-ref" id="cite_ref-AMA1960_103-0"><a href="#cite_note-AMA1960-103" style="counter-reset: mw-Ref 103;"><span class="mw-reflink-text">[103]</span></a></span> DES was the hormonal treatment of choice for advanced breast cancer in postmenopausal women until 1977, when the FDA approved <a href="Tamoxifen.htm" tppabs="https://ptable.com/wiki/compounds/A/Tamoxifen" title="Tamoxifen">tamoxifen</a>, a selective estrogen receptor modulator with efficacy similar to DES but fewer side effects.<span class="mw-ref" id="cite_ref-pmid7001242_104-0"><a href="#cite_note-pmid7001242-104" style="counter-reset: mw-Ref 104;"><span class="mw-reflink-text">[104]</span></a></span></p>

<p>Several sources from medical literature in the 1970s and 1980s indicate that DES was used as a component of hormone therapy for transgender women.<span class="mw-ref" id="cite_ref-105"><a href="#cite_note-105" style="counter-reset: mw-Ref 105;"><span class="mw-reflink-text">[105]</span></a></span><span class="mw-ref" id="cite_ref-106"><a href="#cite_note-106" style="counter-reset: mw-Ref 106;"><span class="mw-reflink-text">[106]</span></a></span><span class="mw-ref" id="cite_ref-107"><a href="#cite_note-107" style="counter-reset: mw-Ref 107;"><span class="mw-reflink-text">[107]</span></a></span></p>

<p>In 1973, in an attempt to restrict off-label use of DES as a postcoital contraceptive (which had become prevalent at many university health services following publication of an influential study in 1971 in <i>JAMA</i>) to emergency situations such as rape, an <i>FDA Drug Bulletin</i> was sent to all U.S. physicians and pharmacists that said the FDA had approved, under restricted conditions, postcoital contraceptive use of DES.<span class="mw-ref" id="cite_ref-pmid5171004_108-0"><a href="#cite_note-pmid5171004-108" style="counter-reset: mw-Ref 108;"><span class="mw-reflink-text">[108]</span></a></span></p>

<p>In 1975, the FDA said it had not actually given (and never did give) approval to any manufacturer to market DES as a postcoital contraceptive, but would approve that indication for emergency situations such as rape or incest if a manufacturer provided patient labeling and special packaging as set out in a FDA final rule published in 1975.<span class="mw-ref" id="cite_ref-109"><a href="#cite_note-109" style="counter-reset: mw-Ref 109;"><span class="mw-reflink-text">[109]</span></a></span> To discourage off-label use of DES as a postcoital contraceptive, the FDA in 1975 removed DES 25<span>&nbsp;</span>mg tablets from the market and ordered the labeling of lower doses (5<span>&nbsp;</span>mg and lower) of DES still approved for other indications changed to state: "This drug product should not be used as a postcoital contraceptive" in block capital letters on the first line of the physician prescribing information package insert and in a prominent and conspicuous location of the container and carton label.<span class="mw-ref" id="cite_ref-des25mg_101-1"><a href="#cite_note-des25mg-101" style="counter-reset: mw-Ref 101;"><span class="mw-reflink-text">[101]</span></a></span><span class="mw-ref" id="cite_ref-110"><a href="#cite_note-110" style="counter-reset: mw-Ref 110;"><span class="mw-reflink-text">[110]</span></a></span> In the 1980s, off-label use of the Yuzpe regimen of certain regular combined oral contraceptive pills superseded off-label use of DES as a postcoital contraceptive.<span class="mw-ref" id="cite_ref-111"><a href="#cite_note-111" style="counter-reset: mw-Ref 111;"><span class="mw-reflink-text">[111]</span></a></span></p>

<p>In 1978, the FDA removed postpartum lactation suppression to prevent breast engorgement from their approved indications for DES and other estrogens.<span class="mw-ref" id="cite_ref-112"><a href="#cite_note-112" style="counter-reset: mw-Ref 112;"><span class="mw-reflink-text">[112]</span></a></span> In the 1990s, the only approved indications for DES were treatment of advanced prostate cancer and treatment of advanced breast cancer in postmenopausal women. The last remaining U.S. manufacturer of DES, Eli Lilly, stopped making and marketing it in 1997.</p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Lawsuits">Lawsuits</h3></summary>
    
<p>In the 1970s, the negative publicity surrounding the discovery of DES's long-term effects resulted in a huge wave of lawsuits in the United States against its manufacturers. These culminated in a landmark 1980 decision of the Supreme Court of California, <i>Sindell v. Abbott Laboratories</i>, in which the court imposed a rebuttable presumption of market share liability upon all DES manufacturers, proportional to their share of the market at the time the drug was consumed by the mother of a particular plaintiff.</p>

<p>A lawsuit was filed in Boston Federal Court by 53 DES daughters who say their breast cancers were the result of DES being prescribed to their mothers while pregnant with them. Their cases survived a Daubert hearing. In 2013, the Fecho sisters who initiated the breast cancer/DES link litigation agreed to an undisclosed settlement amount on the second day of trial. The remaining litigants have received various settlements.<span class="mw-ref" id="cite_ref-113"><a href="#cite_note-113" style="counter-reset: mw-Ref 113;"><span class="mw-reflink-text">[113]</span></a></span></p>

<p>The advocacy group DES Action USA helped provide information and support for DES-exposed persons engaged in lawsuits.<span class="mw-ref" id="cite_ref-114"><a href="#cite_note-114" style="counter-reset: mw-Ref 114;"><span class="mw-reflink-text">[114]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Society_and_culture">Society and culture</h2></summary>
    
<p>Alan Turing, the ground-breaking cryptographer, founder of computing science and programmable computers, who also proposed the actual theoretical model of biological morphogenesis, was forced onto this medication to induce chemical castration as a punitive "treatment" for homosexual behaviour, shortly before he died in ambiguous circumstances.<span class="mw-ref" id="cite_ref-115"><a href="#cite_note-115" style="counter-reset: mw-Ref 115;"><span class="mw-reflink-text">[115]</span></a></span>.</p>

<p>James Herriot describes a case regarding treating a small dog's testicular Sertoli cell tumor in his 1974 book <i>All Things Bright and Beautiful</i>. Herriot decided to prescribe a high dose of the new drug Stilboestrol for the recurring tumor, with the amusing side effect that the male dog became "attractive to other male dogs", who followed the terrier around the village for a few weeks. Herriot comments in the story that he knew "The new drug was said to have a feminising effect, but surely not to that extent."</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Veterinary_use">Veterinary use</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Canine_incontinence">Canine incontinence</h3></summary>
    
<p>DES has been very successful in treating female canine incontinence stemming from poor sphincter control. It is still available from compounding pharmacies, and at the low (1<span>&nbsp;</span>mg) dose, does not have the carcinogenic properties that were so problematic in humans.<span class="mw-ref" id="cite_ref-116"><a href="#cite_note-116" style="counter-reset: mw-Ref 116;"><span class="mw-reflink-text">[116]</span></a></span> It is generally administered once a day for seven to ten days and then once every week as needed.</p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Livestock_growth_promotion">Livestock growth promotion</h3></summary>
    
<p>The greatest usage of DES was in the livestock industry, used to improve feed conversion in beef and poultry. During the 1960s, DES was used as a <a href="Growth_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Growth_hormone" title="Growth hormone">growth hormone</a> in the beef and poultry industries. It was later found to cause cancer by 1971, but was not phased out until 1979.<span class="mw-ref" id="cite_ref-117"><a href="#cite_note-117" style="counter-reset: mw-Ref 117;"><span class="mw-reflink-text">[117]</span></a></span><span class="mw-ref" id="cite_ref-urlenvirocancer.cornell.edu_118-0"><a href="#cite_note-urlenvirocancer.cornell.edu-118" style="counter-reset: mw-Ref 118;"><span class="mw-reflink-text">[118]</span></a></span> When DES was discovered to be harmful to humans, it was moved to veterinary use.</p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-ChabnerLongo1996-1"> <span id="mw-reference-text-cite_note-ChabnerLongo1996-1" class="mw-reference-text"><cite id="CITEREFBruce_ChabnerDan_Louis_Longo1996" class="citation book cs1">Bruce Chabner; Dan Louis Longo (1996). <a href="javascript:if(confirm('https://books.google.com/?id=TZNrAAAAMAAJ  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/?id=TZNrAAAAMAAJ'" tppabs="https://books.google.com/?id=TZNrAAAAMAAJ" class="external text external"><i>Cancer Chemotherapy and Biotherapy: Principles and Practice</i></a>. Lippincott-Raven Publishers. p.<span>&nbsp;</span>186. ISBN<span>&nbsp;</span><bdi>978-0-397-51418-2</bdi>. <q>Piperazine estrone sulfate and micronized estradiol were equipotent with respect to increases in SHBG, whereas [...] DES was 28.4-fold more potent [...]. With respect to decreased FSH, [...] DES was 3.8-fold, and ethinyl estradiol was 80 to 200-fold more potent than was piperazine estrone sulfate. The dose equivalents for ethinyl estradiol (50 µg) and DES (1 mg) reflect these relative potencies.220 [...] DES, a potent synthetic estrogen (Fig. 6-12), is absorbed well after an oral dosage. Patients given 1 mg of DES daily had plasma concentrations at 20 hours ranging from 0.9 to 1.9 ng per mL. The initial half-life of DES is 80 minutes, with a secondary half-life of 24 hours.222 The principal pathways of metabolism are conversion to the glucuronide and oxidation. The oxidative pathways include aromatic hydroxylation of the ethyl side chains and dehydrogenation to (Z,Z)-dienestrol, producing transient quinone-like intermediates that react with cellular macromolecules and cause genetic damage in eukaryotic cells.223 Metabolic activation of DES may explain its well-established carcinogenic properties.224</q></cite></span></li><li id="cite_note-OelschlägerRothley1988-2"> <span id="mw-reference-text-cite_note-OelschlägerRothley1988-2" class="mw-reference-text"><cite id="CITEREFOelschlägerRothleyDunzendorfer1988" class="citation journal cs1">Oelschläger, Herbert; Rothley, Dietrich; Dunzendorfer, Udo (1988). "New Results on the Pharmacokinetics of Fosfestrol". <i>Urologia Internationalis</i>. <b>43</b> (1): 15–23. doi:<a href="javascript:if(confirm('https://doi.org/10.1159%2F000281427  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1159%2F000281427'" tppabs="https://doi.org/10.1159%2F000281427" class="external text external">10.1159/000281427</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1423-0399  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1423-0399'" tppabs="https://www.worldcat.org/issn/1423-0399" class="external text external">1423-0399</a>.</cite></span></li><li id="cite_note-pmid8428334-3"> <span id="mw-reference-text-cite_note-pmid8428334-3" class="mw-reference-text"><cite id="CITEREFDrozKattanBonnayChraibi1993" class="citation journal cs1">Droz JP, Kattan J, Bonnay M, Chraibi Y, Bekradda M, Culine S (February 1993). "High-dose continuous-infusion fosfestrol in hormone-resistant prostate cancer". <i>Cancer</i>. <b>71</b> (3 Suppl): 1123–30. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F1097-0142%2819930201%2971%3A3%2B%3C1123%3A%3AAID-CNCR2820711434%3E3.0.CO%3B2-T  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F1097-0142%2819930201%2971%3A3%2B%3C1123%3A%3AAID-CNCR2820711434%3E3.0.CO%3B2-T'" tppabs="https://doi.org/10.1002%2F1097-0142%2819930201%2971%3A3%2B%3C1123%3A%3AAID-CNCR2820711434%3E3.0.CO%3B2-T" class="external text external">10.1002/1097-0142(19930201)71:3+<span>&lt;</span>1123::AID-CNCR2820711434<span>&gt;</span>3.0.CO;2-T</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8428334  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8428334'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8428334" class="external text external">8428334</a>.</cite></span></li><li id="cite_note-pmid4276416-4"> <span id="mw-reference-text-cite_note-pmid4276416-4" class="mw-reference-text"><cite id="CITEREFNollerFish1974" class="citation journal cs1">Noller KL, Fish CR (July 1974). "Diethylstilbestrol usage: Its interesting past, important present, and questionable future". <i>Med. Clin. North Am</i>. <b>58</b> (4): 793–810. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0025-7125%2816%2932122-8  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0025-7125%2816%2932122-8'" tppabs="https://doi.org/10.1016%2FS0025-7125%2816%2932122-8" class="external text external">10.1016/S0025-7125(16)32122-8</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/4276416  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/4276416'" tppabs="https://pubmed.ncbi.nlm.nih.gov/4276416" class="external text external">4276416</a>.</cite></span></li><li id="cite_note-Elks2014-5"> <span id="mw-reference-text-cite_note-Elks2014-5" class="mw-reference-text"><cite id="CITEREFElks2014" class="citation book cs1">Elks J (14 November 2014). <a href="javascript:if(confirm('https://books.google.com/?id=0vXTBwAAQBAJ&pg=PA396  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/?id=0vXTBwAAQBAJ&pg=PA396'" tppabs="https://books.google.com/?id=0vXTBwAAQBAJ&pg=PA396" class="external text external"><i>The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies</i></a>. Springer. pp.<span>&nbsp;</span>396–. ISBN<span>&nbsp;</span><bdi>978-1-4757-2085-3</bdi>.</cite></span></li><li id="cite_note-Kuhl2005-6"> <span id="mw-reference-text-cite_note-Kuhl2005-6" class="mw-reference-text"><cite id="CITEREFKuhl2005" class="citation journal cs1">Kuhl H (August 2005). <a href="javascript:if(confirm('http://hormonebalance.org/images/documents/Kuhl%2005%20%20Pharm%20Estro%20Progest%20Climacteric_1313155660.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://hormonebalance.org/images/documents/Kuhl%2005%20%20Pharm%20Estro%20Progest%20Climacteric_1313155660.pdf'" tppabs="http://hormonebalance.org/images/documents/Kuhl%2005%20%20Pharm%20Estro%20Progest%20Climacteric_1313155660.pdf" class="external text external">"Pharmacology of estrogens and progestogens: influence of different routes of administration"</a> <span class="cs1-format">(PDF)</span>. <i>Climacteric</i>. <b>8</b> (Suppl 1): 3–63. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F13697130500148875  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F13697130500148875'" tppabs="https://doi.org/10.1080%2F13697130500148875" class="external text external">10.1080/13697130500148875</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16112947  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16112947'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16112947" class="external text external">16112947</a>.</cite></span></li><li id="cite_note-Watkins2007-7"> <span id="mw-reference-text-cite_note-Watkins2007-7" class="mw-reference-text"><cite id="CITEREFElizabeth_Siegel_Watkins2007" class="citation book cs1">Elizabeth Siegel Watkins (16 April 2007). <a href="javascript:if(confirm('https://books.google.com/?id=-tz4J4_hgdIC&pg=PA26  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/?id=-tz4J4_hgdIC&pg=PA26'" tppabs="https://books.google.com/?id=-tz4J4_hgdIC&pg=PA26" class="external text external"><i>The Estrogen Elixir: A History of Hormone Replacement Therapy in America</i></a>. JHU Press. pp.<span>&nbsp;</span>26–. ISBN<span>&nbsp;</span><bdi>978-0-8018-8602-7</bdi>.</cite></span></li><li id="cite_note-pmid16096877-8"> <span id="mw-reference-text-cite_note-pmid16096877-8" class="mw-reference-text"><cite id="CITEREFVeurinkKosterBerg2005" class="citation journal cs1">Veurink M, Koster M, Berg LT (June 2005). "The history of DES, lessons to be learned". <i>Pharm World Sci</i>. <b>27</b> (3): 139–43. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs11096-005-3663-z  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs11096-005-3663-z'" tppabs="https://doi.org/10.1007%2Fs11096-005-3663-z" class="external text external">10.1007/s11096-005-3663-z</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16096877  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16096877'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16096877" class="external text external">16096877</a>.</cite></span></li><li id="cite_note-FeldbergLadd-Taylor2003-9"> <span id="mw-reference-text-cite_note-FeldbergLadd-Taylor2003-9" class="mw-reference-text"><cite id="CITEREFGeorgina_D._FeldbergMolly_Ladd-TaylorAlison_Li2003" class="citation book cs1">Georgina D. Feldberg; Molly Ladd-Taylor; Alison Li (2003). <a href="javascript:if(confirm('https://books.google.com/?id=CRjtHlq1INcC&pg=PA103  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/?id=CRjtHlq1INcC&pg=PA103'" tppabs="https://books.google.com/?id=CRjtHlq1INcC&pg=PA103" class="external text external"><i>Women, Health and Nation: Canada and the United States Since 1945</i></a>. McGill-Queen's Press - MQUP. pp.<span>&nbsp;</span>103–. ISBN<span>&nbsp;</span><bdi>978-0-7735-2501-6</bdi>.</cite></span></li><li id="cite_note-urlDES_Update:_For_Consumers._Centers_for_Disease_Control_and_Prevention-10"> <span id="mw-reference-text-cite_note-urlDES_Update:_For_Consumers._Centers_for_Disease_Control_and_Prevention-10" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.cdc.gov/des/consumers/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.cdc.gov/des/consumers/'" tppabs="https://www.cdc.gov/des/consumers/" class="external text external">"DES Update: For Consumers"</a>. United States Department of Health and Human Services: Centers for Disease Control and Prevention<span class="reference-accessdate">. Retrieved <span class="nowrap">2011-06-30</span></span>.</cite></span></li><li id="cite_note-11"> <span id="mw-reference-text-cite_note-11" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.cancer.gov/about-cancer/causes-prevention/risk/hormones/des-fact-sheet  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.cancer.gov/about-cancer/causes-prevention/risk/hormones/des-fact-sheet'" tppabs="https://www.cancer.gov/about-cancer/causes-prevention/risk/hormones/des-fact-sheet" class="external text external">"Diethylstilbestrol (DES) and Cancer"</a>. National Cancer Institute<span class="reference-accessdate">. Retrieved <span class="nowrap">2011-06-30</span></span>.</cite></span></li><li id="cite_note-Broadly-DES-Daughters-2017-12"> <span id="mw-reference-text-cite_note-Broadly-DES-Daughters-2017-12" class="mw-reference-text"><cite id="CITEREFArnold2017" class="citation news cs1">Arnold, Amanda (January 5, 2017). <a href="javascript:if(confirm('https://www.vice.com/en_us/article/zmbvp9/des-daughters-the-devastating-effects-of-a-1940s-wonder-pill-haunt-women-generations-later  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.vice.com/en_us/article/zmbvp9/des-daughters-the-devastating-effects-of-a-1940s-wonder-pill-haunt-women-generations-later'" tppabs="https://www.vice.com/en_us/article/zmbvp9/des-daughters-the-devastating-effects-of-a-1940s-wonder-pill-haunt-women-generations-later" class="external text external">"The Devastating Effects of a 1940s 'Wonder Pill' Haunt Women Generations Later"</a>. <i>Broadly</i>.</cite></span></li><li id="cite_note-pmid15063479-13"> <span id="mw-reference-text-cite_note-pmid15063479-13" class="mw-reference-text"><cite id="CITEREFCoelingh_Bennink2004" class="citation journal cs1">Coelingh Bennink HJ (April 2004). "Are all estrogens the same?". <i>Maturitas</i>. <b>47</b> (4): 269–275. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.maturitas.2003.11.009  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.maturitas.2003.11.009'" tppabs="https://doi.org/10.1016%2Fj.maturitas.2003.11.009" class="external text external">10.1016/j.maturitas.2003.11.009</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15063479  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15063479'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15063479" class="external text external">15063479</a>.</cite></span></li><li id="cite_note-Vorherr2012-14"> <span id="mw-reference-text-cite_note-Vorherr2012-14" class="mw-reference-text"><cite id="CITEREFHelmuth_Vorherr2012" class="citation book cs1">Helmuth Vorherr (2 December 2012). <a href="javascript:if(confirm('https://books.google.com/?id=wYxirvD2X2IC&pg=PA201  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/?id=wYxirvD2X2IC&pg=PA201'" tppabs="https://books.google.com/?id=wYxirvD2X2IC&pg=PA201" class="external text external"><i>The Breast: Morphology, Physiology, and Lactation</i></a>. Elsevier Science. pp.<span>&nbsp;</span>201–203. ISBN<span>&nbsp;</span><bdi>978-0-323-15726-1</bdi>.</cite></span></li><li id="cite_note-pmid16986003-15"> <span id="mw-reference-text-cite_note-pmid16986003-15" class="mw-reference-text"><cite id="CITEREFThompson2001" class="citation journal cs1">Thompson IM (2001). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1476081  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1476081'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1476081" class="external text external">"Flare Associated with LHRH-Agonist Therapy"</a>. <i>Rev Urol</i>. 3 Suppl 3: S10–4. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1476081  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1476081'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1476081" class="external text external">1476081</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16986003  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16986003'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16986003" class="external text external">16986003</a>.</cite></span></li><li id="cite_note-pmid8481213-16"> <span id="mw-reference-text-cite_note-pmid8481213-16" class="mw-reference-text"><cite id="CITEREFScaletsckySmith1993" class="citation journal cs1">Scaletscky R, Smith JA (April 1993). "Disease flare with gonadotrophin-releasing hormone (GnRH) analogues. How serious is it?". <i>Drug Saf</i>. <b>8</b> (4): 265–70. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00002018-199308040-00001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00002018-199308040-00001'" tppabs="https://doi.org/10.2165%2F00002018-199308040-00001" class="external text external">10.2165/00002018-199308040-00001</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8481213  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8481213'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8481213" class="external text external">8481213</a>.</cite></span></li><li id="cite_note-pmid2973364-17"> <span id="mw-reference-text-cite_note-pmid2973364-17" class="mw-reference-text"><cite id="CITEREFKreisAhmannJordande_Haan1988" class="citation journal cs1">Kreis W, Ahmann FR, Jordan VC, de Haan H, Scott M (October 1988). "Oestrogen pre-treatment abolishes luteinising hormone-releasing hormone testosterone stimulation". <i>Br J Urol</i>. <b>62</b> (4): 352–4. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1464-410X.1988.tb04364.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1464-410X.1988.tb04364.x'" tppabs="https://doi.org/10.1111%2Fj.1464-410X.1988.tb04364.x" class="external text external">10.1111/j.1464-410X.1988.tb04364.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2973364  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2973364'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2973364" class="external text external">2973364</a>.</cite></span></li><li id="cite_note-pmid3920802-18"> <span id="mw-reference-text-cite_note-pmid3920802-18" class="mw-reference-text"><cite id="CITEREFSteinSmith1985" class="citation journal cs1">Stein BS, Smith JA (April 1985). "DES lead-in to use of luteinizing hormone releasing hormone analogs in treatment of metastatic carcinoma of prostate". <i>Urology</i>. <b>25</b> (4): 350–3. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0090-4295%2885%2990484-4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0090-4295%2885%2990484-4'" tppabs="https://doi.org/10.1016%2F0090-4295%2885%2990484-4" class="external text external">10.1016/0090-4295(85)90484-4</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/3920802  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/3920802'" tppabs="https://pubmed.ncbi.nlm.nih.gov/3920802" class="external text external">3920802</a>.</cite></span></li><li id="cite_note-pmid2969641-19"> <span id="mw-reference-text-cite_note-pmid2969641-19" class="mw-reference-text"><cite id="CITEREFFernandez_del_MoralLitjensWeilDebruyne1988" class="citation journal cs1">Fernandez del Moral P, Litjens TT, Weil EH, Debruyne FM (August 1988). "Can combined DES and LHRH depot therapy (ICI 118630) prevent endocrinologic and clinical flare-up in metastatic prostate cancer?". <i>Urology</i>. <b>32</b> (2): 137–40. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0090-4295%2888%2990316-0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0090-4295%2888%2990316-0'" tppabs="https://doi.org/10.1016%2F0090-4295%2888%2990316-0" class="external text external">10.1016/0090-4295(88)90316-0</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2969641  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2969641'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2969641" class="external text external">2969641</a>.</cite></span></li><li id="cite_note-pmid7688656-20"> <span id="mw-reference-text-cite_note-pmid7688656-20" class="mw-reference-text"><cite id="CITEREFBruchovskyGoldenbergAkakuraRennie1993" class="citation journal cs1">Bruchovsky N, Goldenberg SL, Akakura K, Rennie PS (September 1993). "Luteinizing hormone-releasing hormone agonists in prostate cancer. Elimination of flare reaction by pretreatment with cyproterone acetate and low-dose diethylstilbestrol". <i>Cancer</i>. <b>72</b> (5): 1685–91. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F1097-0142%2819930901%2972%3A5%3C1685%3A%3AAID-CNCR2820720532%3E3.0.CO%3B2-3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F1097-0142%2819930901%2972%3A5%3C1685%3A%3AAID-CNCR2820720532%3E3.0.CO%3B2-3'" tppabs="https://doi.org/10.1002%2F1097-0142%2819930901%2972%3A5%3C1685%3A%3AAID-CNCR2820720532%3E3.0.CO%3B2-3" class="external text external">10.1002/1097-0142(19930901)72:5<span>&lt;</span>1685::AID-CNCR2820720532<span>&gt;</span>3.0.CO;2-3</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7688656  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7688656'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7688656" class="external text external">7688656</a>.</cite></span></li><li id="cite_note-pmid10678560-21"> <span id="mw-reference-text-cite_note-pmid10678560-21" class="mw-reference-text"><cite id="CITEREFKotakeUsamiAkazaKoiso1999" class="citation journal cs1">Kotake T, Usami M, Akaza H, Koiso K, Homma Y, Kawabe K, Aso Y, Orikasa S, Shimazaki J, Isaka S, Yoshida O, Hirao Y, Okajima E, Naito S, Kumazawa J, Kanetake H, Saito Y, Ohi Y, Ohashi Y (November 1999). <a href="javascript:if(confirm('https://doi.org/10.1093/jjco/29.11.562  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093/jjco/29.11.562'" tppabs="https://doi.org/10.1093/jjco/29.11.562" class="external text external">"Goserelin acetate with or without antiandrogen or estrogen in the treatment of patients with advanced prostate cancer: a multicenter, randomized, controlled trial in Japan. Zoladex Study Group"</a>. <i>Jpn. J. Clin. Oncol</i>. <b>29</b> (11): 562–70. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1093%2Fjjco%2F29.11.562  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fjjco%2F29.11.562'" tppabs="https://doi.org/10.1093%2Fjjco%2F29.11.562" class="external text external">10.1093/jjco/29.11.562</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10678560  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10678560'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10678560" class="external text external">10678560</a>.</cite></span></li><li id="cite_note-Hamburger1969-22"> <span id="mw-reference-text-cite_note-Hamburger1969-22" class="mw-reference-text"><cite id="CITEREFHamburger1969" class="citation book cs1">Hamburger, Christian (1969). "Endocrine treatment of male and female transsexualism".  In Money, John; Green, Richard (eds.). <a href="javascript:if(confirm('https://books.google.com/books?id=eGm1tQEACAAJ  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=eGm1tQEACAAJ'" tppabs="https://books.google.com/books?id=eGm1tQEACAAJ" class="external text external"><i>Transsexualism and Sex Reassignment</i></a>. Johns Hopkins Press. pp.<span>&nbsp;</span>291–307. OCLC<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/oclc/6866559  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/oclc/6866559'" tppabs="https://www.worldcat.org/oclc/6866559" class="external text external">6866559</a>.</cite></span></li><li id="cite_note-pmid794803-23"> <span id="mw-reference-text-cite_note-pmid794803-23" class="mw-reference-text"><cite id="CITEREFOber1976" class="citation journal cs1">Ober WB (1976). "Stilbestrol: a pathologist's view". <i>Pathol Annu</i>. <b>11</b>: 227–54. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/794803  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/794803'" tppabs="https://pubmed.ncbi.nlm.nih.gov/794803" class="external text external">794803</a>.</cite></span></li><li id="cite_note-Buchsbaum2012-24"> <span id="mw-reference-text-cite_note-Buchsbaum2012-24" class="mw-reference-text"><cite id="CITEREFH.J._Buchsbaum2012" class="citation book cs1">H.J. Buchsbaum (6 December 2012). <a href="javascript:if(confirm('https://books.google.com/?id=z0LuBwAAQBAJ&pg=PA60  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/?id=z0LuBwAAQBAJ&pg=PA60'" tppabs="https://books.google.com/?id=z0LuBwAAQBAJ&pg=PA60" class="external text external"><i>The Menopause</i></a>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>60–. ISBN<span>&nbsp;</span><bdi>978-1-4612-5525-3</bdi>.</cite></span></li><li id="cite_note-pmid29600433-25"> <span id="mw-reference-text-cite_note-pmid29600433-25" class="mw-reference-text"><cite id="CITEREFReisZaniGarcía-Perdomo2018" class="citation journal cs1">Reis LO, Zani EL, García-Perdomo HA (June 2018). "Estrogen therapy in patients with prostate cancer: a contemporary systematic review". <i>Int Urol Nephrol</i>. <b>50</b> (6): 993–1003. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs11255-018-1854-5  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs11255-018-1854-5'" tppabs="https://doi.org/10.1007%2Fs11255-018-1854-5" class="external text external">10.1007/s11255-018-1854-5</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29600433  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29600433'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29600433" class="external text external">29600433</a>.</cite></span></li><li id="cite_note-pmid24256023-26"> <span id="mw-reference-text-cite_note-pmid24256023-26" class="mw-reference-text"><cite id="CITEREFTuroSmolskiEslerKujawa2014" class="citation journal cs1">Turo R, Smolski M, Esler R, Kujawa ML, Bromage SJ, Oakley N, Adeyoju A, Brown SC, Brough R, Sinclair A, Collins GN (February 2014). "Diethylstilboestrol for the treatment of prostate cancer: past, present and future". <i>Scand J Urol</i>. <b>48</b> (1): 4–14. doi:<a href="javascript:if(confirm('https://doi.org/10.3109%2F21681805.2013.861508  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3109%2F21681805.2013.861508'" tppabs="https://doi.org/10.3109%2F21681805.2013.861508" class="external text external">10.3109/21681805.2013.861508</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24256023  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24256023'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24256023" class="external text external">24256023</a>.</cite></span></li><li id="cite_note-pmid22578092-27"> <span id="mw-reference-text-cite_note-pmid22578092-27" class="mw-reference-text"><cite id="CITEREFBossetAlbigesSeisende_la_Motte_Rouge2012" class="citation journal cs1">Bosset PO, Albiges L, Seisen T, de la Motte Rouge T, Phé V, Bitker MO, Rouprêt M (December 2012). "Current role of diethylstilbestrol in the management of advanced prostate cancer". <i>BJU Int</i>. <b>110</b> (11 Pt C): E826–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1464-410X.2012.11206.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1464-410X.2012.11206.x'" tppabs="https://doi.org/10.1111%2Fj.1464-410X.2012.11206.x" class="external text external">10.1111/j.1464-410X.2012.11206.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22578092  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22578092'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22578092" class="external text external">22578092</a>.</cite></span></li><li id="cite_note-pmid14532759-28"> <span id="mw-reference-text-cite_note-pmid14532759-28" class="mw-reference-text"><cite id="CITEREFScherrPitts2003" class="citation journal cs1">Scherr DS, Pitts WR (November 2003). "The nonsteroidal effects of diethylstilbestrol: the rationale for androgen deprivation therapy without estrogen deprivation in the treatment of prostate cancer". <i>J. Urol</i>. <b>170</b> (5): 1703–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F01.ju.0000077558.48257.3d  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F01.ju.0000077558.48257.3d'" tppabs="https://doi.org/10.1097%2F01.ju.0000077558.48257.3d" class="external text external">10.1097/01.ju.0000077558.48257.3d</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/14532759  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/14532759'" tppabs="https://pubmed.ncbi.nlm.nih.gov/14532759" class="external text external">14532759</a>.</cite></span></li><li id="cite_note-pmid15046698-29"> <span id="mw-reference-text-cite_note-pmid15046698-29" class="mw-reference-text"><cite id="CITEREFOh2002" class="citation journal cs1">Oh WK (September 2002). "The evolving role of estrogen therapy in prostate cancer". <i>Clin Prostate Cancer</i>. <b>1</b> (2): 81–9. doi:<a href="javascript:if(confirm('https://doi.org/10.3816%2Fcgc.2002.n.009  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3816%2Fcgc.2002.n.009'" tppabs="https://doi.org/10.3816%2Fcgc.2002.n.009" class="external text external">10.3816/cgc.2002.n.009</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15046698  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15046698'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15046698" class="external text external">15046698</a>.</cite></span></li><li id="cite_note-pmid11502463-30"> <span id="mw-reference-text-cite_note-pmid11502463-30" class="mw-reference-text"><cite id="CITEREFMalkowicz2001" class="citation journal cs1">Malkowicz SB (August 2001). "The role of diethylstilbestrol in the treatment of prostate cancer". <i>Urology</i>. <b>58</b> (2 Suppl 1): 108–13. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fs0090-4295%2801%2901252-3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fs0090-4295%2801%2901252-3'" tppabs="https://doi.org/10.1016%2Fs0090-4295%2801%2901252-3" class="external text external">10.1016/s0090-4295(01)01252-3</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11502463  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11502463'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11502463" class="external text external">11502463</a>.</cite></span></li><li id="cite_note-pmid7500443-31"> <span id="mw-reference-text-cite_note-pmid7500443-31" class="mw-reference-text"><cite id="CITEREFCoxCrawford1995" class="citation journal cs1">Cox RL, Crawford ED (December 1995). "Estrogens in the treatment of prostate cancer". <i>J. Urol</i>. <b>154</b> (6): 1991–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fs0022-5347%2801%2966670-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fs0022-5347%2801%2966670-9'" tppabs="https://doi.org/10.1016%2Fs0022-5347%2801%2966670-9" class="external text external">10.1016/s0022-5347(01)66670-9</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7500443  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7500443'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7500443" class="external text external">7500443</a>.</cite></span></li><li id="cite_note-pmid17239273-32"> <span id="mw-reference-text-cite_note-pmid17239273-32" class="mw-reference-text"><cite id="CITEREFLycetteBlandGarzottoBeer2006" class="citation journal cs1">Lycette JL, Bland LB, Garzotto M, Beer TM (December 2006). "Parenteral estrogens for prostate cancer: can a new route of administration overcome old toxicities?". <i>Clin Genitourin Cancer</i>. <b>5</b> (3): 198–205. doi:<a href="javascript:if(confirm('https://doi.org/10.3816%2FCGC.2006.n.037  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3816%2FCGC.2006.n.037'" tppabs="https://doi.org/10.3816%2FCGC.2006.n.037" class="external text external">10.3816/CGC.2006.n.037</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17239273  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17239273'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17239273" class="external text external">17239273</a>.</cite></span></li><li id="cite_note-pmid27889048-33"> <span id="mw-reference-text-cite_note-pmid27889048-33" class="mw-reference-text"><cite id="CITEREFCoelingh_BenninkVerhoevenDutmanThijssen2017" class="citation journal cs1">Coelingh Bennink HJ, Verhoeven C, Dutman AE, Thijssen J (January 2017). <a href="javascript:if(confirm('https://doi.org/10.1016/j.maturitas.2016.10.010  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016/j.maturitas.2016.10.010'" tppabs="https://doi.org/10.1016/j.maturitas.2016.10.010" class="external text external">"The use of high-dose estrogens for the treatment of breast cancer"</a>. <i>Maturitas</i>. <b>95</b>: 11–23. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.maturitas.2016.10.010  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.maturitas.2016.10.010'" tppabs="https://doi.org/10.1016%2Fj.maturitas.2016.10.010" class="external text external">10.1016/j.maturitas.2016.10.010</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27889048  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27889048'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27889048" class="external text external">27889048</a>.</cite></span></li><li id="cite_note-pmid1627392-34"> <span id="mw-reference-text-cite_note-pmid1627392-34" class="mw-reference-text"><cite id="CITEREFMarselosTomatis1992" class="citation journal cs1">Marselos M, Tomatis L (1992). "Diethylstilboestrol: I, Pharmacology, Toxicology and carcinogenicity in humans". <i>Eur. J. Cancer</i>. <b>28A</b> (6–7): 1182–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0959-8049%2892%2990482-h  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0959-8049%2892%2990482-h'" tppabs="https://doi.org/10.1016%2F0959-8049%2892%2990482-h" class="external text external">10.1016/0959-8049(92)90482-h</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1627392  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1627392'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1627392" class="external text external">1627392</a>.</cite></span></li><li id="cite_note-EllisDehdahti2014-35"> <span id="mw-reference-text-cite_note-EllisDehdahti2014-35" class="mw-reference-text"><cite id="CITEREFEllisDehdahtiKommareddyJamalabadi-Majidi2014" class="citation journal cs1">Ellis, MJ; Dehdahti, F; Kommareddy, A; Jamalabadi-Majidi, S; Crowder, R; Jeffe, DB; Gao, F; Fleming, G; Silverman, P; Dickler, M; Carey, L; Marcom, PK (2014). "A randomized phase 2 trial of low dose (6 mg daily) versus high dose (30 mg daily) estradiol for patients with estrogen receptor positive aromatase inhibitor resistant advanced breast cancer". <i>Cancer Research</i>. <b>69</b> (2 Supplement): 16. doi:<a href="javascript:if(confirm('https://doi.org/10.1158%2F0008-5472.SABCS-16  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1158%2F0008-5472.SABCS-16'" tppabs="https://doi.org/10.1158%2F0008-5472.SABCS-16" class="external text external">10.1158/0008-5472.SABCS-16</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0008-5472  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0008-5472'" tppabs="https://www.worldcat.org/issn/0008-5472" class="external text external">0008-5472</a>.</cite></span></li><li id="cite_note-pmid31367069-36"> <span id="mw-reference-text-cite_note-pmid31367069-36" class="mw-reference-text"><cite id="CITEREFMoorthyLaxman_PrabhuVenugopal2019" class="citation journal cs1">Moorthy HK, Laxman Prabhu GG, Venugopal P (2019). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639989  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639989'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639989" class="external text external">"The resurgence of estrogens in the treatment of castration-resistant prostate cancer"</a>. <i>Indian J Urol</i>. <b>35</b> (3): 189–196. doi:<a href="javascript:if(confirm('https://doi.org/10.4103%2Fiju.IJU_56_19  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4103%2Fiju.IJU_56_19'" tppabs="https://doi.org/10.4103%2Fiju.IJU_56_19" class="external text external">10.4103/iju.IJU_56_19</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639989  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639989'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639989" class="external text external">6639989</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/31367069  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/31367069'" tppabs="https://pubmed.ncbi.nlm.nih.gov/31367069" class="external text external">31367069</a>.</cite></span></li><li id="cite_note-pmid13638626-37"> <span id="mw-reference-text-cite_note-pmid13638626-37" class="mw-reference-text"><cite id="CITEREFSwyer1959" class="citation journal cs1">Swyer GI (April 1959). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1993181  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1993181'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1993181" class="external text external">"The oestrogens"</a>. <i>Br Med J</i>. <b>1</b> (5128): 1029–31. doi:<a href="javascript:if(confirm('https://doi.org/10.1136%2Fbmj.1.5128.1029  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1136%2Fbmj.1.5128.1029'" tppabs="https://doi.org/10.1136%2Fbmj.1.5128.1029" class="external text external">10.1136/bmj.1.5128.1029</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1993181  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1993181'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1993181" class="external text external">1993181</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/13638626  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/13638626'" tppabs="https://pubmed.ncbi.nlm.nih.gov/13638626" class="external text external">13638626</a>. <q>[Diethylstilbestrol] suffers from the serious drawback that in doses above 1 mg. a day it is likely to produce nausea, vomiting, abdominal discomfort, headache, and bloating in a proportion of patients varyingly estimated from 15 to 50%.</q></cite></span></li><li id="cite_note-Del_CastilloArgonz1954-38"> <span id="mw-reference-text-cite_note-Del_CastilloArgonz1954-38" class="mw-reference-text"><cite id="CITEREFDel_CastilloArgonz1954" class="citation journal cs1">Del Castillo, E. B.; Argonz, J. (1954). "Oestrogen treatment in cases of rudimentary ovary syndrome". <i>Acta Endocrinologica</i>. <b>15</b> (4): 299–312. doi:<a href="javascript:if(confirm('https://doi.org/10.1530%2Facta.0.0150299  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1530%2Facta.0.0150299'" tppabs="https://doi.org/10.1530%2Facta.0.0150299" class="external text external">10.1530/acta.0.0150299</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0804-4643  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0804-4643'" tppabs="https://www.worldcat.org/issn/0804-4643" class="external text external">0804-4643</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/13157878  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/13157878'" tppabs="https://pubmed.ncbi.nlm.nih.gov/13157878" class="external text external">13157878</a>.</cite></span></li><li id="cite_note-Labhart2012-39"> <span id="mw-reference-text-cite_note-Labhart2012-39" class="mw-reference-text"><cite id="CITEREFA._Labhart2012" class="citation book cs1">A. Labhart (6 December 2012). <a href="javascript:if(confirm('https://books.google.com/?id=DAgJCAAAQBAJ&pg=PA720  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/?id=DAgJCAAAQBAJ&pg=PA720'" tppabs="https://books.google.com/?id=DAgJCAAAQBAJ&pg=PA720" class="external text external"><i>Clinical Endocrinology: Theory and Practice</i></a>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>720–. ISBN<span>&nbsp;</span><bdi>978-3-642-96158-8</bdi>.</cite></span></li><li id="cite_note-DavisBoynton1941-40"> <span id="mw-reference-text-cite_note-DavisBoynton1941-40" class="mw-reference-text"><cite id="CITEREFDavisBoynton1941" class="citation journal cs1">Davis, M.Edward; Boynton, Melbourne W. (1941). "Indications, clinical use and toxicity of 4-4' dihydroxy diethyl stilbene". <i>The Journal of Clinical Endocrinology &amp; Metabolism</i>. <b>1</b> (4): 339–345. doi:<a href="javascript:if(confirm('https://doi.org/10.1210%2Fjcem-1-4-339  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1210%2Fjcem-1-4-339'" tppabs="https://doi.org/10.1210%2Fjcem-1-4-339" class="external text external">10.1210/jcem-1-4-339</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0021-972X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0021-972X'" tppabs="https://www.worldcat.org/issn/0021-972X" class="external text external">0021-972X</a>.</cite></span></li><li id="cite_note-DavisBoynton1945-41"> <span id="mw-reference-text-cite_note-DavisBoynton1945-41" class="mw-reference-text"><cite id="CITEREFDavisBoyntonFergusonRothman1945" class="citation journal cs1">Davis, M. Edward; Boynton, M. W.; Ferguson, J. H.; Rothman, S. (1945). "Studies on Pigmentation of Endocrine Origin1". <i>The Journal of Clinical Endocrinology &amp; Metabolism</i>. <b>5</b> (3): 138–146. doi:<a href="javascript:if(confirm('https://doi.org/10.1210%2Fjcem-5-3-138  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1210%2Fjcem-5-3-138'" tppabs="https://doi.org/10.1210%2Fjcem-5-3-138" class="external text external">10.1210/jcem-5-3-138</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0021-972X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0021-972X'" tppabs="https://www.worldcat.org/issn/0021-972X" class="external text external">0021-972X</a>.</cite></span></li><li id="cite_note-pmid21433876-42"> <span id="mw-reference-text-cite_note-pmid21433876-42" class="mw-reference-text"><cite id="CITEREFLewis1939" class="citation journal cs1">Lewis RM (December 1939). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2602231  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2602231'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2602231" class="external text external">"The Clinical Use of Stilbestrol, A Synthetic Estrogen: Preliminary Report"</a>. <i>Yale J Biol Med</i>. <b>12</b> (2): 235–8. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2602231  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2602231'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2602231" class="external text external">2602231</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21433876  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21433876'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21433876" class="external text external">21433876</a>.</cite></span></li><li id="cite_note-LisserCurtis1947-43"> <span id="mw-reference-text-cite_note-LisserCurtis1947-43" class="mw-reference-text"><cite id="CITEREFLisserCurtisEscamillaGoldberg1947" class="citation journal cs1">Lisser, H.; Curtis, L. E.; Escamilla, R. F.; Goldberg, Minnie B. (1947). "The syndrome of congenitally aplastic ovaries with sexual infantilism, high urinary gonadotropins, short stature and other congenital abnormalities: tabular presentation of twenty-five previously unpublished cases". <i>The Journal of Clinical Endocrinology &amp; Metabolism</i>. <b>7</b> (10): 665–687. doi:<a href="javascript:if(confirm('https://doi.org/10.1210%2Fjcem-7-10-665  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1210%2Fjcem-7-10-665'" tppabs="https://doi.org/10.1210%2Fjcem-7-10-665" class="external text external">10.1210/jcem-7-10-665</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0021-972X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0021-972X'" tppabs="https://www.worldcat.org/issn/0021-972X" class="external text external">0021-972X</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20270944  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20270944'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20270944" class="external text external">20270944</a>.</cite></span></li><li id="cite_note-Hamblen1943-44"> <span id="mw-reference-text-cite_note-Hamblen1943-44" class="mw-reference-text"><cite id="CITEREFHamblen1943" class="citation journal cs1">Hamblen, E.C. (1943). "Endocrine therapy in gynecology and obstetrics". <i>American Journal of Obstetrics and Gynecology</i>. <b>45</b> (1): 147–160. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0002-9378%2843%2990672-6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0002-9378%2843%2990672-6'" tppabs="https://doi.org/10.1016%2FS0002-9378%2843%2990672-6" class="external text external">10.1016/S0002-9378(43)90672-6</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0002-9378  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0002-9378'" tppabs="https://www.worldcat.org/issn/0002-9378" class="external text external">0002-9378</a>.</cite></span></li><li id="cite_note-pmid14278040-45"> <span id="mw-reference-text-cite_note-pmid14278040-45" class="mw-reference-text"><cite id="CITEREFCrowleyMacDonald1965" class="citation journal cs1">Crowley LG, MacDonald I (April 1965). "Delalutin and estrogens for the treatment of advanced mammary carcinoma in the postmenopausal woman". <i>Cancer</i>. <b>18</b>: 436–46. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F1097-0142%28196504%2918%3A4%3C436%3A%3Aaid-cncr2820180407%3E3.0.co%3B2-d  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F1097-0142%28196504%2918%3A4%3C436%3A%3Aaid-cncr2820180407%3E3.0.co%3B2-d'" tppabs="https://doi.org/10.1002%2F1097-0142%28196504%2918%3A4%3C436%3A%3Aaid-cncr2820180407%3E3.0.co%3B2-d" class="external text external">10.1002/1097-0142(196504)18:4<span>&lt;</span>436::aid-cncr2820180407<span>&gt;</span>3.0.co;2-d</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/14278040  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/14278040'" tppabs="https://pubmed.ncbi.nlm.nih.gov/14278040" class="external text external">14278040</a>.</cite></span></li><li id="cite_note-pmid16321765-46"> <span id="mw-reference-text-cite_note-pmid16321765-46" class="mw-reference-text"><cite id="CITEREFDi_LorenzoAutorinoPerdonàDe_Placido2005" class="citation journal cs1">Di Lorenzo G, Autorino R, Perdonà S, De Placido S (December 2005). "Management of gynaecomastia in patients with prostate cancer: a systematic review". <i>Lancet Oncol</i>. <b>6</b> (12): 972–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS1470-2045%2805%2970464-2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS1470-2045%2805%2970464-2'" tppabs="https://doi.org/10.1016%2FS1470-2045%2805%2970464-2" class="external text external">10.1016/S1470-2045(05)70464-2</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16321765  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16321765'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16321765" class="external text external">16321765</a>.</cite></span></li><li id="cite_note-pmid24932461-47"> <span id="mw-reference-text-cite_note-pmid24932461-47" class="mw-reference-text"><cite id="CITEREFPhillipsShahDuongAbel2014" class="citation journal cs1">Phillips I, Shah SI, Duong T, Abel P, Langley RE (2014). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052190  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052190'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052190" class="external text external">"Androgen Deprivation Therapy and the Re-emergence of Parenteral Estrogen in Prostate Cancer"</a>. <i>Oncol Hematol Rev</i>. <b>10</b> (1): 42–47. doi:<a href="javascript:if(confirm('https://doi.org/10.17925%2Fohr.2014.10.1.42  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.17925%2Fohr.2014.10.1.42'" tppabs="https://doi.org/10.17925%2Fohr.2014.10.1.42" class="external text external">10.17925/ohr.2014.10.1.42</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052190  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052190'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052190" class="external text external">4052190</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24932461  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24932461'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24932461" class="external text external">24932461</a>.</cite></span></li><li id="cite_note-pmid12918007-48"> <span id="mw-reference-text-cite_note-pmid12918007-48" class="mw-reference-text"><cite id="CITEREFBamigboyeMorris2003" class="citation journal cs1">Bamigboye AA, Morris J (2003). "Oestrogen supplementation, mainly diethylstilbestrol, for preventing miscarriages and other adverse pregnancy outcomes". <i>Cochrane Database Syst Rev</i> (3): CD004353. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD004353  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD004353'" tppabs="https://doi.org/10.1002%2F14651858.CD004353" class="external text external">10.1002/14651858.CD004353</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12918007  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12918007'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12918007" class="external text external">12918007</a>.</cite></span></li><li id="cite_note-49"> <span id="mw-reference-text-cite_note-49" class="mw-reference-text"><cite id="CITEREFMarselos_M,_Tomatis_L1993" class="citation journal cs1">Marselos M, Tomatis L (1993). "Diethylstilboestrol: II, Pharmacology, Toxicology and Carcinogenicity in Experimental Animals". <i>European Journal of Cancer</i>. <b>29</b> (1): 149–155. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0959-8049%2893%2990597-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0959-8049%2893%2990597-9'" tppabs="https://doi.org/10.1016%2F0959-8049%2893%2990597-9" class="external text external">10.1016/0959-8049(93)90597-9</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1445734  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1445734'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1445734" class="external text external">1445734</a>.</cite></span></li><li id="cite_note-50"> <span id="mw-reference-text-cite_note-50" class="mw-reference-text"><cite id="CITEREFKioumourtzoglou_MA,_Coull_BA,_O'Reilly_ÉJ,_Ascherio_A,_Weisskopf_MG2018" class="citation journal cs1">Kioumourtzoglou MA, Coull BA, O'Reilly ÉJ, Ascherio A, Weisskopf MG (2018). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137513  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137513'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137513" class="external text external">"Association of Exposure to Diethylstilbestrol During Pregnancy With Multigenerational Neurodevelopmental Deficits"</a>. <i>JAMA Pediatr</i>. <b>172</b> (7): 670–677. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1001%2Fjamapediatrics.2018.0727  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Fjamapediatrics.2018.0727'" tppabs="https://doi.org/10.1001%2Fjamapediatrics.2018.0727" class="external text external">10.1001/jamapediatrics.2018.0727</a></span>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137513  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137513'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137513" class="external text external">6137513</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29799929  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29799929'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29799929" class="external text external">29799929</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-51"> <span id="mw-reference-text-cite_note-51" class="mw-reference-text"><cite id="CITEREFTitus-Ernstoff_L,_Troisi_R,_Hatch_EE,_Wise_LA,_Palmer_J,_Hyer_M,_Kaufman_R,_Adam_E,_Strohsnitter_W,_Noller_K,_Herbst_AL,_Gibson-Chambers_J,_Hartge_P,_Hoover_RN2006" class="citation journal cs1">Titus-Ernstoff L, Troisi R, Hatch EE, Wise LA, Palmer J, Hyer M, Kaufman R, Adam E, Strohsnitter W, Noller K, Herbst AL, Gibson-Chambers J, Hartge P, Hoover RN (Aug 2006). <a href="javascript:if(confirm('https://doi.org/10.1093/ije/dyl106  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093/ije/dyl106'" tppabs="https://doi.org/10.1093/ije/dyl106" class="external text external">"Menstrual and reproductive characteristics of women whose mothers were exposed in utero to diethylstilbestrol (DES)"</a>. <i>Int J Epidemiol</i>. <b>35</b> (4): 862–8. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1093%2Fije%2Fdyl106  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fije%2Fdyl106'" tppabs="https://doi.org/10.1093%2Fije%2Fdyl106" class="external text external">10.1093/ije/dyl106</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16723367  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16723367'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16723367" class="external text external">16723367</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-52"> <span id="mw-reference-text-cite_note-52" class="mw-reference-text"><cite id="CITEREFKalfa_N,_Paris_F,_Soyer-Gobillard_MO,_Daures_JP,_Sultan_C2011" class="citation journal cs1">Kalfa N, Paris F, Soyer-Gobillard MO, Daures JP, Sultan C (Jun 2011). "Prevalence of hypospadias in grandsons of women exposed to diethylstilbestrol during pregnancy: a multigenerational national cohort study". <i>Fertil Steril</i>. <b>95</b> (8): 2574–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.fertnstert.2011.02.047  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.fertnstert.2011.02.047'" tppabs="https://doi.org/10.1016%2Fj.fertnstert.2011.02.047" class="external text external">10.1016/j.fertnstert.2011.02.047</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21458804  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21458804'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21458804" class="external text external">21458804</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (link)</span></span></li><li id="cite_note-pmid576887-53"> <span id="mw-reference-text-cite_note-pmid576887-53" class="mw-reference-text"><cite id="CITEREFCarterSedranskKelleyAnsfield1977" class="citation journal cs1">Carter AC, Sedransk N, Kelley RM, Ansfield FJ, Ravdin RG, Talley RW, Potter NR (May 1977). "Diethylstilbestrol: recommended dosages for different categories of breast cancer patients. Report of the Cooperative Breast Cancer Group". <i>JAMA</i>. <b>237</b> (19): 2079–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1001%2Fjama.1977.03270460065023  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Fjama.1977.03270460065023'" tppabs="https://doi.org/10.1001%2Fjama.1977.03270460065023" class="external text external">10.1001/jama.1977.03270460065023</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/576887  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/576887'" tppabs="https://pubmed.ncbi.nlm.nih.gov/576887" class="external text external">576887</a>.</cite></span></li><li id="cite_note-pmid13005120-54"> <span id="mw-reference-text-cite_note-pmid13005120-54" class="mw-reference-text"><cite id="CITEREFKarnaky1952" class="citation journal cs1">Karnaky KJ (December 1952). "Micronized stilbestrol for dysfunctional uterine bleeding and endometriosis". <i>South. Med. J</i>. <b>45</b> (12): 1166–72. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F00007611-195212000-00009  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F00007611-195212000-00009'" tppabs="https://doi.org/10.1097%2F00007611-195212000-00009" class="external text external">10.1097/00007611-195212000-00009</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/13005120  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/13005120'" tppabs="https://pubmed.ncbi.nlm.nih.gov/13005120" class="external text external">13005120</a>.</cite></span></li><li id="cite_note-Jordan2013-55"> <span id="mw-reference-text-cite_note-Jordan2013-55" class="mw-reference-text"><cite id="CITEREFJordan2013" class="citation book cs1">Jordan VC (2013). <a href="javascript:if(confirm('https://books.google.com/?id=ejS6CgAAQBAJ&pg=PA143  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/?id=ejS6CgAAQBAJ&pg=PA143'" tppabs="https://books.google.com/?id=ejS6CgAAQBAJ&pg=PA143" class="external text external"><i>Estrogen Action, Selective Estrogen Receptor Modulators, and Women's Health: Progress and Promise</i></a>. World Scientific. pp.<span>&nbsp;</span>143–. ISBN<span>&nbsp;</span><bdi>978-1-84816-958-6</bdi>.</cite></span></li><li id="cite_note-SeilerAutrup2012-56"> <span id="mw-reference-text-cite_note-SeilerAutrup2012-56" class="mw-reference-text"><cite id="CITEREFSeilerAutrupAutrup2012" class="citation book cs1">Seiler JP, Autrup JL, Autrup H (6 December 2012). <a href="javascript:if(confirm('https://books.google.com/?id=ZlfrCAAAQBAJ&pg=PA23  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/?id=ZlfrCAAAQBAJ&pg=PA23'" tppabs="https://books.google.com/?id=ZlfrCAAAQBAJ&pg=PA23" class="external text external"><i>Diversification in Toxicology — Man and Environment: Proceedings of the 1997 EUROTOX Congress Meeting Held in Århus, Denmark, June 25–28, 1997</i></a>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>23–. ISBN<span>&nbsp;</span><bdi>978-3-642-46856-8</bdi>.</cite></span></li><li id="cite_note-pmid9048584-57"> <span id="mw-reference-text-cite_note-pmid9048584-57" class="mw-reference-text"><cite id="CITEREFKuiperCarlssonGrandienEnmark1997" class="citation journal cs1">Kuiper GG, Carlsson B, Grandien K, Enmark E, Häggblad J, Nilsson S, Gustafsson JA (March 1997). <a href="javascript:if(confirm('https://doi.org/10.1210/endo.138.3.4979  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1210/endo.138.3.4979'" tppabs="https://doi.org/10.1210/endo.138.3.4979" class="external text external">"Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta"</a>. <i>Endocrinology</i>. <b>138</b> (3): 863–70. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1210%2Fendo.138.3.4979  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1210%2Fendo.138.3.4979'" tppabs="https://doi.org/10.1210%2Fendo.138.3.4979" class="external text external">10.1210/endo.138.3.4979</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9048584  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9048584'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9048584" class="external text external">9048584</a>.</cite></span></li><li id="cite_note-pmid22294742-58"> <span id="mw-reference-text-cite_note-pmid22294742-58" class="mw-reference-text"><cite id="CITEREFCossJonesParkeNarayanan2012" class="citation journal cs1">Coss CC, Jones A, Parke DN, Narayanan R, Barrett CM, Kearbey JD, Veverka KA, Miller DD, Morton RA, Steiner MS, Dalton JT (March 2012). <a href="javascript:if(confirm('https://doi.org/10.1210/en.2011-1608  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1210/en.2011-1608'" tppabs="https://doi.org/10.1210/en.2011-1608" class="external text external">"Preclinical characterization of a novel diphenyl benzamide selective ERα agonist for hormone therapy in prostate cancer"</a>. <i>Endocrinology</i>. <b>153</b> (3): 1070–81. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1210%2Fen.2011-1608  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1210%2Fen.2011-1608'" tppabs="https://doi.org/10.1210%2Fen.2011-1608" class="external text external">10.1210/en.2011-1608</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22294742  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22294742'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22294742" class="external text external">22294742</a>.</cite></span></li><li id="cite_note-pmid26023144-59"> <span id="mw-reference-text-cite_note-pmid26023144-59" class="mw-reference-text"><cite id="CITEREFProssnitzArterburn2015" class="citation journal cs1">Prossnitz ER, Arterburn JB (July 2015). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485017  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485017'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485017" class="external text external">"International Union of Basic and Clinical Pharmacology. XCVII. G Protein-Coupled Estrogen Receptor and Its Pharmacologic Modulators"</a>. <i>Pharmacol. Rev</i>. <b>67</b> (3): 505–40. doi:<a href="javascript:if(confirm('https://doi.org/10.1124%2Fpr.114.009712  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1124%2Fpr.114.009712'" tppabs="https://doi.org/10.1124%2Fpr.114.009712" class="external text external">10.1124/pr.114.009712</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485017  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485017'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485017" class="external text external">4485017</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26023144  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26023144'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26023144" class="external text external">26023144</a>.</cite></span></li><li id="cite_note-DenisGriffiths1999-60"> <span id="mw-reference-text-cite_note-DenisGriffiths1999-60" class="mw-reference-text"><cite id="CITEREFLouis_J_DenisKeith_GriffithsAmir_V_KaisaryGerald_P_Murphy1999" class="citation book cs1">Louis J Denis; Keith Griffiths; Amir V Kaisary; Gerald P Murphy (1 March 1999). <a href="javascript:if(confirm('https://books.google.com/?id=GreZlojD-tYC&pg=PA297  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/?id=GreZlojD-tYC&pg=PA297'" tppabs="https://books.google.com/?id=GreZlojD-tYC&pg=PA297" class="external text external"><i>Textbook of Prostate Cancer: Pathology, Diagnosis and Treatment: Pathology, Diagnosis and Treatment</i></a>. CRC Press. pp.<span>&nbsp;</span>294, 297–. ISBN<span>&nbsp;</span><bdi>978-1-85317-422-3</bdi>.</cite></span></li><li id="cite_note-RunnebaumRabe2013-61"> <span id="mw-reference-text-cite_note-RunnebaumRabe2013-61" class="mw-reference-text"><cite id="CITEREFBenno_RunnebaumThomas_Rabe2013" class="citation book cs1">Benno Runnebaum; Thomas Rabe (17 April 2013). <a href="javascript:if(confirm('https://books.google.com/?id=mBF9BwAAQBAJ&pg=PA88  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/?id=mBF9BwAAQBAJ&pg=PA88'" tppabs="https://books.google.com/?id=mBF9BwAAQBAJ&pg=PA88" class="external text external"><i>Gynäkologische Endokrinologie und Fortpflanzungsmedizin: Band 1: Gynäkologische Endokrinologie</i></a>. Springer-Verlag. pp.<span>&nbsp;</span>88–. ISBN<span>&nbsp;</span><bdi>978-3-662-07635-4</bdi>.</cite></span></li><li id="cite_note-WallachHammond1982-62"> <span id="mw-reference-text-cite_note-WallachHammond1982-62" class="mw-reference-text"><cite id="CITEREFWallachHammondMaxson1982" class="citation journal cs1">Wallach, Edward E.; Hammond, Charles B.; Maxson, Wayne S. (1982). "Current status of estrogen therapy for the menopause". <i>Fertility and Sterility</i>. <b>37</b> (1): 5–25. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0015-0282%2816%2945970-4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0015-0282%2816%2945970-4'" tppabs="https://doi.org/10.1016%2FS0015-0282%2816%2945970-4" class="external text external">10.1016/S0015-0282(16)45970-4</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0015-0282  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0015-0282'" tppabs="https://www.worldcat.org/issn/0015-0282" class="external text external">0015-0282</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/6277697  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/6277697'" tppabs="https://pubmed.ncbi.nlm.nih.gov/6277697" class="external text external">6277697</a>.</cite></span></li><li id="cite_note-pmid4359746-63"> <span id="mw-reference-text-cite_note-pmid4359746-63" class="mw-reference-text"><cite id="CITEREFShearerHendrySommervilleFergusson1973" class="citation journal cs1">Shearer RJ, Hendry WF, Sommerville IF, Fergusson JD (December 1973). "Plasma testosterone: an accurate monitor of hormone treatment in prostatic cancer". <i>Br J Urol</i>. <b>45</b> (6): 668–77. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1464-410x.1973.tb12238.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1464-410x.1973.tb12238.x'" tppabs="https://doi.org/10.1111%2Fj.1464-410x.1973.tb12238.x" class="external text external">10.1111/j.1464-410x.1973.tb12238.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/4359746  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/4359746'" tppabs="https://pubmed.ncbi.nlm.nih.gov/4359746" class="external text external">4359746</a>.</cite></span></li><li id="cite_note-pmid4699685-64"> <span id="mw-reference-text-cite_note-pmid4699685-64" class="mw-reference-text"><cite id="CITEREFKentBischoffArduinoMellinger1973" class="citation journal cs1">Kent JR, Bischoff AJ, Arduino LJ, Mellinger GT, Byar DP, Hill M, Kozbur X (May 1973). "Estrogen dosage and suppression of testosterone levels in patients with prostatic carcinoma". <i>J. Urol</i>. <b>109</b> (5): 858–60. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fs0022-5347%2817%2960564-0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fs0022-5347%2817%2960564-0'" tppabs="https://doi.org/10.1016%2Fs0022-5347%2817%2960564-0" class="external text external">10.1016/s0022-5347(17)60564-0</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/4699685  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/4699685'" tppabs="https://pubmed.ncbi.nlm.nih.gov/4699685" class="external text external">4699685</a>.</cite></span></li><li id="cite_note-pmid29603164-65"> <span id="mw-reference-text-cite_note-pmid29603164-65" class="mw-reference-text"><cite id="CITEREFScottMenonWalsh1980" class="citation journal cs1">Scott WW, Menon M, Walsh PC (April 1980). "Hormonal Therapy of Prostatic Cancer". <i>Cancer</i>. 45 Suppl 7: 1929–1936. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fcncr.1980.45.s7.1929  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fcncr.1980.45.s7.1929'" tppabs="https://doi.org/10.1002%2Fcncr.1980.45.s7.1929" class="external text external">10.1002/cncr.1980.45.s7.1929</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29603164  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29603164'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29603164" class="external text external">29603164</a>.</cite></span></li><li id="cite_note-Salam2003-66"> <span id="mw-reference-text-cite_note-Salam2003-66" class="mw-reference-text"><cite id="CITEREFMuhammad_A._Salam2003" class="citation book cs1">Muhammad A. Salam (2003). <a href="javascript:if(confirm('https://books.google.com/?id=y50kTcCCfEcC&pg=PA684  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/?id=y50kTcCCfEcC&pg=PA684'" tppabs="https://books.google.com/?id=y50kTcCCfEcC&pg=PA684" class="external text external"><i>Principles &amp; Practice of Urology: A Comprehensive Text</i></a>. Universal-Publishers. pp.<span>&nbsp;</span>684–. ISBN<span>&nbsp;</span><bdi>978-1-58112-412-5</bdi>.</cite></span></li><li id="cite_note-pmid16406864-67"> <span id="mw-reference-text-cite_note-pmid16406864-67" class="mw-reference-text"><cite id="CITEREFLamLeppertVemulapalliShvarts2006" class="citation journal cs1">Lam JS, Leppert JT, Vemulapalli SN, Shvarts O, Belldegrun AS (January 2006). "Secondary hormonal therapy for advanced prostate cancer". <i>J. Urol</i>. <b>175</b> (1): 27–34. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0022-5347%2805%2900034-0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0022-5347%2805%2900034-0'" tppabs="https://doi.org/10.1016%2FS0022-5347%2805%2900034-0" class="external text external">10.1016/S0022-5347(05)00034-0</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16406864  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16406864'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16406864" class="external text external">16406864</a>.</cite></span></li><li id="cite_note-Greenblatt1966-68"> <span id="mw-reference-text-cite_note-Greenblatt1966-68" class="mw-reference-text"><cite id="CITEREFJorge_Martinez-ManautouHarry_W._Rudel1966" class="citation book cs1">Jorge Martinez-Manautou; Harry W. Rudel (1966). "Antiovulatory Activity of Several Synthetic and Natural Estrogens".  In Robert Benjamin Greenblatt (ed.). <a href="javascript:if(confirm('https://books.google.com/?id=le1qAAAAMAAJ  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/?id=le1qAAAAMAAJ'" tppabs="https://books.google.com/?id=le1qAAAAMAAJ" class="external text external"><i>Ovulation: Stimulation, Suppression, and Detection</i></a>. Lippincott. pp.<span>&nbsp;</span>243–253.</cite></span></li><li id="cite_note-HerrRevesz1970-69"> <span id="mw-reference-text-cite_note-HerrRevesz1970-69" class="mw-reference-text"><cite id="CITEREFHerrReveszMansonJewell1970" class="citation book cs1">Herr, F.; Revesz, C.; Manson, A. J.; Jewell, J. B. (1970). "Biological Properties of Estrogen Sulfates". <i>Chemical and Biological Aspects of Steroid Conjugation</i>. pp.<span>&nbsp;</span>368–408. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2F978-3-642-49793-3_8  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2F978-3-642-49793-3_8'" tppabs="https://doi.org/10.1007%2F978-3-642-49793-3_8" class="external text external">10.1007/978-3-642-49793-3_8</a>. ISBN<span>&nbsp;</span><bdi>978-3-642-49506-9</bdi>.</cite></span></li><li id="cite_note-pmid2669792-70"> <span id="mw-reference-text-cite_note-pmid2669792-70" class="mw-reference-text"><cite id="CITEREFSeftelSpirnakResnick1989" class="citation journal cs1">Seftel AD, Spirnak JP, Resnick MI (1989). "Hormonal therapy for advanced prostatic carcinoma". <i>J Surg Oncol Suppl</i>. <b>1</b>: 14–20. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fjso.2930420505  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fjso.2930420505'" tppabs="https://doi.org/10.1002%2Fjso.2930420505" class="external text external">10.1002/jso.2930420505</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2669792  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2669792'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2669792" class="external text external">2669792</a>.</cite></span></li><li id="cite_note-SchröderRadlmaier2009-71"> <span id="mw-reference-text-cite_note-SchröderRadlmaier2009-71" class="mw-reference-text"><cite id="CITEREFSchröderRadlmaier2009" class="citation book cs1">Schröder, Fritz H.; Radlmaier, Albert (2009). "Steroidal Antiandrogens". <i>Hormone Therapy in Breast and Prostate Cancer</i>. pp.<span>&nbsp;</span>325–346. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2F978-1-59259-152-7_15  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2F978-1-59259-152-7_15'" tppabs="https://doi.org/10.1007%2F978-1-59259-152-7_15" class="external text external">10.1007/978-1-59259-152-7_15</a>. ISBN<span>&nbsp;</span><bdi>978-1-60761-471-5</bdi>.</cite></span></li><li id="cite_note-pmid2973529-72"> <span id="mw-reference-text-cite_note-pmid2973529-72" class="mw-reference-text"><cite id="CITEREFGoldenbergBruchovskyRennieCoppin1988" class="citation journal cs1">Goldenberg SL, Bruchovsky N, Rennie PS, Coppin CM (December 1988). "The combination of cyproterone acetate and low dose diethylstilbestrol in the treatment of advanced prostatic carcinoma". <i>J. Urol</i>. <b>140</b> (6): 1460–5. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0022-5347%2817%2942073-8  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0022-5347%2817%2942073-8'" tppabs="https://doi.org/10.1016%2FS0022-5347%2817%2942073-8" class="external text external">10.1016/S0022-5347(17)42073-8</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2973529  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2973529'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2973529" class="external text external">2973529</a>.</cite></span></li><li id="cite_note-pmid8677581-73"> <span id="mw-reference-text-cite_note-pmid8677581-73" class="mw-reference-text"><cite id="CITEREFGoldenbergBruchovskyGleaveSullivan1996" class="citation journal cs1">Goldenberg SL, Bruchovsky N, Gleave ME, Sullivan LD (June 1996). "Low-dose cyproterone acetate plus mini-dose diethylstilbestrol--a protocol for reversible medical castration". <i>Urology</i>. <b>47</b> (6): 882–4. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0090-4295%2896%2900048-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0090-4295%2896%2900048-9'" tppabs="https://doi.org/10.1016%2FS0090-4295%2896%2900048-9" class="external text external">10.1016/S0090-4295(96)00048-9</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8677581  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8677581'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8677581" class="external text external">8677581</a>.</cite></span></li><li id="cite_note-pmid5124437-74"> <span id="mw-reference-text-cite_note-pmid5124437-74" class="mw-reference-text"><cite id="CITEREFRobinsonThomas1971" class="citation journal cs1">Robinson MR, Thomas BS (November 1971). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1799485  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1799485'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1799485" class="external text external">"Effect of hormonal therapy on plasma testosterone levels in prostatic carcinoma"</a>. <i>Br Med J</i>. <b>4</b> (5784): 391–4. doi:<a href="javascript:if(confirm('https://doi.org/10.1136%2Fbmj.4.5784.391  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1136%2Fbmj.4.5784.391'" tppabs="https://doi.org/10.1136%2Fbmj.4.5784.391" class="external text external">10.1136/bmj.4.5784.391</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1799485  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1799485'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1799485" class="external text external">1799485</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/5124437  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/5124437'" tppabs="https://pubmed.ncbi.nlm.nih.gov/5124437" class="external text external">5124437</a>.</cite></span></li><li id="cite_note-pmid15161930-75"> <span id="mw-reference-text-cite_note-pmid15161930-75" class="mw-reference-text"><cite id="CITEREFGreschikFlaigRenaudMoras2004" class="citation journal cs1">Greschik H, Flaig R, Renaud JP, Moras D (August 2004). <a href="javascript:if(confirm('https://doi.org/10.1074/jbc.M402195200  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1074/jbc.M402195200'" tppabs="https://doi.org/10.1074/jbc.M402195200" class="external text external">"Structural basis for the deactivation of the estrogen-related receptor gamma by diethylstilbestrol or 4-hydroxytamoxifen and determinants of selectivity"</a>. <i>The Journal of Biological Chemistry</i>. <b>279</b> (32): 33639–46. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1074%2Fjbc.M402195200  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1074%2Fjbc.M402195200'" tppabs="https://doi.org/10.1074%2Fjbc.M402195200" class="external text external">10.1074/jbc.M402195200</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15161930  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15161930'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15161930" class="external text external">15161930</a>.</cite></span></li><li id="cite_note-RabinowitzMyerson1967-76"> <span id="mw-reference-text-cite_note-RabinowitzMyerson1967-76" class="mw-reference-text"><cite id="CITEREFJoseph_L._RabinowitzRalph_M._Myerson1967" class="citation book cs1">Joseph L. Rabinowitz; Ralph M. Myerson (1967). <a href="javascript:if(confirm('https://books.google.com/?id=YXBtAAAAMAAJ  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/?id=YXBtAAAAMAAJ'" tppabs="https://books.google.com/?id=YXBtAAAAMAAJ" class="external text external"><i>Topics in Medicinal Chemistry</i></a>. Wiley-Interscience. p.<span>&nbsp;</span>16. ISBN<span>&nbsp;</span><bdi>978-0-471-70468-3</bdi>.</cite></span></li><li id="cite_note-pmid14926876-77"> <span id="mw-reference-text-cite_note-pmid14926876-77" class="mw-reference-text"><cite id="CITEREFFriedberg1951" class="citation journal cs1">Friedberg V (October 1951). "Die Behandlung der genitalen Hypoplasie mit intrauterinen Cyren-B-Kristallsuspensionen" <span>[</span>Intrauterine Cyren-B Crystal Suspensions in Therapy of Genital Hypoplasia<span>]</span>. <i>Geburtshilfe Frauenheilkd</i> (in German). <b>11</b> (10): 923–30. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0016-5751  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0016-5751'" tppabs="https://www.worldcat.org/issn/0016-5751" class="external text external">0016-5751</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/14926876  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/14926876'" tppabs="https://pubmed.ncbi.nlm.nih.gov/14926876" class="external text external">14926876</a>.</cite></span></li><li id="cite_note-pmid7195405-78"> <span id="mw-reference-text-cite_note-pmid7195405-78" class="mw-reference-text"><cite id="CITEREFPugeatDunnNisula1981" class="citation journal cs1">Pugeat MM, Dunn JF, Nisula BC (July 1981). "Transport of steroid hormones: interaction of 70 drugs with testosterone-binding globulin and corticosteroid-binding globulin in human plasma". <i>J. Clin. Endocrinol. Metab</i>. <b>53</b> (1): 69–75. doi:<a href="javascript:if(confirm('https://doi.org/10.1210%2Fjcem-53-1-69  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1210%2Fjcem-53-1-69'" tppabs="https://doi.org/10.1210%2Fjcem-53-1-69" class="external text external">10.1210/jcem-53-1-69</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7195405  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7195405'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7195405" class="external text external">7195405</a>.</cite></span></li><li id="cite_note-.v-79"> <span id="mw-reference-text-cite_note-.v-79" class="mw-reference-text"><cite id="CITEREFChambersGünzel2013" class="citation book cs1">Chambers P, Günzel P (12 March 2013). <a href="javascript:if(confirm('https://books.google.com/?id=zUH1CAAAQBAJ&pg=PA276  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/?id=zUH1CAAAQBAJ&pg=PA276'" tppabs="https://books.google.com/?id=zUH1CAAAQBAJ&pg=PA276" class="external text external"><i>Mechanism of Toxic Action on Some Target Organs: Drugs and Other Substances</i></a>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>276–. ISBN<span>&nbsp;</span><bdi>978-3-642-67265-1</bdi>.</cite></span></li><li id="cite_note-pmid15458790-80"> <span id="mw-reference-text-cite_note-pmid15458790-80" class="mw-reference-text"><cite id="CITEREFCouseKorach2004" class="citation journal cs1">Couse JF, Korach KS (December 2004). "Estrogen receptor-alpha mediates the detrimental effects of neonatal diethylstilbestrol (DES) exposure in the murine reproductive tract". <i>Toxicology</i>. <b>205</b> (1–2): 55–63. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.tox.2004.06.046  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.tox.2004.06.046'" tppabs="https://doi.org/10.1016%2Fj.tox.2004.06.046" class="external text external">10.1016/j.tox.2004.06.046</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15458790  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15458790'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15458790" class="external text external">15458790</a>.</cite></span></li><li id="cite_note-pmid19737574-81"> <span id="mw-reference-text-cite_note-pmid19737574-81" class="mw-reference-text"><cite id="CITEREFJensenJacobsonWalfFrye2010" class="citation journal cs1">Jensen EV, Jacobson HI, Walf AA, Frye CA (February 2010). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834267  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834267'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834267" class="external text external">"Estrogen action: a historic perspective on the implications of considering alternative approaches"</a>. <i>Physiol. Behav</i>. <b>99</b> (2): 151–62. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.physbeh.2009.08.013  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.physbeh.2009.08.013'" tppabs="https://doi.org/10.1016%2Fj.physbeh.2009.08.013" class="external text external">10.1016/j.physbeh.2009.08.013</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834267  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834267'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834267" class="external text external">2834267</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19737574  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19737574'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19737574" class="external text external">19737574</a>.</cite></span></li><li id="cite_note-WermuthAldous2015-82"> <span id="mw-reference-text-cite_note-WermuthAldous2015-82" class="mw-reference-text"><cite id="CITEREFCamille_Georges_WermuthDavid_AldousPierre_RaboissonDidier_Rognan2015" class="citation book cs1">Camille Georges Wermuth; David Aldous; Pierre Raboisson; Didier Rognan (1 July 2015). <a href="javascript:if(confirm('https://books.google.com/?id=dtScBAAAQBAJ&pg=PA244  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/?id=dtScBAAAQBAJ&pg=PA244'" tppabs="https://books.google.com/?id=dtScBAAAQBAJ&pg=PA244" class="external text external"><i>The Practice of Medicinal Chemistry</i></a>. Elsevier Science. pp.<span>&nbsp;</span>244–245. ISBN<span>&nbsp;</span><bdi>978-0-12-417213-5</bdi>.</cite></span></li><li id="cite_note-Sneader2005-83"> <span id="mw-reference-text-cite_note-Sneader2005-83" class="mw-reference-text"><cite id="CITEREFSneader2005" class="citation book cs1">Sneader W (31 October 2005). <a href="javascript:if(confirm('https://books.google.com/?id=jglFsz5EJR8C&pg=PA196  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/?id=jglFsz5EJR8C&pg=PA196'" tppabs="https://books.google.com/?id=jglFsz5EJR8C&pg=PA196" class="external text external"><i>Drug Discovery: A History</i></a>. John Wiley &amp; Sons. pp.<span>&nbsp;</span>196–197. ISBN<span>&nbsp;</span><bdi>978-0-470-01552-0</bdi>.</cite></span></li><li id="cite_note-Ravina2011-84"> <span id="mw-reference-text-cite_note-Ravina2011-84" class="mw-reference-text"><cite id="CITEREFRavina2011" class="citation book cs1">Ravina E (11 January 2011). <a href="javascript:if(confirm('https://books.google.com/?id=iDNy0XxGqT8C&pg=PA177  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/?id=iDNy0XxGqT8C&pg=PA177'" tppabs="https://books.google.com/?id=iDNy0XxGqT8C&pg=PA177" class="external text external"><i>T he Evolution of Drug Discovery: From Traditional Medicines to Modern Drugs</i></a>. John Wiley &amp; Sons. pp.<span>&nbsp;</span>177–. ISBN<span>&nbsp;</span><bdi>978-3-527-32669-3</bdi>.</cite></span></li><li id="cite_note-AcademicPress1945-85"> <span id="mw-reference-text-cite_note-AcademicPress1945-85" class="mw-reference-text"><cite class="citation book cs1"><a href="javascript:if(confirm('https://archive.org/details/in.ernet.dli.2015.5563  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://archive.org/details/in.ernet.dli.2015.5563'" tppabs="https://archive.org/details/in.ernet.dli.2015.5563" class="external text external"><i>Vitamins and Hormones</i></a>. Academic Press. 1945. pp.<span>&nbsp;</span><a href="javascript:if(confirm('https://archive.org/details/in.ernet.dli.2015.5563/page/n253  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://archive.org/details/in.ernet.dli.2015.5563/page/n253'" tppabs="https://archive.org/details/in.ernet.dli.2015.5563/page/n253" class="external text external">233</a>–. ISBN<span>&nbsp;</span><bdi>978-0-08-086600-0</bdi>.</cite></span></li><li id="cite_note-MaximovMcDaniel2013-86"> <span id="mw-reference-text-cite_note-MaximovMcDaniel2013-86" class="mw-reference-text"><cite id="CITEREFMaximovMcDanielJordan2013" class="citation book cs1">Maximov PY, McDaniel RE, Jordan VC (23 July 2013). <a href="javascript:if(confirm('https://books.google.com/?id=p-W5BAAAQBAJ&pg=PA3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/?id=p-W5BAAAQBAJ&pg=PA3'" tppabs="https://books.google.com/?id=p-W5BAAAQBAJ&pg=PA3" class="external text external"><i>Tamoxifen: Pioneering Medicine in Breast Cancer</i></a>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>3–. ISBN<span>&nbsp;</span><bdi>978-3-0348-0664-0</bdi>.</cite></span></li><li id="cite_note-Dodds_1938-87"> <span id="mw-reference-text-cite_note-Dodds_1938-87" class="mw-reference-text"><cite id="CITEREFDoddsGoldbergLawsonRobinson1938" class="citation journal cs1">Dodds EC, Goldberg L, Lawson W, Robinson R (1938). "Estrogenic activity of certain synthetic compounds". <i>Nature</i>. <b>141</b> (3562): 247–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2F141247b0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2F141247b0'" tppabs="https://doi.org/10.1038%2F141247b0" class="external text external">10.1038/141247b0</a>.</cite></span></li><li id="cite_note-dodds2-88"> <span id="mw-reference-text-cite_note-dodds2-88" class="mw-reference-text"><cite id="CITEREFDodds1957" class="citation book cs1">Dodds EC (1957). <i>Biochemical contributions to endocrinology; experiments in hormonal research</i>. Stanford: Stanford University Press. OCLC<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/oclc/1483899  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/oclc/1483899'" tppabs="https://www.worldcat.org/oclc/1483899" class="external text external">1483899</a>.</cite></span></li><li id="cite_note-meyers-89"> <span id="mw-reference-text-cite_note-meyers-89" class="mw-reference-text"><cite id="CITEREFMeyers1983" class="citation book cs1">Meyers R (1983). <span class="cs1-lock-registration"><a href="javascript:if(confirm('https://archive.org/details/desbitterpill00meye  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://archive.org/details/desbitterpill00meye'" tppabs="https://archive.org/details/desbitterpill00meye" class="external text external"><i>D.E.S., the bitter pill</i></a></span>. New York: Seaview/Putnam. ISBN<span>&nbsp;</span><bdi>0-399-31008-8</bdi>.</cite></span></li><li id="cite_note-langston-90"> <span id="mw-reference-text-cite_note-langston-90" class="mw-reference-text"><cite id="CITEREFLangston2010" class="citation book cs1">Langston N (2010). <i>Toxic bodies: Hormone disruptors and the legacy of DES</i>. New Haven, CT: Yale University Press. ISBN<span>&nbsp;</span><bdi>978-0-300-13607-4</bdi>.</cite></span></li><li id="cite_note-seaman-91"> <span id="mw-reference-text-cite_note-seaman-91" class="mw-reference-text"><cite id="CITEREFSeaman2003" class="citation book cs1">Seaman B (2003). <span class="cs1-lock-registration"><a href="javascript:if(confirm('https://archive.org/details/greatestexperime00barb  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://archive.org/details/greatestexperime00barb'" tppabs="https://archive.org/details/greatestexperime00barb" class="external text external"><i>The greatest experiment ever performed on women: Exploding the estrogen myth</i></a></span>. New York: Hyperion. ISBN<span>&nbsp;</span><bdi>978-0-7868-6853-7</bdi>.</cite></span></li><li id="cite_note-pmid4625049-92"> <span id="mw-reference-text-cite_note-pmid4625049-92" class="mw-reference-text"><cite id="CITEREFHugginsHodges1972" class="citation journal cs1">Huggins C, Hodges CV (1972). "Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate". <i>CA</i>. <b>22</b> (4): 232–40. doi:<a href="javascript:if(confirm('https://doi.org/10.3322%2Fcanjclin.22.4.232  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3322%2Fcanjclin.22.4.232'" tppabs="https://doi.org/10.3322%2Fcanjclin.22.4.232" class="external text external">10.3322/canjclin.22.4.232</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/4625049  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/4625049'" tppabs="https://pubmed.ncbi.nlm.nih.gov/4625049" class="external text external">4625049</a>.</cite></span></li><li id="cite_note-93"> <span id="mw-reference-text-cite_note-93" class="mw-reference-text"><cite class="citation journal cs1"><a href="javascript:if(confirm('https://www.nytimes.com/1943/12/15/archives/prostate-cancer-yields-to-a-drug-control-of-disease-by-taking.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nytimes.com/1943/12/15/archives/prostate-cancer-yields-to-a-drug-control-of-disease-by-taking.html'" tppabs="https://www.nytimes.com/1943/12/15/archives/prostate-cancer-yields-to-a-drug-control-of-disease-by-taking.html" class="external text external">"Prostate cancer yields to a drug"</a>. <i>The New York Times</i>: 29. 15 December 1943.</cite></span></li><li id="cite_note-Lupulescu1990-94"> <span id="mw-reference-text-cite_note-Lupulescu1990-94" class="mw-reference-text"><cite id="CITEREFAurel_Lupulescu1990" class="citation book cs1">Aurel Lupulescu (24 October 1990). <a href="javascript:if(confirm('https://books.google.com/?id=VddUa-2cp-YC&pg=PA36  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/?id=VddUa-2cp-YC&pg=PA36'" tppabs="https://books.google.com/?id=VddUa-2cp-YC&pg=PA36" class="external text external"><i>Hormones and Vitamins in Cancer Treatment</i></a>. CRC Press. pp.<span>&nbsp;</span>36–. ISBN<span>&nbsp;</span><bdi>978-0-8493-5973-6</bdi>.</cite></span></li><li id="cite_note-pmid6436700-95"> <span id="mw-reference-text-cite_note-pmid6436700-95" class="mw-reference-text"><cite id="CITEREFThe_Leuprolide_Study_Group1984" class="citation journal cs1">The Leuprolide Study Group (November 1984). "Leuprolide versus diethylstilbestrol for metastatic prostate cancer". <i>The New England Journal of Medicine</i>. <b>311</b> (20): 1281–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1056%2FNEJM198411153112004  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056%2FNEJM198411153112004'" tppabs="https://doi.org/10.1056%2FNEJM198411153112004" class="external text external">10.1056/NEJM198411153112004</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/6436700  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/6436700'" tppabs="https://pubmed.ncbi.nlm.nih.gov/6436700" class="external text external">6436700</a>.</cite></span></li><li id="cite_note-dutton-96"> <span id="mw-reference-text-cite_note-dutton-96" class="mw-reference-text"><cite id="CITEREFDutton1988" class="citation book cs1">Dutton DB (1988). <span class="cs1-lock-registration"><a href="javascript:if(confirm('https://archive.org/details/worsethandisease0000dutt  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://archive.org/details/worsethandisease0000dutt'" tppabs="https://archive.org/details/worsethandisease0000dutt" class="external text external"><i>Worse than the disease: pitfalls of medical progress</i></a></span>. Cambridge: Cambridge University Press. ISBN<span>&nbsp;</span><bdi>0-521-34023-3</bdi>.</cite></span></li><li id="cite_note-pdr1961-97"> <span id="mw-reference-text-cite_note-pdr1961-97" class="mw-reference-text"><cite class="citation book cs1"><i>Physicians' desk reference to pharmaceutical specialties and biologicals</i> (15th ed.). Oradell NJ: Medical Economics. 1961. p.<span>&nbsp;</span>625. ISBN<span>&nbsp;</span><bdi>0-00-093447-X</bdi>.</cite></span></li><li id="cite_note-dieckmann-98"> <span id="mw-reference-text-cite_note-dieckmann-98" class="mw-reference-text"><cite id="CITEREFDieckmannDavisRynkiewiczPottinger1953" class="citation journal cs1">Dieckmann WJ, Davis ME, Rynkiewicz LM, Pottinger RE (November 1953). "Does the administration of diethylstilbestrol during pregnancy have therapeutic value?". <i>American Journal of Obstetrics and Gynecology</i>. <b>66</b> (5): 1062–81. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0002-9378%2816%2938617-3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0002-9378%2816%2938617-3'" tppabs="https://doi.org/10.1016%2FS0002-9378%2816%2938617-3" class="external text external">10.1016/S0002-9378(16)38617-3</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/13104505  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/13104505'" tppabs="https://pubmed.ncbi.nlm.nih.gov/13104505" class="external text external">13104505</a>.</cite></span></li><li id="cite_note-apfel-99"> <span id="mw-reference-text-cite_note-apfel-99" class="mw-reference-text"><cite id="CITEREFApfelFisher1984" class="citation book cs1">Apfel RJ, Fisher SM (1984). <span class="cs1-lock-registration"><a href="javascript:if(confirm('https://archive.org/details/todonoharmdesdil0000apfe  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://archive.org/details/todonoharmdesdil0000apfe'" tppabs="https://archive.org/details/todonoharmdesdil0000apfe" class="external text external"><i>To do no harm: DES and the dilemmas of modern medicine</i></a></span>. New Haven: Yale University Press. ISBN<span>&nbsp;</span><bdi>0-300-03192-0</bdi>.</cite></span></li><li id="cite_note-fr1971-100"> <span id="mw-reference-text-cite_note-fr1971-100" class="mw-reference-text"><cite id="CITEREFUnited_States_Food_and_Drug_Administration1971" class="citation journal cs1">United States Food and Drug Administration (1971). "Certain estrogens for oral or parenteral use. Drugs for human use; drug efficacy study implementation". <i>Fed Regist</i>. <b>36</b> (217): 21537–8.</cite>; <span>36 </span>FR<span> </span><a href="javascript:if(confirm('https://www.govinfo.gov/link/fr/36/21537  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.govinfo.gov/link/fr/36/21537'" tppabs="https://www.govinfo.gov/link/fr/36/21537" class="external text external">21537</a></span></li><li id="cite_note-des25mg-101"> <span id="mw-reference-text-cite_note-des25mg-101" class="mw-reference-text"><cite id="CITEREFFDA1975" class="citation journal cs1">FDA (1975). "Certain estrogens for oral use. Notice of withdrawal of approval of new drug applications". <i>Fed Regist</i>. <b>40</b> (25): 5384.</cite>; <span>25 </span>FR<span> </span><a href="javascript:if(confirm('https://www.govinfo.gov/link/fr/25/5384  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.govinfo.gov/link/fr/25/5384'" tppabs="https://www.govinfo.gov/link/fr/25/5384" class="external text external">5384</a></span></li><li id="cite_note-102"> <span id="mw-reference-text-cite_note-102" class="mw-reference-text"><cite id="CITEREFZuger2009" class="citation web cs1">Zuger A (2009-07-27). <a href="javascript:if(confirm('https://www.nytimes.com/2009/07/28/health/28book.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nytimes.com/2009/07/28/health/28book.html'" tppabs="https://www.nytimes.com/2009/07/28/health/28book.html" class="external text external">"At What Height, Happiness? A Medical Tale"</a>. <i>The New York Times</i>. NY Times.</cite></span></li><li id="cite_note-AMA1960-103"> <span id="mw-reference-text-cite_note-AMA1960-103" class="mw-reference-text"><cite id="CITEREFCouncil_on_Drugs1960" class="citation journal cs1">Council on Drugs (1960). "Androgens and estrogens in the treatment of disseminated mammary carcinoma: retrospective study of nine hundred forty-four patients". <i>JAMA</i>. <b>172</b> (12): 1271–83. doi:<a href="javascript:if(confirm('https://doi.org/10.1001%2Fjama.1960.03020120049010  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Fjama.1960.03020120049010'" tppabs="https://doi.org/10.1001%2Fjama.1960.03020120049010" class="external text external">10.1001/jama.1960.03020120049010</a>.</cite></span></li><li id="cite_note-pmid7001242-104"> <span id="mw-reference-text-cite_note-pmid7001242-104" class="mw-reference-text"><cite id="CITEREFIngleAhmannGreenEdmonson1981" class="citation journal cs1">Ingle JN, Ahmann DL, Green SJ, Edmonson JH, Bisel HF, Kvols LK, Nichols WC, Creagan ET, Hahn RG, Rubin J, Frytak S (January 1981). "Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer". <i>The New England Journal of Medicine</i>. <b>304</b> (1): 16–21. doi:<a href="javascript:if(confirm('https://doi.org/10.1056%2FNEJM198101013040104  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056%2FNEJM198101013040104'" tppabs="https://doi.org/10.1056%2FNEJM198101013040104" class="external text external">10.1056/NEJM198101013040104</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7001242  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7001242'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7001242" class="external text external">7001242</a>.</cite></span></li><li id="cite_note-105"> <span id="mw-reference-text-cite_note-105" class="mw-reference-text"><cite id="CITEREFGoodwinCummings1984" class="citation journal cs1">Goodwin WE, Cummings RH (March 1984). "Squamous metaplasia of the verumontanum with obstruction due to hypertrophy: long-term effects of estrogen on the prostate in an aging male-to-female transsexual". <i>The Journal of Urology</i>. <b>131</b> (3): 553–4. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fs0022-5347%2817%2950493-0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fs0022-5347%2817%2950493-0'" tppabs="https://doi.org/10.1016%2Fs0022-5347%2817%2950493-0" class="external text external">10.1016/s0022-5347(17)50493-0</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/6199525  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/6199525'" tppabs="https://pubmed.ncbi.nlm.nih.gov/6199525" class="external text external">6199525</a>.</cite></span></li><li id="cite_note-106"> <span id="mw-reference-text-cite_note-106" class="mw-reference-text"><cite id="CITEREFLehrman1976" class="citation journal cs1">Lehrman KL (February 1976). "Pulmonary embolism in a transsexual man taking diethylstilbestrol". <i>JAMA</i>. <b>235</b> (5): 532–3. doi:<a href="javascript:if(confirm('https://doi.org/10.1001%2Fjama.1976.03260310046024  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Fjama.1976.03260310046024'" tppabs="https://doi.org/10.1001%2Fjama.1976.03260310046024" class="external text external">10.1001/jama.1976.03260310046024</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/946104  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/946104'" tppabs="https://pubmed.ncbi.nlm.nih.gov/946104" class="external text external">946104</a>.</cite></span></li><li id="cite_note-107"> <span id="mw-reference-text-cite_note-107" class="mw-reference-text"><cite id="CITEREFSeylerCanalisSpareReichlin1978" class="citation journal cs1">Seyler LE, Canalis E, Spare S, Reichlin S (July 1978). "Abnormal gonadotropin secretory responses to LRH in transsexual women after diethylstilbestrol priming". <i>The Journal of Clinical Endocrinology and Metabolism</i>. <b>47</b> (1): 176–83. doi:<a href="javascript:if(confirm('https://doi.org/10.1210%2Fjcem-47-1-176  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1210%2Fjcem-47-1-176'" tppabs="https://doi.org/10.1210%2Fjcem-47-1-176" class="external text external">10.1210/jcem-47-1-176</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/122396  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/122396'" tppabs="https://pubmed.ncbi.nlm.nih.gov/122396" class="external text external">122396</a>.</cite></span></li><li id="cite_note-pmid5171004-108"> <span id="mw-reference-text-cite_note-pmid5171004-108" class="mw-reference-text"><cite id="CITEREFKuchera1971" class="citation journal cs1">Kuchera LK (October 1971). "Postcoital contraception with diethylstilbestrol". <i>JAMA</i>. <b>218</b> (4): 562–3. doi:<a href="javascript:if(confirm('https://doi.org/10.1001%2Fjama.218.4.562  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Fjama.218.4.562'" tppabs="https://doi.org/10.1001%2Fjama.218.4.562" class="external text external">10.1001/jama.218.4.562</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/5171004  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/5171004'" tppabs="https://pubmed.ncbi.nlm.nih.gov/5171004" class="external text external">5171004</a>.</cite></span></li><li id="cite_note-109"> <span id="mw-reference-text-cite_note-109" class="mw-reference-text"><cite class="citation journal cs1">FDA (1975). "Diethylstilbestrol as posticoital oral contraceptive; patient labeling". <i>Fed Regist</i>. <b>40</b> (25): 5451–5.</cite>; <span>40 </span>FR<span> </span><a href="javascript:if(confirm('https://www.govinfo.gov/link/fr/40/5451  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.govinfo.gov/link/fr/40/5451'" tppabs="https://www.govinfo.gov/link/fr/40/5451" class="external text external">5451</a></span></li><li id="cite_note-110"> <span id="mw-reference-text-cite_note-110" class="mw-reference-text"><cite class="citation journal cs1">FDA (1975). "Estrogens for oral or parenteral use. Drugs for human use; drug efficacy study; amended notice". <i>Fed Regist</i>. <b>40</b> (39): 8242.</cite>; <span>39 </span>FR<span> </span><a href="javascript:if(confirm('https://www.govinfo.gov/link/fr/39/8242  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.govinfo.gov/link/fr/39/8242'" tppabs="https://www.govinfo.gov/link/fr/39/8242" class="external text external">8242</a></span></li><li id="cite_note-111"> <span id="mw-reference-text-cite_note-111" class="mw-reference-text"><cite id="CITEREFHatcherStewartStewartGuest1982" class="citation book cs1">Hatcher RA, Stewart GK, Stewart F, Guest F, Josephs N, Dale J (1982). <a href="javascript:if(confirm('https://archive.org/details/contraceptivetec0000hatc/page/152  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://archive.org/details/contraceptivetec0000hatc/page/152'" tppabs="https://archive.org/details/contraceptivetec0000hatc/page/152" class="external text external"><i>Contraceptive Technology 1982–1983</i></a>. New York: Irvington Publishers. pp.<span>&nbsp;</span><a href="javascript:if(confirm('https://archive.org/details/contraceptivetec0000hatc/page/152  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://archive.org/details/contraceptivetec0000hatc/page/152'" tppabs="https://archive.org/details/contraceptivetec0000hatc/page/152" class="external text external">152–7</a>. ISBN<span>&nbsp;</span><bdi>0-8290-0705-9</bdi>.</cite></span></li><li id="cite_note-112"> <span id="mw-reference-text-cite_note-112" class="mw-reference-text"><cite id="CITEREFFDA1978" class="citation journal cs1">FDA (1978). "Estrogens for postpartum breast engorgement". <i>Fed Regist</i>. <b>43</b> (206): 49564–7.</cite>; <span>43 </span>FR<span> </span><a href="javascript:if(confirm('https://www.govinfo.gov/link/fr/43/49564  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.govinfo.gov/link/fr/43/49564'" tppabs="https://www.govinfo.gov/link/fr/43/49564" class="external text external">49564</a></span></li><li id="cite_note-113"> <span id="mw-reference-text-cite_note-113" class="mw-reference-text"><cite id="CITEREFLavoie2013" class="citation news cs1">Lavoie D (9 January 2013). <a href="javascript:if(confirm('https://web.archive.org/web/20130110093212/http://www.huffingtonpost.com/2013/01/09/des-pregnancy-drug-lawsuit-melnick-sisters_n_2442937.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20130110093212/http://www.huffingtonpost.com/2013/01/09/des-pregnancy-drug-lawsuit-melnick-sisters_n_2442937.html'" tppabs="https://web.archive.org/web/20130110093212/http://www.huffingtonpost.com/2013/01/09/des-pregnancy-drug-lawsuit-melnick-sisters_n_2442937.html" class="external text external">"DES Pregnancy Drug Lawsuit: Settlement Reached Between Melnick Sisters And Eli Lilly And Co"</a>. <i>Huffington Post</i>. Archived from <a href="javascript:if(confirm('http://www.huffingtonpost.com/2013/01/09/des-pregnancy-drug-lawsuit-melnick-sisters_n_2442937.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.huffingtonpost.com/2013/01/09/des-pregnancy-drug-lawsuit-melnick-sisters_n_2442937.html'" tppabs="http://www.huffingtonpost.com/2013/01/09/des-pregnancy-drug-lawsuit-melnick-sisters_n_2442937.html" class="external text external">the original</a> on 10 January 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">19 March</span> 2014</span>.</cite></span></li><li id="cite_note-114"> <span id="mw-reference-text-cite_note-114" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://findingaids.smith.edu/repositories/2/resources/996  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://findingaids.smith.edu/repositories/2/resources/996'" tppabs="https://findingaids.smith.edu/repositories/2/resources/996" class="external text external">"Collection: DES Action USA records | Smith College Finding Aids"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-06-09</span></span>.</cite></span></li><li id="cite_note-115"> <span id="mw-reference-text-cite_note-115" class="mw-reference-text"><cite id="CITEREFWest-Taylor2016" class="citation web cs1">West-Taylor Z (24 September 2016). <a href="javascript:if(confirm('http://affinitymagazine.us/2016/09/24/the-alan-turing-law-a-formal-pardon-for-unpardonable-homophobia/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://affinitymagazine.us/2016/09/24/the-alan-turing-law-a-formal-pardon-for-unpardonable-homophobia/'" tppabs="http://affinitymagazine.us/2016/09/24/the-alan-turing-law-a-formal-pardon-for-unpardonable-homophobia/" class="external text external">"The Alan Turing Law – a Formal Pardon for Unpardonable Homophobia"</a>. <i>Affinity magazine</i><span class="reference-accessdate">. Retrieved <span class="nowrap">3 December</span> 2016</span>.</cite></span></li><li id="cite_note-116"> <span id="mw-reference-text-cite_note-116" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.merckvetmanual.com/?cfile=htm/bc/191024.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.merckvetmanual.com/?cfile=htm/bc/191024.htm'" tppabs="https://www.merckvetmanual.com/?cfile=htm/bc/191024.htm" class="external text external">"Urinary Incontinence"</a>. <i>Merck Veterinary Manual</i>. Merck Veterinary Manual<span class="reference-accessdate">. Retrieved <span class="nowrap">30 November</span> 2012</span>.</cite></span></li><li id="cite_note-117"> <span id="mw-reference-text-cite_note-117" class="mw-reference-text"><cite id="CITEREFHarrisWaring2012" class="citation journal cs1">Harris RM, Waring RH (June 2012). "Diethylstilboestrol--a long-term legacy". <i>Maturitas</i>. <b>72</b> (2): 108–12. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.maturitas.2012.03.002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.maturitas.2012.03.002'" tppabs="https://doi.org/10.1016%2Fj.maturitas.2012.03.002" class="external text external">10.1016/j.maturitas.2012.03.002</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22464649  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22464649'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22464649" class="external text external">22464649</a>.</cite></span></li><li id="cite_note-urlenvirocancer.cornell.edu-118"> <span id="mw-reference-text-cite_note-urlenvirocancer.cornell.edu-118" class="mw-reference-text"><cite id="CITEREFGandhiSnedeker2000" class="citation web cs1">Gandhi R, Snedeker S (2000-06-01). <a href="javascript:if(confirm('https://ecommons.cornell.edu/bitstream/handle/1813/14514/fs37.hormones.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ecommons.cornell.edu/bitstream/handle/1813/14514/fs37.hormones.pdf'" tppabs="https://ecommons.cornell.edu/bitstream/handle/1813/14514/fs37.hormones.pdf" class="external text external">"Consumer Concerns About Hormones in Food"</a> <span class="cs1-format">(PDF)</span>. <i>Fact Sheet #37, June 2000</i>. Program on Breast Cancer and Environmental Risk Factors, Cornell University. <a href="javascript:if(confirm('https://web.archive.org/web/20110719175735/http://envirocancer.cornell.edu/Factsheet/Diet/fs37.hormones.cfm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20110719175735/http://envirocancer.cornell.edu/Factsheet/Diet/fs37.hormones.cfm'" tppabs="https://web.archive.org/web/20110719175735/http://envirocancer.cornell.edu/Factsheet/Diet/fs37.hormones.cfm" class="external text external">Archived</a> from the original on 2011-07-19<span class="reference-accessdate">. Retrieved <span class="nowrap">2011-07-20</span></span>.</cite></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Further_reading">Further reading</h2></summary>
    
<ul><li><cite id="CITEREFJohnston2017" class="citation journal cs1">Johnston, Emily (2017). <a href="javascript:if(confirm('http://muse.jhu.edu/article/653258  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://muse.jhu.edu/article/653258'" tppabs="http://muse.jhu.edu/article/653258" class="external text external">"Poisoned subjects: life writing of DES daughters"</a>. <i>Frontiers: A Journal of Women Studies</i>. University of Nebraska Press. <b>38</b> (1): 31–63. doi:<a href="javascript:if(confirm('https://doi.org/10.5250%2Ffronjwomestud.38.1.0031  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.5250%2Ffronjwomestud.38.1.0031'" tppabs="https://doi.org/10.5250%2Ffronjwomestud.38.1.0031" class="external text external">10.5250/fronjwomestud.38.1.0031</a>. JSTOR<span>&nbsp;</span><a href="javascript:if(confirm('https://www.jstor.org/stable/10.5250/fronjwomestud.38.1.0031  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.jstor.org/stable/10.5250/fronjwomestud.38.1.0031'" tppabs="https://www.jstor.org/stable/10.5250/fronjwomestud.38.1.0031" class="external text external">10.5250/fronjwomestud.38.1.0031</a>.</cite></li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><a href="javascript:if(confirm('https://www.cancer.gov/about-cancer/causes-prevention/risk/hormones/des-fact-sheet  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.cancer.gov/about-cancer/causes-prevention/risk/hormones/des-fact-sheet'" tppabs="https://www.cancer.gov/about-cancer/causes-prevention/risk/hormones/des-fact-sheet" class="external text external">Diethylstilbestrol (DES) and Cancer</a> National Cancer Institute</li>
<li><a href="javascript:if(confirm('https://www.cdc.gov/DES/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.cdc.gov/DES/'" tppabs="https://www.cdc.gov/DES/" class="external text external">DES Update</a> from the U.S. Centers for Disease Control and Prevention</li>
<li><a href="javascript:if(confirm('https://desaction.org/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://desaction.org/'" tppabs="https://desaction.org/" class="external text external">DES Action USA</a> national consumer organization providing comprehensive information for DES-exposed individuals</li>
<li><a href="javascript:if(confirm('https://web.archive.org/web/20070604145531/http://dccps.nci.nih.gov/ACSRB/pubs/DES_Pubs/directory.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20070604145531/http://dccps.nci.nih.gov/ACSRB/pubs/DES_Pubs/directory.html'" tppabs="https://web.archive.org/web/20070604145531/http://dccps.nci.nih.gov/ACSRB/pubs/DES_Pubs/directory.html" class="external text external">DES Booklets</a> from the U.S. National Institutes of Health (circa 1980)</li>
<li><a href="javascript:if(confirm('https://www.desfollowupstudy.org/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.desfollowupstudy.org/'" tppabs="https://www.desfollowupstudy.org/" class="external text external">DES Follow-up Study</a> National Cancer Institute's longterm study of DES-exposed persons (including the DES-AD Project)</li>
<li><a href="javascript:if(confirm('http://obg.bsd.uchicago.edu/registry.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://obg.bsd.uchicago.edu/registry.html'" tppabs="http://obg.bsd.uchicago.edu/registry.html" class="external text external">University of Chicago DES Registry</a> of patients with CCA (clear cell adenocarcinoma) of the vagina and/or cervix</li>
<li><a href="javascript:if(confirm('https://diethylstilbestrol.co.uk/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://diethylstilbestrol.co.uk/'" tppabs="https://diethylstilbestrol.co.uk/" class="external text external">DES Diethylstilbestrol</a> Provides resources and social media links for general DES awareness</li></ul>
<p>
<br></p>
<div role="navigation" class="navbox" aria-labelledby="Estrogens_and_antiestrogens" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Estrogens_and_antiestrogens" style="font-size:114%;margin:0 4em">Estrogens and antiestrogens</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Estrogens</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;background:#DDDDFF;"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:10em;;text-align:center;"><abbr>ER</abbr> agonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Steroidal:</i> <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Alfatradiol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Alfatradiol'" tppabs="https://ptable.com/wiki/compounds/A/Alfatradiol" title="Alfatradiol">Alfatradiol</a></li>
<li>Certain androgens/anabolic steroids (e.g., testosterone, testosterone esters, <a href="Methyltestosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methyltestosterone" title="Methyltestosterone">methyltestosterone</a>, metandienone, nandrolone esters) (via estrogenic metabolites)</li>
<li>Certain progestins (e.g., <a href="Norethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Norethisterone" title="Norethisterone">norethisterone</a>, noretynodrel, <a href="Etynodiol_diacetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Etynodiol_diacetate" title="Etynodiol diacetate">etynodiol diacetate</a>, tibolone)</li>
<li>Clomestrone</li>
<li>Cloxestradiol acetate</li>
<li>Conjugated estriol</li>
<li>Conjugated estrogens</li>
<li>Epiestriol</li>
<li>Epimestrol</li>
<li>Esterified estrogens</li>
<li>Estetrol<sup>†</sup></li>
<li>Estradiol</li>
<li>Estradiol esters (e.g., estradiol acetate, estradiol benzoate, estradiol cypionate, estradiol enanthate, estradiol undecylate, estradiol valerate, polyestradiol phosphate, estradiol ester mixtures (Climacteron))</li>
<li>Estramustine phosphate</li>
<li>Estriol</li>
<li>Estriol esters (e.g., estriol succinate, polyestriol phosphate)</li>
<li>Estrogenic substances</li>
<li>Estrone</li>
<li>Estrone esters
<ul><li>Estrone sulfate</li>
<li>Estropipate (piperazine estrone sulfate)</li></ul></li>
<li>Ethinylestradiol<sup>#</sup>
<ul><li>Ethinylestradiol sulfonate</li></ul></li>
<li>Hydroxyestrone diacetate</li>
<li><a href="Mestranol.htm" tppabs="https://ptable.com/wiki/compounds/A/Mestranol" title="Mestranol">Mestranol</a></li>
<li>Methylestradiol</li>
<li>Moxestrol</li>
<li>Nilestriol</li>
<li>Prasterone (dehydroepiandrosterone; DHEA)
<ul><li>Prasterone enanthate</li>
<li>Prasterone sulfate</li></ul></li>
<li>Promestriene</li>
<li>Quinestradol</li>
<li><a href="Quinestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinestrol" title="Quinestrol">Quinestrol</a></li></ul>

<ul><li><i>Nonsteroidal:</i> Benzestrol</li>
<li>Bifluranol</li>
<li><a href="Chlorotrianisene.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorotrianisene" title="Chlorotrianisene">Chlorotrianisene</a></li>
<li><a href="Dienestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Dienestrol" title="Dienestrol">Dienestrol</a>
<ul><li>Dienestrol diacetate</li></ul></li>
<li><a href="Diethylstilbestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Diethylstilbestrol" title="Diethylstilbestrol">Diethylstilbestrol (stilbestrol)</a></li>
<li>Diethylstilbestrol esters/ethers
<ul><li>Dimestrol (diethylstilbestrol dimethyl ether)</li>
<li><a href="Fosfestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Fosfestrol" title="Fosfestrol">Fosfestrol (diethylstilbestrol diphosphate)</a></li>
<li>Mestilbol (diethylstilbestrol monomethyl ether)</li></ul></li>
<li>Doisynoestrol (fenocycline)</li>
<li>Hexestrol
<ul><li>Hexestrol esters</li></ul></li>
<li><a href="Methallenestril.htm" tppabs="https://ptable.com/wiki/compounds/A/Methallenestril" title="Methallenestril">Methallenestril</a></li>
<li>Methestrol (promethestrol)
<ul><li>Methestrol dipropionate (promethestrol dipropionate)</li></ul></li>
<li>Paroxypropione</li>
<li>Quadrosilan</li>
<li>Triphenylbromoethylene</li>
<li>Triphenylchloroethylene</li>
<li><a href="Zeranol.htm" tppabs="https://ptable.com/wiki/compounds/A/Zeranol" title="Zeranol">Zeranol</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:10em;;text-align:center;">Progonadotropins</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Antiandrogens (e.g., <a href="Bicalutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Bicalutamide" title="Bicalutamide">bicalutamide</a>)</li>
<li><abbr>GnRH</abbr> agonists (e.g., <a href="Gonadotropin-releasing_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Gonadotropin-releasing_hormone" title="Gonadotropin-releasing hormone"><abbr>GnRH</abbr> (gonadorelin)</a>, <a href="Leuprorelin.htm" tppabs="https://ptable.com/wiki/compounds/A/Leuprorelin" title="Leuprorelin">leuprorelin</a>)</li>
<li>Gonadotropins (e.g., <abbr>FSH</abbr>, <a href="Luteinizing_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Luteinizing_hormone" title="Luteinizing hormone"><abbr>LH</abbr></a>)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Antiestrogens</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;background:#DDDDFF;"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:10em;;text-align:center;"><abbr>ER</abbr> antagonists<br>(incl. <abbr>SERMs</abbr>/<abbr>SERDs</abbr>)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Acolbifene<sup>†</sup></li>
<li>Anordrin</li>
<li>Bazedoxifene</li>
<li>Broparestrol</li>
<li><a href="Clomifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Clomifene" title="Clomifene">Clomifene</a><sup>#</sup></li>
<li><a href="Cyclofenil.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclofenil" title="Cyclofenil">Cyclofenil</a></li>
<li>Enclomifene<sup>†</sup></li>
<li>Epitiostanol</li>
<li>Lasofoxifene</li>
<li>Mepitiostane</li>
<li>Ormeloxifene</li>
<li>Ospemifene</li>
<li><a href="Raloxifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Raloxifene" title="Raloxifene">Raloxifene</a></li>
<li><a href="Tamoxifen.htm" tppabs="https://ptable.com/wiki/compounds/A/Tamoxifen" title="Tamoxifen">Tamoxifen</a><sup>#</sup></li>
<li><a href="Toremifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Toremifene" title="Toremifene">Toremifene</a></li></ul>

<ul><li><i>Exclusively antagonistic:</i> <a href="Fulvestrant.htm" tppabs="https://ptable.com/wiki/compounds/A/Fulvestrant" title="Fulvestrant">Fulvestrant</a></li></ul>

<ul><li><i>Noncompetitive inhibitors:</i> <a href="Trilostane.htm" tppabs="https://ptable.com/wiki/compounds/A/Trilostane" title="Trilostane">Trilostane</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:10em;;text-align:center;">Aromatase inhibitors</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>First-generation:</i> <a href="Aminoglutethimide.htm" tppabs="https://ptable.com/wiki/compounds/A/Aminoglutethimide" title="Aminoglutethimide">Aminoglutethimide</a></li>
<li><a href="Testolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Testolactone" title="Testolactone">Testolactone</a></li></ul>

<ul><li><i>Second-generation:</i> Fadrozole</li>
<li><a href="Formestane.htm" tppabs="https://ptable.com/wiki/compounds/A/Formestane" title="Formestane">Formestane</a></li></ul>

<ul><li><i>Third-generation:</i> <a href="Anastrozole.htm" tppabs="https://ptable.com/wiki/compounds/A/Anastrozole" title="Anastrozole">Anastrozole</a></li>
<li><a href="Exemestane.htm" tppabs="https://ptable.com/wiki/compounds/A/Exemestane" title="Exemestane">Exemestane</a></li>
<li><a href="Letrozole.htm" tppabs="https://ptable.com/wiki/compounds/A/Letrozole" title="Letrozole">Letrozole</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:10em;;text-align:center;">Antigonadotropins</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Androgens/anabolic steroids (e.g., <a href="Testosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Testosterone" title="Testosterone">testosterone</a>, testosterone esters, nandrolone esters, <a href="Oxandrolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxandrolone" title="Oxandrolone">oxandrolone</a>, <a href="Fluoxymesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluoxymesterone" title="Fluoxymesterone">fluoxymesterone</a>)</li>
<li>D<sub>2</sub> receptor antagonists (prolactin releasers) (e.g., <a href="Domperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Domperidone" title="Domperidone">domperidone</a>, <a href="Metoclopramide.htm" tppabs="https://ptable.com/wiki/compounds/A/Metoclopramide" title="Metoclopramide">metoclopramide</a>, <a href="Risperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Risperidone" title="Risperidone">risperidone</a>, <a href="Haloperidol.htm" tppabs="https://ptable.com/wiki/compounds/A/Haloperidol" title="Haloperidol">haloperidol</a>, <a href="Chlorpromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpromazine" title="Chlorpromazine">chlorpromazine</a>, <a href="Sulpiride.htm" tppabs="https://ptable.com/wiki/compounds/A/Sulpiride" title="Sulpiride">sulpiride</a>)</li>
<li><abbr>GnRH</abbr> agonists (e.g., <a href="Leuprorelin.htm" tppabs="https://ptable.com/wiki/compounds/A/Leuprorelin" title="Leuprorelin">leuprorelin</a>, <a href="Goserelin.htm" tppabs="https://ptable.com/wiki/compounds/A/Goserelin" title="Goserelin">goserelin</a>)</li>
<li><abbr>GnRH</abbr> antagonists (e.g., <a href="Cetrorelix.htm" tppabs="https://ptable.com/wiki/compounds/A/Cetrorelix" title="Cetrorelix">cetrorelix</a>, elagolix)</li>
<li>Progestogens (e.g., chlormadinone acetate, cyproterone acetate, gestonorone caproate, hydroxyprogesterone caproate, <a href="Medroxyprogesterone_acetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">medroxyprogesterone acetate</a>, megestrol acetate)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:10em;;text-align:center;">Others</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Mixed mechanism of action:</i> <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Danazol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Danazol'" tppabs="https://ptable.com/wiki/compounds/A/Danazol" title="Danazol">Danazol</a></li>
<li><a href="Gestrinone.htm" tppabs="https://ptable.com/wiki/compounds/A/Gestrinone" title="Gestrinone">Gestrinone</a></li></ul>

<ul><li><i>Androstenedione immunogens:</i> Androvax (androstenedione albumin)</li>
<li>Ovandrotone albumin (Fecundin)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0px;background:#DDDDFF;"><div style="padding:0em 0.25em"><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div>
<dl><dt>See also</dt>
<dd>Estrogen receptor modulators</dd>
<dd>Androgens and antiandrogens</dd>
<dd>Progestogens and antiprogestogens</dd>
<dd>List of estrogens</dd></dl></div></td></tr></tbody></table></div><span>
</span>
<div role="navigation" class="navbox" aria-labelledby="Estrogen_receptor_modulators" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Estrogen_receptor_modulators" style="font-size:114%;margin:0 4em">Estrogen receptor modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>ER</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Agonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Steroidal:</i> 2-Hydroxyestradiol</li>
<li>2-Hydroxyestrone</li>
<li>3-Methyl-19-methyleneandrosta-3,5-dien-17β-ol</li>
<li>3α-Androstanediol</li>
<li><span class="new">3α,5α-Dihydrolevonorgestrel</span></li>
<li><span class="new">3β,5α-Dihydrolevonorgestrel</span></li>
<li>3α-Hydroxytibolone</li>
<li>3β-Hydroxytibolone</li>
<li>3β-Androstanediol</li>
<li><a href="4-Androstenediol.htm" tppabs="https://ptable.com/wiki/compounds/A/4-Androstenediol" title="4-Androstenediol">4-Androstenediol</a></li>
<li><a href="Androstenedione.htm" tppabs="https://ptable.com/wiki/compounds/A/4-Androstenedione" title="4-Androstenedione" class="mw-redirect">4-Androstenedione</a></li>
<li>4-Fluoroestradiol</li>
<li>4-Hydroxyestradiol</li>
<li>4-Hydroxyestrone</li>
<li>4-Methoxyestradiol</li>
<li>4-Methoxyestrone</li>
<li><a href="5-Androstenediol.htm" tppabs="https://ptable.com/wiki/compounds/A/5-Androstenediol" title="5-Androstenediol" class="mw-redirect">5-Androstenediol</a></li>
<li>7-Oxo-DHEA</li>
<li>7α-Hydroxy-DHEA</li>
<li>7α-Methylestradiol</li>
<li>7β-Hydroxyepiandrosterone</li>
<li>8,9-Dehydroestradiol</li>
<li>8,9-Dehydroestrone</li>
<li>8β-VE2</li>
<li>10β,17β-Dihydroxyestra-1,4-dien-3-one (DHED)</li>
<li>11β-Chloromethylestradiol</li>
<li>11β-Methoxyestradiol</li>
<li>15α-Hydroxyestradiol</li>
<li>16-Ketoestradiol</li>
<li>16-Ketoestrone</li>
<li>16α-Fluoroestradiol</li>
<li>16α-Hydroxy-DHEA</li>
<li>16α-Hydroxyestrone</li>
<li>16α-Iodoestradiol</li>
<li>16α-LE2</li>
<li>16β-Hydroxyestrone</li>
<li>16β,17α-Epiestriol (16β-hydroxy-17α-estradiol)</li>
<li>17α-Estradiol (<a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Alfatradiol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Alfatradiol'" tppabs="https://ptable.com/wiki/compounds/A/Alfatradiol" title="Alfatradiol">alfatradiol</a>)</li>
<li>17α-Dihydroequilenin</li>
<li>17α-Dihydroequilin</li>
<li>17α-Epiestriol (16α-hydroxy-17α-estradiol)</li>
<li>17α-Ethynyl-3α-androstanediol</li>
<li>17α-Ethynyl-3β-androstanediol</li>
<li>17β-Dihydroequilenin</li>
<li>17β-Dihydroequilin</li>
<li>17β-Methyl-17α-dihydroequilenin</li>
<li>Abiraterone</li>
<li>Abiraterone acetate</li>
<li>Alestramustine</li>
<li>Almestrone</li>
<li>Anabolic steroids (e.g., <a href="Testosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Testosterone" title="Testosterone">testosterone</a> and esters, <a href="Methyltestosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methyltestosterone" title="Methyltestosterone">methyltestosterone</a>, metandienone (methandrostenolone), <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Nandrolone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Nandrolone'" tppabs="https://ptable.com/wiki/compounds/A/Nandrolone" title="Nandrolone">nandrolone</a> and esters, many others; via estrogenic metabolites)</li>
<li>Atrimustine</li>
<li>Bolandiol</li>
<li>Bolandiol dipropionate</li>
<li>Butolame</li>
<li>Clomestrone</li>
<li>Cloxestradiol
<ul><li>Cloxestradiol acetate</li></ul></li>
<li>Conjugated estriol</li>
<li>Conjugated estrogens</li>
<li>Cyclodiol</li>
<li>Cyclotriol</li>
<li><a href="Dehydroepiandrosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dehydroepiandrosterone" title="Dehydroepiandrosterone">DHEA</a></li>
<li><a href="Dehydroepiandrosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dehydroepiandrosterone" title="Dehydroepiandrosterone">DHEA-S</a></li>
<li><i>ent</i>-Estradiol</li>
<li>Epiestriol (16β-epiestriol, 16β-hydroxy-17β-estradiol)</li>
<li>Epimestrol</li>
<li><a href="Equilenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Equilenin" title="Equilenin">Equilenin</a></li>
<li><a href="Equilin.htm" tppabs="https://ptable.com/wiki/compounds/A/Equilin" title="Equilin">Equilin</a></li>
<li>ERA-63 (ORG-37663)</li>
<li>Esterified estrogens</li>
<li>Estetrol</li>
<li><a href="Estradiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Estradiol" title="Estradiol">Estradiol</a>
<ul><li>Estradiol esters</li>
<li>Lipoidal estradiol</li>
<li>Polyestradiol phosphate</li></ul></li>
<li><a href="Estramustine.htm" tppabs="https://ptable.com/wiki/compounds/A/Estramustine" title="Estramustine">Estramustine</a></li>
<li>Estramustine phosphate</li>
<li>Estrapronicate</li>
<li>Estrazinol</li>
<li><a href="Estriol.htm" tppabs="https://ptable.com/wiki/compounds/A/Estriol" title="Estriol">Estriol</a>
<ul><li>Estriol esters</li>
<li>Polyestriol phosphate</li></ul></li>
<li>Estrofurate</li>
<li>Estrogenic substances</li>
<li>Estromustine</li>
<li><a href="Estrone.htm" tppabs="https://ptable.com/wiki/compounds/A/Estrone" title="Estrone">Estrone</a>
<ul><li>Estrone esters</li>
<li>Estrone methyl ether</li>
<li>Estropipate</li></ul></li>
<li>Etamestrol (eptamestrol)</li>
<li>Ethinylandrostenediol
<ul><li>Ethandrostate</li></ul></li>
<li>Ethinylestradiol
<ul><li>Ethinylestradiol 3-benzoate</li>
<li>Ethinylestradiol sulfonate</li></ul></li>
<li>Ethinylestriol</li>
<li>Ethylestradiol</li>
<li>Etynodiol</li>
<li><a href="Etynodiol_diacetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Etynodiol_diacetate" title="Etynodiol diacetate">Etynodiol diacetate</a></li>
<li>Hexolame</li>
<li>Hippulin</li>
<li>Hydroxyestrone diacetate</li>
<li>Lynestrenol</li>
<li>Lynestrenol phenylpropionate</li>
<li><a href="Mestranol.htm" tppabs="https://ptable.com/wiki/compounds/A/Mestranol" title="Mestranol">Mestranol</a></li>
<li>Methylestradiol</li>
<li>Moxestrol</li>
<li>Mytatrienediol</li>
<li>Nilestriol</li>
<li><a href="Norethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Norethisterone" title="Norethisterone">Norethisterone</a></li>
<li>Noretynodrel</li>
<li>Orestrate</li>
<li>Pentolame</li>
<li>Prodiame</li>
<li>Prolame</li>
<li>Promestriene</li>
<li>RU-16117</li>
<li>Quinestradol</li>
<li><a href="Quinestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinestrol" title="Quinestrol">Quinestrol</a></li>
<li>Tibolone</li></ul>

<ul><li><i>Nonsteroidal:</i> (R,R)-THC</li>
<li>(S,S)-THC</li>
<li>2,8-DHHHC</li>
<li><span class="new">β-LGND1</span></li>
<li>β-LGND2 (GTx-878)</li>
<li><span class="new">AC-186</span></li>
<li>Allenestrol</li>
<li>Allenolic acid</li>
<li>Benzestrol</li>
<li>Bifluranol</li>
<li>Bisdehydrodoisynolic acid</li>
<li>Butestrol</li>
<li>Carbestrol</li>
<li>D-15414</li>
<li>DCW234</li>
<li>Diarylpropionitrile</li>
<li><a href="Dienestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Dienestrol" title="Dienestrol">Dienestrol</a>
<ul><li>Dienestrol diacetate</li></ul></li>
<li><a href="Diethylstilbestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Diethylstilbestrol" title="Diethylstilbestrol">Diethylstilbestrol</a>
<ul><li>Diethylstilbestrol esters</li></ul></li>
<li>Dimestrol (dianisylhexene)</li>
<li>Dimethylstilbestrol</li>
<li>Doisynoestrol (fenocycline)</li>
<li>Doisynolic acid</li>
<li><a href="Efavirenz.htm" tppabs="https://ptable.com/wiki/compounds/A/Efavirenz" title="Efavirenz">Efavirenz</a></li>
<li>ERB-196 (WAY-202196)</li>
<li>Erteberel (SERBA-1, LY-500307)</li>
<li>Estrobin (DBE)</li>
<li>Fenestrel</li>
<li>FERb 033</li>
<li><a href="Fosfestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Fosfestrol" title="Fosfestrol">Fosfestrol (diethylstilbestrol diphosphate)</a></li>
<li>Furostilbestrol (diethylstilbestrol difuroate)</li>
<li>GTx-758</li>
<li>Hexestrol
<ul><li>Hexestrol esters</li></ul></li>
<li>ICI-85966 (Stilbostat)</li>
<li>M2613</li>
<li><i>meso</i>-Butestrol</li>
<li><i>meso</i>-Hexestrol</li>
<li>Mestilbol</li>
<li><a href="Methallenestril.htm" tppabs="https://ptable.com/wiki/compounds/A/Methallenestril" title="Methallenestril">Methallenestril</a></li>
<li>Methestrol</li>
<li>Methestrol dipropionate</li>
<li>Paroxypropione</li>
<li>Pentafluranol</li>
<li>Phenestrol</li>
<li>Prinaberel (ERB-041, WAY-202041)</li>
<li>Propylpyrazoletriol</li>
<li>Quadrosilan</li>
<li><span class="new">SC-3296</span></li>
<li>SC-4289</li>
<li>SERBA-2</li>
<li>SKF-82,958</li>
<li>Terfluranol</li>
<li>Triphenylbromoethylene</li>
<li>Triphenylchloroethylene</li>
<li>Triphenyliodoethylene</li>
<li>Triphenylmethylethylene (triphenylpropene)</li>
<li>WAY-166818</li>
<li><span class="new">WAY-169916</span></li>
<li>WAY-200070</li>
<li>WAY-204688 (SIM-688)</li>
<li>WAY-214156</li></ul>

<ul><li><i>Unknown/unsorted:</i> ERB-26</li>
<li>ERA-45</li>
<li>ERB-79</li>
<li>ZK-283197</li></ul>

<ul><li><i>Xenoestrogens:</i> <a href="Anise.htm" tppabs="https://ptable.com/wiki/compounds/A/Anise" title="Anise">Anise</a>-related (e.g., <a href="Anethole.htm" tppabs="https://ptable.com/wiki/compounds/A/Anethole" title="Anethole">anethole</a>, anol, dianethole, dianol, photoanethole)</li>
<li>Chalconoids (e.g., <a href="Isoliquiritigenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Isoliquiritigenin" title="Isoliquiritigenin">isoliquiritigenin</a>, <a href="Phloretin.htm" tppabs="https://ptable.com/wiki/compounds/A/Phloretin" title="Phloretin">phloretin</a>, <a href="Phlorizin.htm" tppabs="https://ptable.com/wiki/compounds/A/Phlorizin" title="Phlorizin">phlorizin (phloridzin)</a>, wedelolactone)</li>
<li>Coumestans (e.g., <a href="Coumestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Coumestrol" title="Coumestrol">coumestrol</a>, psoralidin)</li>
<li><a href="Flavonoid.htm" tppabs="https://ptable.com/wiki/compounds/A/Flavonoid" title="Flavonoid">Flavonoids</a> (incl. 7,8-DHF, 8-prenylnaringenin, <a href="Apigenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Apigenin" title="Apigenin">apigenin</a>, <a href="Baicalein.htm" tppabs="https://ptable.com/wiki/compounds/A/Baicalein" title="Baicalein">baicalein</a>, <a href="Baicalin.htm" tppabs="https://ptable.com/wiki/compounds/A/Baicalin" title="Baicalin">baicalin</a>, <a href="Biochanin_A.htm" tppabs="https://ptable.com/wiki/compounds/A/Biochanin_A" title="Biochanin A">biochanin A</a>, <a href="Calycosin.htm" tppabs="https://ptable.com/wiki/compounds/A/Calycosin" title="Calycosin">calycosin</a>, <a href="Catechin.htm" tppabs="https://ptable.com/wiki/compounds/A/Catechin" title="Catechin">catechin</a>, <a href="Daidzein.htm" tppabs="https://ptable.com/wiki/compounds/A/Daidzein" title="Daidzein">daidzein</a>, daidzin, ECG, <a href="Epigallocatechin_gallate.htm" tppabs="https://ptable.com/wiki/compounds/A/Epigallocatechin_gallate" title="Epigallocatechin gallate">EGCG</a>, <a href="Catechin.htm" tppabs="https://ptable.com/wiki/compounds/A/Epicatechin" title="Epicatechin" class="mw-redirect">epicatechin</a>, <a href="Equol.htm" tppabs="https://ptable.com/wiki/compounds/A/Equol" title="Equol">equol</a>, <a href="Formononetin.htm" tppabs="https://ptable.com/wiki/compounds/A/Formononetin" title="Formononetin">formononetin</a>, glabrene, glabridin, <a href="Genistein.htm" tppabs="https://ptable.com/wiki/compounds/A/Genistein" title="Genistein">genistein</a>, <a href="Genistin.htm" tppabs="https://ptable.com/wiki/compounds/A/Genistin" title="Genistin">genistin</a>, <a href="Glycitein.htm" tppabs="https://ptable.com/wiki/compounds/A/Glycitein" title="Glycitein">glycitein</a>, <a href="Kaempferol.htm" tppabs="https://ptable.com/wiki/compounds/A/Kaempferol" title="Kaempferol">kaempferol</a>, <a href="Liquiritigenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Liquiritigenin" title="Liquiritigenin">liquiritigenin</a>, mirificin, <a href="Myricetin.htm" tppabs="https://ptable.com/wiki/compounds/A/Myricetin" title="Myricetin">myricetin</a>, <a href="Naringenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Naringenin" title="Naringenin">naringenin</a>, <span class="new">penduletin</span>, pinocembrin, <a href="Prunetin.htm" tppabs="https://ptable.com/wiki/compounds/A/Prunetin" title="Prunetin">prunetin</a>, puerarin, <a href="Quercetin.htm" tppabs="https://ptable.com/wiki/compounds/A/Quercetin" title="Quercetin">quercetin</a>, tectoridin, tectorigenin)</li>
<li>Lavender oil</li>
<li>Lignans (e.g., enterodiol, enterolactone, nyasol (<i>cis</i>-hinokiresinol))</li>
<li>Metalloestrogens (e.g., <a href="Cadmium.htm" tppabs="https://ptable.com/wiki/compounds/A/Cadmium" title="Cadmium">cadmium</a>)</li>
<li>Pesticides (e.g., alternariol, <a href="Dieldrin.htm" tppabs="https://ptable.com/wiki/compounds/A/Dieldrin" title="Dieldrin">dieldrin</a>, <a href="Endosulfan.htm" tppabs="https://ptable.com/wiki/compounds/A/Endosulfan" title="Endosulfan">endosulfan</a>, <a href="Fenarimol.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenarimol" title="Fenarimol">fenarimol</a>, HPTE, <a href="Methiocarb.htm" tppabs="https://ptable.com/wiki/compounds/A/Methiocarb" title="Methiocarb">methiocarb</a>, <a href="Methoxychlor.htm" tppabs="https://ptable.com/wiki/compounds/A/Methoxychlor" title="Methoxychlor">methoxychlor</a>, <a href="Triclocarban.htm" tppabs="https://ptable.com/wiki/compounds/A/Triclocarban" title="Triclocarban">triclocarban</a>, triclosan)</li>
<li>Phytosteroids (e.g., <a href="Digitoxin.htm" tppabs="https://ptable.com/wiki/compounds/A/Digitoxin" title="Digitoxin">digitoxin</a> (digitalis), <a href="Diosgenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Diosgenin" title="Diosgenin">diosgenin</a>, guggulsterone)</li>
<li><a href="Phytosterol.htm" tppabs="https://ptable.com/wiki/compounds/A/Phytosterol" title="Phytosterol">Phytosterols</a> (e.g., β-sitosterol, <a href="Campesterol.htm" tppabs="https://ptable.com/wiki/compounds/A/Campesterol" title="Campesterol">campesterol</a>, <a href="Stigmasterol.htm" tppabs="https://ptable.com/wiki/compounds/A/Stigmasterol" title="Stigmasterol">stigmasterol</a>)</li>
<li>Resorcylic acid lactones (e.g., zearalanone, α-zearalenol, β-zearalenol, <a href="Zearalenone.htm" tppabs="https://ptable.com/wiki/compounds/A/Zearalenone" title="Zearalenone">zearalenone</a>, <a href="Zeranol.htm" tppabs="https://ptable.com/wiki/compounds/A/Zeranol" title="Zeranol">zeranol (α-zearalanol)</a>, taleranol (teranol, β-zearalanol))</li>
<li>Steroid-like (e.g., deoxymiroestrol, miroestrol)</li>
<li>Stilbenoids (e.g., <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Resveratrol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Resveratrol'" tppabs="https://ptable.com/wiki/compounds/A/Resveratrol" title="Resveratrol">resveratrol</a>, <a href="Rhaponticin.htm" tppabs="https://ptable.com/wiki/compounds/A/Rhaponticin" title="Rhaponticin">rhaponticin</a>)</li>
<li>Synthetic xenoestrogens (e.g., alkylphenols, <a href="Bisphenol.htm" tppabs="https://ptable.com/wiki/compounds/A/Bisphenol" title="Bisphenol">bisphenols</a> (e.g., <a href="Bisphenol_A.htm" tppabs="https://ptable.com/wiki/compounds/A/Bisphenol_A" title="Bisphenol A">BPA</a>, BPF, <a href="Bisphenol_S.htm" tppabs="https://ptable.com/wiki/compounds/A/Bisphenol_S" title="Bisphenol S">BPS</a>), DDT, parabens, <a href="Polybrominated_biphenyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Polybrominated_biphenyl" title="Polybrominated biphenyl">PBBs</a>, PHBA, phthalates, <a href="Polychlorinated_biphenyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Polychlorinated_biphenyl" title="Polychlorinated biphenyl">PCBs</a>)</li>
<li>Others (e.g., agnuside, <span class="new">rotundifuran</span>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Mixed<br>(<abbr>SERMs</abbr>)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><span class="new">2-Phenylbenzofuran</span></li>
<li><span class="new">2-Phenylbenzothiophene</span></li>
<li>4'-Hydroxynorendoxifen</li>
<li>27-Hydroxycholesterol</li>
<li>Acefluranol</li>
<li>Acolbifene</li>
<li>Afimoxifene</li>
<li>Anordiol</li>
<li>Anordrin</li>
<li>Arzoxifene</li>
<li>Bazedoxifene</li>
<li>Brilanestrant</li>
<li>Broparestrol</li>
<li><a href="Chlorotrianisene.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorotrianisene" title="Chlorotrianisene">Chlorotrianisene</a></li>
<li><a href="Clomifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Clomifene" title="Clomifene">Clomifene</a></li>
<li>Clomifenoxide</li>
<li><span class="new">CN-55945-27</span></li>
<li><a href="Cyclofenil.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclofenil" title="Cyclofenil">Cyclofenil</a></li>
<li><span class="new">D-15413</span></li>
<li>Desmethylchlorotrianisene</li>
<li>Droloxifene</li>
<li>Elacestrant</li>
<li>Enclomifene</li>
<li>Endoxifen</li>
<li>Etacstil (GW-5638, DPC-974)</li>
<li>Ethamoxytriphetol (MER-25)</li>
<li>Femarelle</li>
<li>Fispemifene</li>
<li><span class="new">GW-7604</span></li>
<li><span class="new">ICI-55548</span></li>
<li><a href="Idoxifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Idoxifene" title="Idoxifene">Idoxifene</a></li>
<li>Lasofoxifene</li>
<li>Levormeloxifene</li>
<li>LN-1643</li>
<li>LN-2299</li>
<li><span class="new">LY-117018</span></li>
<li>Menerba</li>
<li>Miproxifene</li>
<li>Miproxifene phosphate</li>
<li><span class="new">MRL-37</span></li>
<li>Nafoxidine</li>
<li>Nitromifene</li>
<li>NNC 45-0095</li>
<li><span class="new">NNC 45-0320</span></li>
<li><span class="new">NNC 45-0781</span></li>
<li><span class="new">NNC 45-1506</span></li>
<li>Ormeloxifene</li>
<li>Ospemifene</li>
<li>Panomifene</li>
<li>Pipendoxifene</li>
<li><span class="new">Promensil</span></li>
<li><a href="Raloxifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Raloxifene" title="Raloxifene">Raloxifene</a></li>
<li>Rimostil (P-081)</li>
<li><a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">Spironolactone</a></li>
<li><span class="new">SS1010</span></li>
<li><a href="Tamoxifen.htm" tppabs="https://ptable.com/wiki/compounds/A/Tamoxifen" title="Tamoxifen">Tamoxifen</a></li>
<li>TAS-108 (SR-16234)</li>
<li><a href="Toremifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Toremifene" title="Toremifene">Toremifene</a></li>
<li>Trioxifene</li>
<li><span class="new">TZE-5323</span></li>
<li><span class="new">U-11555A</span></li>
<li><span class="new">U-11634</span></li>
<li><span class="new">Y-134</span></li>
<li>Zindoxifene</li>
<li>Zuclomifene</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Antagonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>(R,R)-THC</li>
<li>7β-Hydroxy-DHEA</li>
<li><span class="new">Chloroindazole</span></li>
<li>Cytestrol acetate</li>
<li><span class="new">EM-800 (SCH-57050)</span></li>
<li>Epitiostanol</li>
<li><span class="new">ERA-90</span></li>
<li><span class="new">ERB-88</span></li>
<li><a href="Fulvestrant.htm" tppabs="https://ptable.com/wiki/compounds/A/Fulvestrant" title="Fulvestrant">Fulvestrant (ICI-182780)</a></li>
<li><a href="Glyceollin.htm" tppabs="https://ptable.com/wiki/compounds/A/Glyceollin" title="Glyceollin">Glyceollins</a> (I, <span class="new">II</span>, III, <span class="new">IV</span>)</li>
<li>ICI-164384</li>
<li><span class="new">MDL-101906</span></li>
<li>Mepitiostane</li>
<li>Methylepitiostanol</li>
<li>Methylpiperidinopyrazole</li>
<li>MIBE</li>
<li><span class="new">Oxabicycloheptene sulfonate</span></li>
<li><a href="Phenytoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenytoin" title="Phenytoin">Phenytoin</a></li>
<li>PHTPP</li>
<li>Prochloraz</li>
<li><span class="new">RU-39411</span></li>
<li><span class="new">RU-58668</span></li>
<li><span class="new">SS1020</span></li>
<li>TAS-108 (SR-16234)</li>
<li>ZB716</li>
<li><span class="new">ZK-164015</span></li>
<li><span class="new">ZK-191703</span></li></ul>

<ul><li><i>Coregulator-binding modulators:</i> ERX-11</li></ul>

<ul><li><i>Noncompetitive inhibitors:</i> <a href="Trilostane.htm" tppabs="https://ptable.com/wiki/compounds/A/Trilostane" title="Trilostane">Trilostane</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>GPER</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Agonists</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="2-Methoxyestradiol.htm" tppabs="https://ptable.com/wiki/compounds/A/2-Methoxyestradiol" title="2-Methoxyestradiol">2-Methoxyestradiol</a></li>
<li>7β-Hydroxyepiandrosterone</li>
<li>Afimoxifene (4-hydroxytamoxifen)</li>
<li><a href="Aldosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Aldosterone" title="Aldosterone">Aldosterone</a></li>
<li><a href="Atrazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Atrazine" title="Atrazine">Atrazine</a></li>
<li><a href="Bisphenol_A.htm" tppabs="https://ptable.com/wiki/compounds/A/Bisphenol_A" title="Bisphenol A">Bisphenol A</a></li>
<li><a href="Daidzein.htm" tppabs="https://ptable.com/wiki/compounds/A/Daidzein" title="Daidzein">Daidzein</a></li>
<li>DDT (p,p'-DDT, <span class="new">o',p'-DDE</span>)</li>
<li>Diarylpropionitrile</li>
<li><a href="Equol.htm" tppabs="https://ptable.com/wiki/compounds/A/Equol" title="Equol">Equol</a></li>
<li><a href="Estradiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Estradiol" title="Estradiol">Estradiol</a></li>
<li>Ethinylestradiol</li>
<li><a href="Fulvestrant.htm" tppabs="https://ptable.com/wiki/compounds/A/Fulvestrant" title="Fulvestrant">Fulvestrant (ICI-182780)</a></li>
<li><span class="new">G-1</span></li>
<li><a href="Genistein.htm" tppabs="https://ptable.com/wiki/compounds/A/Genistein" title="Genistein">Genistein</a></li>
<li><span class="new">GPER-L1</span></li>
<li><span class="new">GPER-L2</span></li>
<li>Hydroxytyrosol</li>
<li><a href="Kepone.htm" tppabs="https://ptable.com/wiki/compounds/A/Kepone" title="Kepone">Kepone</a></li>
<li><a href="Niacin.htm" tppabs="https://ptable.com/wiki/compounds/A/Niacin" title="Niacin">Niacin</a></li>
<li><a href="Nicotinamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicotinamide" title="Nicotinamide">Nicotinamide</a></li>
<li><a href="Nonylphenol.htm" tppabs="https://ptable.com/wiki/compounds/A/Nonylphenol" title="Nonylphenol">Nonylphenol</a></li>
<li><a href="Oleuropein.htm" tppabs="https://ptable.com/wiki/compounds/A/Oleuropein" title="Oleuropein">Oleuropein</a></li>
<li><a href="Polychlorinated_biphenyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Polychlorinated_biphenyl" title="Polychlorinated biphenyl">PCBs</a> (<span class="new">2,2',5'-PCB-4-OH</span>)</li>
<li>Propylpyrazoletriol</li>
<li><a href="Quercetin.htm" tppabs="https://ptable.com/wiki/compounds/A/Quercetin" title="Quercetin">Quercetin</a></li>
<li><a href="Raloxifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Raloxifene" title="Raloxifene">Raloxifene</a></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Resveratrol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Resveratrol'" tppabs="https://ptable.com/wiki/compounds/A/Resveratrol" title="Resveratrol">Resveratrol</a></li>
<li><span class="new">STX</span></li>
<li><a href="Tamoxifen.htm" tppabs="https://ptable.com/wiki/compounds/A/Tamoxifen" title="Tamoxifen">Tamoxifen</a></li>
<li>Tectoridin</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Antagonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>CCL18</li>
<li><a href="Estriol.htm" tppabs="https://ptable.com/wiki/compounds/A/Estriol" title="Estriol">Estriol</a></li>
<li><span class="new">G-15</span></li>
<li><span class="new">G-36</span></li>
<li>MIBE</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Unknown</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Diethylstilbestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Diethylstilbestrol" title="Diethylstilbestrol">Diethylstilbestrol</a></li>
<li><a href="Zearalenone.htm" tppabs="https://ptable.com/wiki/compounds/A/Zearalenone" title="Zearalenone">Zearalenone</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div>
<dl><dt>See also</dt>
<dd>Receptor/signaling modulators</dd>
<dd>Estrogens and antiestrogens</dd>
<dd>Androgen receptor modulators</dd>
<dd>Progesterone receptor modulators</dd>
<dd>List of estrogens</dd></dl>
</div></td></tr></tbody></table></div><span>
</span>
<div role="navigation" class="navbox" aria-labelledby="Estrogen-related_receptor_modulators" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Estrogen-related_receptor_modulators" style="font-size:114%;margin:0 4em">Estrogen-related receptor modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>ERRα</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">6,3′,4′-Trihydroxyflavone</span></li>
<li><a href="Biochanin_A.htm" tppabs="https://ptable.com/wiki/compounds/A/Biochanin_A" title="Biochanin A">Biochanin A</a></li>
<li><a href="Bisphenol_AF.htm" tppabs="https://ptable.com/wiki/compounds/A/Bisphenol_AF" title="Bisphenol AF">Bisphenol AF</a></li>
<li><a href="Cholesterol.htm" tppabs="https://ptable.com/wiki/compounds/A/Cholesterol" title="Cholesterol">Cholesterol</a></li>
<li><a href="Daidzein.htm" tppabs="https://ptable.com/wiki/compounds/A/Daidzein" title="Daidzein">Daidzein</a></li>
<li><a href="Genistein.htm" tppabs="https://ptable.com/wiki/compounds/A/Genistein" title="Genistein">Genistein</a></li></ul>

<ul><li><i>Antagonists:</i> <a href="Diethylstilbestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Diethylstilbestrol" title="Diethylstilbestrol">Diethylstilbestrol</a></li>
<li>XCT-790</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>ERRβ</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">DY-131 (GSK-9089)</span></li>
<li><span class="new">GSK-4716 (GW-4716)</span></li></ul>

<ul><li><i>Antagonists:</i> 4-Hydroxytamoxifen (afimoxifene)</li>
<li><a href="Bisphenol_AF.htm" tppabs="https://ptable.com/wiki/compounds/A/Bisphenol_AF" title="Bisphenol AF">Bisphenol AF</a></li>
<li><a href="Diethylstilbestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Diethylstilbestrol" title="Diethylstilbestrol">Diethylstilbestrol</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>ERRγ</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <a href="Bisphenol_A.htm" tppabs="https://ptable.com/wiki/compounds/A/Bisphenol_A" title="Bisphenol A">Bisphenol A</a></li>
<li><span class="new">DY-131 (GSK-9089)</span></li>
<li><span class="new">GSK-4716 (GW-4716)</span></li></ul>

<ul><li><i>Antagonists:</i> 4-Hydroxytamoxifen (afimoxifene)</li>
<li><a href="Diethylstilbestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Diethylstilbestrol" title="Diethylstilbestrol">Diethylstilbestrol</a></li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div>
<dl><dt>See also</dt>
<dd><i>Receptor/signaling modulators</i></dd></dl>
</div></td></tr></tbody></table></div>













<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-08-09" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Diethylstilbestrol&oldid=971924834  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Diethylstilbestrol&oldid=971924834'" tppabs="https://en.wikipedia.org/wiki/?title=Diethylstilbestrol&oldid=971924834">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>